PROCEEDINGS ONE HUNDRED AND Nineteenth ANNUAL MEETING of the UNITED STATES
ANIMAL HEALTH ASSOCIATION Rhode Island Convention Center Providence, Rhode
Island October 22 28, 2015
snip...
II. C. USAHA JOINT SCIENTIFIC SESSION ABSTRACTS AND POSTERS
46
MANAGING CWD IN FARMED CERVIDS
Nicholas J. Haley
Diagnostic Medicine and Pathobiology, Kansas State University, Manhattan,
KS
Chronic wasting disease (CWD) is an efficiently transmitted spongiform
encephalopathy of cervids (e.g. deer, elk, and moose), and is the only known
prion disease affecting both free-ranging wildlife and captive animals. The
management of CWD in farmed cervids will require three avenues of research: 1)
the development of a sensitive live animal test, 2) the discovery and
implementation of a safe and effective vaccine strategy, and 3) with or without
a vaccine, the identification and cultivation of CWD-resistant cervids. The
antemortem detection of CWD and other prion diseases has proven difficult, due
in part to difficulties in identifying an appropriate peripheral tissue specimen
and complications with conventional test sensitivity. At present, biopsies of
the recto-anal mucosalassociated lymphoid tissues (RAMALT) have shown promising
sensitivity in various assays and are not impractical to collect in live
animals. Nasal brush collections have likewise proven both sensitive and
practical for identification of prion infections in humans, though in cervids
both rectal biopsy and nasal brush collection sensitivity is critically
dependent on stage of infection and genetic background. A blood test would be
ideal; however rudimentary assays currently in development have yet to be
evaluated blindly on naturally occurring populations or on a large scale.
Vaccine development is currently underway at several institutions, though an
effectively protective strategy has yet to be identified. Ultimately, genetic
resistance to CWD may be a critical corner piece in the management of CWD in
farmed cervids – an approach which has been used effectively to reduce the
incidence of scrapie in sheep worldwide. By exploiting resistant PrP alleles in
currently available white-tail and elk genetic pools, and searching various
isolated populations for evidence of additional resistance mechanisms, a
suitable approach to improving CWD resistance in farmed cervids may be
identified. Our research has specifically sought to develop an antemortem test
for CWD using amplification-based assays on collections from recent CWD
depopulations, while additionally using these assays to model CWD resistance in
cervid populations. Our findings from this research represent the early stages
in the management and ultimately eradication of CWD in farmed deer and
elk.
snip...
REPORT OF THE COMMITTEE ON CAPTIVE WILDLIFE AND
ALTERNATIVE LIVESTOCK
Chair: Peregrine Wolff, NV
Vice Chair: Julie Napier, NE
Thomas Albert, VA; Paul Anderson, MN; James Averill, MI; Kay Backues, OK;
Bill Barton, ID; Scott Bender, AZ; Warren Bluntzer, TX; Tom Bragg, NE; Rhonda
Brakke, IA; Deborah Brennan, MS; Sarah Cannizzo, OR; Beth Carlson, ND; Susan
Culp, TX; Donald Davis, TX; Barbara Determan, IA; Mark Drew, ID; John Fischer,
GA; Nancy Frank, MI; Richard French, NH; Tam Garland, TX; Robert Gerlach, AK;
Paul Gibbs, FL; Colin Gillin, OR; Michael Gilsdorf, MD; Chester Gipson, MD; Paul
Grosdidier, KS; Keith Haffer, SD; Greg Hawkins, TX; Bill Hawks, DC; Kristi
Henderson, IL; Terry Hensley, TX; Michael Herrin, OK; Linda Hickam, MO; Robert
Hilsenroth, FL; David Hunter, MT; John Huntley, WA; Russell Iselt, TX; Donald
Janssen, CA; Diane Kitchen, FL; Patrice Klein, MD; Todd Landt, IA; John
Lawrence, ME; Charles Lewis, IA; Travis Lowe, MN; Mark Luedtke, MN; Bret Marsh,
IN; David Marshall, NC; Chuck Massengill, MO; Robert Meyer, CO; Eric Mohlman,
NE; Yvonne Nadler, IL; Jeffrey Nelson, IA; Sandra Norman, IN; Dustin Oedekoven,
SD; Mitchell Palmer, IA; Janet Payeur, IA; William Pittenger, MO; Jewell
Plumley, WV; Justin Roach, OK; Jonathan Roberts, LA; Keith Roehr, CO; Susan
Rollo, TX; Shawn Schafer, OH; David Schmitt, IA; Dennis Schmitt, MO; Marc
Schwabenlander, MN; Andy Schwartz, TX; Charly Seale, TX; Laurie Seale, WI; Daryl
Simon, MN; Jonathan Sleeman, WI; David Smith, NY; Diane Stacy, LA; Kelly Straka,
MO; Manoel Tamassia, NJ; Robert Temple, OH; Lee Ann Thomas, MD; Brad Thurston,
IN; Jeff Turner, TX; Kathleen Turner, FL; Rick Wahlert, CO; Curt Waldvogel, OH;
Ray Waters, IA; Steve Weber, CO; Skip West, OK; Ellen Wiedner, FL; Margaret
Wild, CO; Kyle Wilson, TN; Nora Wineland, MO; Richard Winters, Jr., TX; Mary
Wood, WY; Glen Zebarth, MN.
The Committee met on October 27, 2015, at the Rhode Island Convention
Center in Providence, Rhode Island from 8:00 a.m. to 12:35 p.m. There were 39
members and 40 guests present. The one previous resolution from 2014 was
addressed in the Annual update for the Cervid Health Team, Fiscal year (FY)
2015.
Charly Seale presented the report of the Subcommittee on Farmed Cervidae.
The full report is found at the end of this report.
Presentations
Evaluation of a Novel Recombinant Protein Fusion Vaccine for CWD in Elk –
Preliminary Data
Mary Wood, Wyoming Game and Fish Department
Chronic wasting disease (CWD) is a fatal neurologic disease of cervids
which threatens both free-ranging and captive populations. Currently there are
minimal management options for limiting spread of CWD. We evaluated a novel
recombinant protein fusion vaccine developed by Pan-Provincial Vaccine
CAPTIVE WILDLIFE AND ALTERNATIVE LIVESTOCK
135
Enterprises (PREVENT), in elk. Thirty-eight female elk calves (Cervus
elaphus) were captured on the South Park Feedground in Western Wyoming and
transported to the Thorne-Williams Wildlife Research Center (TWRC). Calves were
divided randomly into two groups, control (n=19) and vaccine (n=19). All elk
were genotyped to determine Prnp codon 132 polymorphisms. Primary and booster
vaccines were given intramuscularly six weeks apart approximately 2-3 weeks
after arrival at the TWRC and yearly thereafter. Elk were challenged via natural
environmental exposure to CWD at the facility. Elk were monitored daily for
behavioral and physical signs of clinical CWD and were evaluated for CWD
infection via rectal biopsy. All elk with clinical CWD were humanely euthanized
and infection was confirmed via ELISA and immunohistochemistry. Both vaccinates
and controls developed clinical CWD, with vaccinates showing a shorter survival
time (p=0.014). This research is ongoing and further results are necessary
before final conclusions are made.
snip...
CAPTIVE WILDLIFE AND ALTERNATIVE LIVESTOCK
137
Rectal Biopsy as an Ante Mortem Assay for CWD: Diagnostic and Regulatory
Considerations
Tracy Nichols, USDA Wildlife Services, National Wildlife Research
Center
Summary:
A considerable amount of research has been done in both deer and elk
regarding rectal biopsy
High quality rectal biopsies are needed to have reliable results
Route and dose of CWD exposure likely influences disease incubation
period
Rectal biopsy has high specificity and moderate sensitivity that is
dependent upon disease progression and genotype
Disease progression and subsequent detection in the rectal mucosa is
influenced by genetics at codon 96 in WTD and at codon 132 in elk
CWD proliferates and trafficks faster in codon 96 GG WTD than in GS or SS
animals, making detection by rectal biopsy less reliable in GS or SS deer
Deer and elk with CWD prions present only in the retropharyngeal lymph
nodes often do not have positive rectal biopsies
Annual Update for the Cervid Health Team, Fiscal Year (FY) 2015
Randy Pritchard, US Department of Agriculture, Animal and Plant Health
Inspection Service, (APHIS) Veterinary Services (VS)
Voluntary Chronic Wasting Disease (CWD) Herd Certification Program The
APHIS National CWD Herd Certification Program (HCP) was implemented in 2014. It
is a voluntary Federal-State-industry cooperative program administered by APHIS
and implemented by participating States. The program provides uniform national
herd certification standards that minimize the risk of spreading CWD in farmed
cervid populations. Participating States and herd owners must comply with
requirements for animal identification, fencing, recordkeeping,
inspections/inventories, as well as animal mortality testing and response to any
CWD-exposed, suspect, and positive herds. APHIS monitors the Approved State HCPs
to ensure consistency with Federal standards through annual reporting by the
States. With each year of successful surveillance, participating herds will
advance in status until reaching five years with no evidence of CWD, at which
time herds are certified as being low-risk for CWD. Only captive cervids from
enrolled herds certified as low risk for CWD may move interstate. Currently, 30
States participate in the voluntary CWD Herd Certification Program; 29 have
Approved HCPs and one has Provisional Approved status. VS is working with the
remaining State to transition it to Approved status. FY2015 marks the second
year that Approved States have submitted their CWD HCP annual reports to APHIS.
APHIS is currently reviewing these reports.
Review of CWD Program Standards
The CWD Program Standards provide clarification and guidance on how to meet
CWD Herd Certification Program and interstate movement requirements.
REPORT OF THE COMMITTEE
138
VS committed to an annual review of the Program Standards by
representatives of the cervid industry and appropriate State and Federal
agencies. VS planned to perform a review in FY2015; however, this did not occur
due to the response to highly pathogenic avian influenza (HPAI). VS expects to
conduct a review in FY2016.
CWD in Farmed and Wild Cervids
Retrospective Epidemiology of CWD in Farmed Cervids
In response to a 2014 USAHA Resolution, VS asked States to include a
retrospective summary of the epidemiology of all positive herds with their
annual HCP reports for FY2015. Unfortunately, the response to HPAI delayed
completion of this summary. Five States reported information to date. A few
States indicated that they did not have the resources to devote to this request.
VS will continue to gather this data and to collect more comprehensive data in
the future.
Summary of CWD detections
As of September 30, 2015, CWD has been confirmed in wild deer and elk in 21
US States, and in farmed cervids in 16 States. In total, 23 States have
identified CWD in wild and/or farmed cervids. CWD has been reported in 70 farmed
cervid herds in the United States. Confirmation of the disease in three
free-ranging, wild white-tailed deer in Michigan in 2015 marked the first report
of CWD in the wild cervid population in this State.
FY2015 CWD Detections in Farmed Cervids
In FY2015, CWD was identified in eight farmed cervid herds: one whitetailed
deer breeding herd in Pennsylvania, one elk breeding herd in Utah (traced back
from a hunting facility in Utah), one white-tailed deer (WTD) breeding herd and
one WTD hunting preserve in Ohio (owned by the same producer), two WTD breeding
herds in Wisconsin, one WTD and elk herd in Texas, and a second WTD herd in
Texas (traced from the first positive herd in Texas). The positive animals in
Utah, Ohio, and Texas represented the first reported cases of CWD in captive
cervids in all three of these States. White-Tailed Deer Breeding Herd,
Pennsylvania
On October 6, 2014, the National Veterinary Services Laboratories (NVSL)
confirmed CWD in a 6-year-old doe from a captive WTD breeding facility in
Reynoldsville, Pennsylvania. The doe was euthanized and tested because she was
classified as a CWD-exposed animal that had previously resided in two trace back
exposed herds. This herd was assembled in 2013 through the purchase of 16
animals from other HCP-certified herds in Pennsylvania, and had been under
quarantine for receiving exposed animals from a trace back exposed herd. The
remaining herd of eight WTD was depopulated with Federal indemnity on February
18, 2015, and no additional positive animals were detected. USDA collected
samples for research purposes.
Elk Breeding Herd, Utah
On December 23, 2014, NVSL confirmed CWD in 3-year-old captive elk. The elk
had been at a hunting park located in northern Utah, where he had resided for
approximately 3 weeks prior to being hunter killed. All hunter-killed animals at
the hunt park are required to be tested for CWD, and this animal
CAPTIVE WILDLIFE AND ALTERNATIVE LIVESTOCK
139
was sampled through routine surveillance. The elk was traced back to its
herd of origin, and that facility was quarantined. The herd was assembled in
1999 with bulls, and later elk cows, that originated from Colorado. Historical
testing records for the herd were unavailable. The remaining 70 elk were
depopulated using Federal indemnity funds on March 3, 2015, and an additional 25
elk were confirmed as CWD-positive. USDA collected samples for research
purposes. White-Tailed Deer Hunting Preserve, Ohio
On October 22, 2014, NVSL confirmed CWD in a buck taken from a captive WTD
deer hunting preserve in Ohio. This was the first time that CWD had been
detected in Ohio. The preserve was tested as part of Ohio’s CWD monitoring
program. The herd had been under quarantine since April 2014 because it was a
trace-forward herd associated with a CWD-exposed herd in Pennsylvania. The
positive animal was traced to its herd of origin, a captive WTD breeding herd in
Pennsylvania, through DNA identity testing. On November 26, 2014, the Ohio State
Veterinarian issued an Order of Destruction for animals on the hunting preserve.
The State executed this Order on April 27-30, 2015. The herd of 224 WTD was
depopulated and no other positives were detected. USDA did not provide Federal
indemnity.
White-Tailed Deer Breeding Herd, Ohio
On March 31, 2015, NVSL confirmed CWD infection in a 5-year-old WTD doe
from a captive breeding herd in Holmesville, Ohio. The index animal was received
from a Wisconsin WTD farm in January 2013. The CWD-positive herd was owned by
the same individual as the Ohio hunt preserve that was found to be CWD positive
in October 2014. On May 22, 2015, NVSL confirmed a second positive case in the
same herd - a yearling WTD doe that was a natural addition in the same breeding
herd. The herd had been under quarantine since April 1, 2014 due to
epidemiological linkages with two WTD herds in Pennsylvania – one a positive
herd and the other a traceback exposed herd. USDA provided Federal indemnity and
depopulated this herd on June 15 and 16, 2015. USDA collected samples for
research purposes. NVSL confirmed CWD in 16 additional animals in the herd. Of
the 16 positives, one was natural addition and the rest were purchased
additions. The positive animals were purchased from February 26, 2013 through
September 24, 2013, except for one purchased in 2012. Eleven purchased additions
traced-back to three herds in Pennsylvania and four purchased additions traced
to three other herds in Ohio.
White-Tailed Deer Breeding Herd, Wisconsin
On October 6, 2014, NVSL confirmed CWD in a 2-year-old doe born in June of
2012 that died on a Richland County farm. The facility is within the CWD
management zone in Wisconsin. The remaining 51 deer were euthanized on November
20, 2014, and seven additional positives (all males born in 2012) were found.
Two of these seven were purchased additions with the last added to the herd in
January 2013. All sales from this herd were to shooting preserves. This premise
was double fenced and had been compliant in a herd certification program for
over ten years.
White-Tailed Deer Breeding Herd, Wisconsin
REPORT OF THE COMMITTEE
140
On June 19, 2015, NVSL confirmed CWD in a seven-year-old female WTD from a
breeding facility in Eau Claire County. The doe was a natural addition to this
breeding herd. This is the first positive CWD case, captive or wild, in this
county. The doe was found dead and was showing no clinical signs of CWD at the
time of death. Since 2003, this herd has tested 391 animals for CWD and all had
“not detected” results. In addition, 317 animals have tested “not detected” from
the associated hunting preserve over the same time period. A second positive
natural addition doe from this herd was confirmed positive by NVSL on September
10, 2015. Several escape episodes have occurred from this herd. The herd is
currently under quarantine and plans are underway for depopulation with State
indemnity.
White-Tailed Deer and Elk Breeding Herd, Texas
On June 30, 2015, NVSL confirmed CWD in a 2-year-old WTD buck from a
captive WTD and elk breeding herd in Medina County, Texas, approximately 500
miles from previously reported positive free-ranging mule deer in far West
Texas. This was the first time that the disease had been detected in farmed
cervids in the State. The index buck was born on the premises and found dead on
June 18, 2015. Over 40 high-risk deer (i.e., pen mates, dam, others) were
euthanized and tested after the index case was found. The NVSL confirmed CWD
infection in two of those deer. Interestingly, all three of the positive deer
identified to date on this premises have the same AI sire. However, the
significance of this finding is unclear. In the past five years, records
indicate that 130 WTD from 33 facilities moved into the positive herd and 838
WTD moved out of the positive herd to 147 different herds. One positive WTD was
found in one of these trace-out herds (see herd description below).
Additionally, 23 elk were also moved from this herd to another herd in TX in
2014. All trace-outs have been intrastate except for movements to two premises
in Mexico. Premises that have received deer from the index herd are under
movement restrictions. VS is collaborating with animal health authorities in
Mexico. VS paid indemnity and depopulated this herd on September 30, 2015, and
no additional positive animals were detected. USDA collected samples for
research purposes.
White-Tailed Deer Herd, Texas
On September 14, 2015 NVSL confirmed CWD from tissues from a WTD in Lavaca
County, Texas. This animal was a traceout from the first CWD positive herd from
June 30, 2015. Additional epidemiology is ongoing.
snip...
Chronic Wasting Disease Risk Perception: Why Can’t We All Just Get
Along?
Krysten Schuler, Animal Health Diagnostic Center, Cornell University,
College of Veterinary Medicine
Additional authors: Alyssa Wetterau, Elizabeth M. Bunting, and Hussni
Mohammed
Chronic wasting disease (CWD) is a disease of concern to agencies,
sportsmen, and businesses dependent on cervid species. However, disease risk
perceptions may vary considerably between groups on wildlife and agriculture
sides. We administered an online survey using Qualtrics survey software to the
state wildlife agency (n=20), state agriculture agency (n=20), federal (United
States Geological Survey (USGS), USDA) and other state agencies (n=9), academics
(n=5), sportsmen (n=45), and captive cervid farmers (n=13) between March 2013
and 2014 to gauge attitudes toward potential hazards for CWD transmission to
wild white-tailed deer or captive cervids. Of 15 hazards, the high-ranking risks
were CWD existing undetected in the wild >1 year, decreased testing without
subsidies, high wild deer densities, fence line contact, intrastate movement and
importation of captive deer. State wildlife and agriculture officials ranked
risks higher than other groups, with captive cervid farmers 50% below the
average. Of six identified
CAPTIVE WILDLIFE AND ALTERNATIVE LIVESTOCK
143
hazard pathways, importation of live cervids and escaped cervids was the
highest risk for the wildlife agency (72% probability of CWD introduction),
other agency and academic professionals (45%), and sportsmen (43%,) while the
agriculture agency was most concerned by wild deer migration with high deer
densities (46%). Captive cervid operators were threatened by importation of wild
deer parts and then infected carcasses or parts left on the landscape (29%).
Professional groups ranked generalized risks similarly, particularly for wild
deer, but varied on the most likely disease pathway scenario. These regulating
agencies also ranked risks higher than those in the captive cervid industry.
Recommendations from this study include reaching agreement that CWD is a problem
and strive for prevention and containment. Adequate funding by state and federal
agencies for wildlife health programs and stakeholder education, as well as
improved wild deer surveillance, would decrease CWD risks. The captive cervid
industry could investigate selfregulation or insurance options, in addition to
the USDA program. This information could be used to further investigate risk
management and communication strategies.
snip...
REPORT OF THE COMMITTEE
144
Modeling CWD Resistance in Vitro
Nicholas Haley, Department of Microbiology and Immunology, Midwestern
University
A review of the current science involving in vitro amplification assays
which can help predict transmissible spongiform encephalopathies (TSE)
resistance and how this modeling strategy may be utilized to manage CWD through
host resistance.
Committee Business:
The Committee received, discussed and voted on the following five
resolutions. The first four were approved and forwarded to the Committee on
Resolutions. The fifth did not pass.
1. Live Animal Testing for Chronic Wasting Disease
2. Chronic Wasting Disease Program Standards - Guidance on Responding to
CWD Positive Herds
3. Chronic Wasting Disease Testing Protocol for Wild Cervidae
4. Tuberculosis Testing Protocol for Farmed cervidae
5. External Review of APHIS-VS CWD Program (not approved).
There was not further business, and the meeting was adjourned.
CAPTIVE WILDLIFE AND ALTERNATIVE LIVESTOCK
145
REPORT OF THE SUBCOMMITTEE ON FARMED CERVIDAE
Co-chairs: Charly Seale, Exotic Wildlife Association Brett Marsh, Indiana
Board of Animal Health Paul Anderson, Minnesota Board of Animal Health The
Subcommittee on Farmed Cervidae met on October 26, 2015 at the Rhode Island
Convention Center in Providence, Rhode Island. The following committee members
were present: Shawn Schafer, ND; Eric Mohlman, NE; John Fischer, GA; David
Hunter, MT; Collin Gillin, OR; and Glen Zebarth, MN. Warren Bluntzer, TX and
Robert Meyer, WY were not able to attend. There were a total of 80 people in
attendance at the meeting.
Reports
Dr. Tracy Nichols, USDA-Animal Plant Health Inspection Service (APHIS),
Wildlife Services (WS), National Wildlife Research Center (NWRC) presented new
information on Ante Mortem Testing for Chronic Wasting Disease (CWD).
Dr. Nathan Shotts, Veterinary Reproduction and Genetics PLLC and Tom Van
Kleef, VERGE, presented on the Verge surgical procedure for Ante Mortem
CWD-Testing-Options and Implementation.
Dr. Walt Cook, Texas A&M University, presented the results of his
research on drug residues in white tailed deer.
Dr. Alecia Naugle and Dr. Randy Pritchard, USDA-APHIS-Veterinary Services
(VS), presented on recent cases of CWD in the United States, issues surrounding
the CWD Program Standards, protocols for dealing with CWD positive herds
including trace forward and trace back, current status of developing an approved
live test for CWD, and issues surrounding the use of the Dual Path Platform
(DPP) tuberculosis test in cervidae.
Four resolutions were drafted, discussed, voted upon and passed out of the
Subcommittee on Farmed Cervidae for subsequent consideration and possible action
by the full USAHA Committee on Captive Wildlife and Alternative Livestock. These
resolutions are as follows:
1. Live Animal Testing for Chronic Wasting Disease
2. Chronic Wasting Disease Program Standards - Guidance on Responding to
CWD positive Herds
3. Chronic Wasting Disease Testing Protocol for Wild Cervidae
4. Tuberculosis testing protocol for farmed cervidae
snip...
287 potent and efficacious for animals is imperative for quality patient
care. This includes ketamine, which is used for animal immobilization, sedation
and pain management. In some areas, ketamine is the only analgesic/anesthetic
agent available to the veterinary profession and additional restrictions on its
use would have a significant negative impact on animal health and welfare on a
global scale.
RESOLUTION:
The United States Animal Health Association (USAHA) opposes international
and domestic regulatory action, specifically changes in scheduling, that would
result in ketamine becoming more difficult, if not impossible, to obtain within
the United States by licensed veterinarians for the authorized treatment of
animals. The USAHA also requests that the Food and Drug Administration consider
this resolution as they develop their comments to the World Health Organization
Expert Committee.
*****
RESOLUTION NUMBER: 9 APPROVED
SOURCE: COMMITTEE ON CAPTIVE WILDLIFE AND ALTERNATIVE LIVESTOCK
SUBJECT MATTER: CHRONIC WASTING DISEASE PROGRAM STANDARDS - GUIDANCE ON
RESPONDING TO CHRONIC WASTING DISEASE POSITIVE HERDS
BACKGROUND INFORMATION:
There is a need to review, revise and update the protocols for how the
cervidae industry and state and federal agencies respond to chronic wasting
disease (CWD) positive herds, trace back herds and trace forward herds. There is
also a need to update and revise the protocols for how to release movement
restrictions and reinstate herds to the appropriate herd certification program
status. In order to (1) complete CWD investigations more quickly, (2) avoid
unnecessary depopulation of farmed cervidae herds, and (3) avoid unnecessarily
long quarantine periods, these protocols must include the use of live animal
tests for CWD such as the rectal biopsy (rectoanal mucosa-associated lymphoid
tissue (RAMALT)).
RESOLUTION:
The United States Animal Health Association urges the United States
Department of Agriculture, Animal and Plant Health Inspection Service,
Veterinary Services to amend the Chronic Wasting Disease (CWD) Program Standards
by deleting all language in Part B, “Guidance on Responding to CWD Affected
Herds” and rewrite Part B under the guidance of a working group of state and
federal regulatory officials and representatives from the farmed cervidae
industry.
*****
REPORT OF THE COMMITTEE
288
RESOLUTION NUMBER: 10 APPROVED SOURCE: COMMITTEE ON CAPTIVE WILDLIFE AND
ALTERNATIVE LIVESTOCK
SUBJECT MATTER: CHRONIC WASTING DISEASE TESTING PROTOCOL FOR WILD
CERVIDAE
BACKGROUND INFORMATION:
Over the last 15 years the United States Department of Agriculture (USDA),
Animal and Plant Health Inspection Service (APHIS), Veterinary Services (VS) and
state regulatory officials have worked to prevent and control the spread of
Chronic Wasting Disease (CWD).
Producers farming CWD susceptible species can only move their animals
interstate if they are in compliance with the CWD program set forth in 9 Code of
Federal Regulations (CFR) Parts 55 and 81 that states animals must originate
from herds with five years of CWD monitored status. State Wildlife agencies that
plan and execute elk restoration projects from one state to another are moving
CWD susceptible species interstate without following minimum interstate movement
requirements set for farmed cervidae. Instead, CFR 81.3 states the source
population be considered “low risk” by the receiving state and USDA-APHIS.
To date, over two dozen herds of wild elk have been captured and
transported to other states across the nation without following the Chronic
Wasting Disease protocol set forth in the CWD program for farmed cervidae. The
movement of CWD susceptible cervid species with unknown CWD status by state
wildlife agencies can undermine the success of CWD control programs that have
been in place in many states for more than a decade. CWD has been found in 23
states. Eight of the 23 states have detected CWD in the free-ranging deer
populations but not in the farmed cervid herds.
RESOLUTION:
The United States Animal Health Association urges the United States
Department of Agriculture, Animal and Plant Health Inspection Service,
Veterinary Services to work with stakeholders to develop a guidance document on
determining chronic wasting disease risk levels of source herds for interstate
cervid restoration projects.
*****
RESOLUTION NUMBER: 11 APPROVED
SOURCE: COMMITTEE ON CAPTIVE WILDLIFE AND ALTERNATIVE LIVESTOCK
SUBJECT MATTER: Live Animal Testing For Chronic Wasting Disease BACKGROUND
INFORMATION:
Detection of Chronic Wasting Disease (CWD) in live animals remains an
important component of CWD Prevention and Control Programs. The United
NOMINATIONS AND RESOLUTIONS
289
States Animal Health Association (USAHA) and the United States Department
of Agriculture (USDA) recognize this and have stated such for several years (see
USAHA resolutions 14 (2011), 16 (2011), 20 (2012), 13 and 23 combined (2012), 24
(2012), and 28 (2015), with associated USDA replies).
Notwithstanding the development and evaluation of the rectoanal
mucosa-associated lymphoid tissue (RAMALT) test, CWD program regulatory analysis
and actions continue to rely on post-mortem tissue collections, with
Immunohistochemistry (IHC) testing in the laboratory, in accordance with current
USDA CWD Program Standards.
This continues to impose significant adverse impacts on the industry, the
economies of local communities, and the regulatory agencies involved. Postmortem
testing also limits the data and information that can be gathered and used to
improve management and control of CWD.
The need for a successful live test option, with the accuracy and
sensitivity equal to current post-mortem testing, is critical. A rational
deployment of such a solution will require regulatory updates and guidelines to
account for live testing of white-tailed deer, in both a trace-forward /
traceback scenario, as well as in CWD Herd Certification and/or Management
Programs.
A group of veterinarians with specific white-tailed deer experience, led by
VERGE PLLC, has successfully developed an ante-mortem procedure to collect the
tissues required for IHC testing, as well as enzyme linked immunosorbent assay
and other approved test protocols. This solution, the VERGE procedure, provides
the same medial retropharyngeal lymph node (MRPLNs) tissues with negligible
morbidity or mortality, for the same regulatory lab tests as are currently in
use, thus virtually eliminating the concerns for sensitivity and accuracy
associated with live tests using other tissues or lab protocols.
Preliminary regulatory reviews indicate that the VERGE procedure may be
employed under 9 Code of Federal Regulations 55.8, as implemented by USDA CWD
Program Standards (May 2014). The VERGE group has done preliminary work on
implementation guidelines for an effective live test to allow integration of the
live test option into existing programs and standards for both
trace-forward/trace-back and herd certification and management programs, as well
as refinement and development work for rapid training and wide-spread deployment
to Industry.
RESOLUTION:
The United States Animal Health Association (USAHA) urges the United States
Department of Agriculture (USDA), Animal and Plant Health Inspection Service
(APHIS), Veterinary Services (VS) as well as state animal health officials to
continue and to expedite discussions and evaluation of ante-mortem collection
procedures for medial retropharyngeal lymph node (MRPLN) tissues for the live
testing for chronic wasting disease (CWD) in white-tailed deer. USAHA also urges
USDA-APHIS-VS to issue a VS
REPORT OF THE COMMITTEE
290
Guidance Document stating that ante-mortem collection procedures for MRPLN
tissues are acceptable and authorized in accordance with current federal
regulations (9 Code of Federal Regulations (CFR) 55 and 9 CFR 81) and existing
federal CWD Program Standards (MAY 2014).
*****
snip...
Chronic Wasting Disease Research and Updates in Colorado Michael Miller,
Colorado Division of Parks and Wildlife
Dr. Michael Miller, Colorado Division of Parks and Wildlife, led a brief
discussion on the implications of a recent study on chronic wasting disease
(CWD) host range. The Case Western study results, presented at an international
prion conference in May 2015, complement other efforts to assess human
susceptibility to chronic wasting disease that have been ongoing since the
mid-1990s. Findings from a variety of experimental and epidemiological studies
support messaging since the mid-1990s that human illness resulting from CWD
exposure appears unlikely. The new study’s results are consistent with other
previous and contemporary data suggesting a low probability of human prion
disease resulting from CWD exposure. Dr. Miller noted that even though human
illness seems unlikely, minimizing the occurrence of CWD and encouraging other
precautions for minimizing human exposure to CWD may be prudent. Trends observed
in Colorado since 2002 suggest increasing infection rates in affected mule deer
and elk herds, with the exception of one population unit intensively managed
through harvest in the early 2000s. Controlling CWD will likely need to rely on
hunting in order to remain politically, socially, and fiscally sustainable.
Consequently, early intervention, while infection rates are still low, may offer
the best opportunity to both suppress epidemics and minimize the likelihood of
hunters harvesting infected animals. Dr. Miller suggested that the timing and
approaches to CWD control may deserve more attention and reconsideration than
given in recent years.
Summary of Recent Chronic Wasting Disease Events in Texas Mitch Lockwood,
Texas Parks and Wildlife Department
Other contributing authors: Bob Ditmar Texas Parks and Wildlife Department,
Andy Schwartz, Texas Animal Health Commission
Introduction:
WILDLIFE DISEASES
513
3.9 million free-ranging white-tailed deer
700K white-tailed deer hunters
600K white-tailed deer harvested annually
$3.6 billion economic output for all hunting
$2.1 billion for deer hunting
1,300 deer breeding facilities
> 110,000 deer in breeding facilities
> 2,200 free-ranging deer moved annually through various permits
Texas Parks and Wildlife Department (TPWD) has been conducting chronic
wasting disease (CWD) surveillance throughout the state since 2002.
Biologists have collected more than 26,000 samples from hunter-harvested
deer, and others have collected more than 21,000 samples in order to meet TPWD
permitting requirements, totaling almost 48,000 samples. Additionally, Texas
Animal Health Commission (TAHC) has maintained a Voluntary CWD Herd
Certification Program since 1995.
In 2012, CWD was discovered in two mule deer samples from far West Texas
(Hueco Mountains) as a result of a targeted surveillance effort. This area is
directly adjacent to a region in New Mexico with documented CWD occurrence. To
date, five more positive samples have been obtained from this population through
hunter harvested mule deer, indicating a disease prevalence of 10%.
Mule deer and white-tailed deer are regulated by TPWD, while other
susceptible species (including elk) are regulated by the TAHC. This has
generated the need for enhanced coordination and communication between these two
agencies.
The TPWD/TAHC CWD Management Plan was developed by both agencies in
consultation with the state’s CWD Task Force. The Task Force is comprised of
wildlife biologists, deer and elk breeders, veterinarians and other
animal-health experts from TPWD, TAHC, Texas Veterinary Medical Diagnostic
Laboratory, Texas Department of State Health Services, Texas A&M College of
Veterinary Medicine, and USDA. The plan includes mandatory check stations for
susceptible species taken inside the CWD Containment Zone, which covers portions
of Hudspeth, Culberson, and El Paso counties. Artificial movement of deer is
prohibited in the CWD Containment Zone.
On June 30, 2015 a sample from a Medina County (area on border of southern
Edwards Plateau and northern South Texas Plains ecoregions) deer breeding
facility was confirmed positive for CWD. The index breeding facility
participated in TAHC’s voluntary CWD Herd Certification Program, and had tested
62 of 65 mortalities prior to June 2015 (60 not detected, two location results)
since permitted in 2006. There were a total of 136 adult deer in the inventory
on June 30, 2015, and the herd was considered to be relatively young.
During the previous five years, 107 deer were transferred from 30 deer
breeding facilities into the index facility. During that same period, 835 were
transferred from the index facility to 147 different facilities including 96
deer
REPORT OF THE COMMITTEE
514
breeding facilities, 46 release sites, three Deer Management Permit (DMP)
sites, and two sites in Mexico.
TPWD and TAHC immediately placed a temporary moratorium on movements of all
captive deer in the state, and TAHC placed a Hold Order on the 177 “Tier 1”
facilities. Since then, TPWD and TAHC worked with the CWD Task Force and
industry stakeholders to develop a plan to lift the moratorium on deer
transfers, which includes additional CWD testing requirements in deer breeding
facilities or on registered release sites. Additionally, TAHC has removed the
Hold Order for 120 facilities, leaving a total 57 facilities remaining under a
Hold Order as of October 16, 2015. Most deer breeding facilities were authorized
to transfer deer by August 24, 2015.
Depopulation at the index facility was initiated in July 28 and completed
on September 30, 2015. CWD was detected in a total of 4 (out of 136 adults)
white-tailed deer in the index facility, all of which were 2-year-old bucks that
were natural additions.
On September 15, 2015, CWD was confirmed in one of the trace-forward
facilities, from which 84 deer had transferred out to nine different facilities
(five deer breeding facilities, three release sites, and one nursing facility)
since it received deer from the index herd. This resulted in seven additional
Hold Orders being issued by TAHC, four of which have since been released. The
CWD-positive at the trace-forward facility was also a 2-year-old buck that was
born in the index facility.
In summary, CWD has been detected in a total of five captive white-tailed
deer in Texas, four of which were located in the index facility, and one was
located in a trace-forward facility. There are 36 deer from the 2-year-old
cohort originating in the index facility that are reported to be alive in seven
deer breeding facilities, and possibly as many as six deer from that cohort
still alive on release sites. Additionally, there are 33 deer that traced
through the index facility that are still alive in 15 deer breeding facilities,
and possibly as many as 51 trace-through deer are still alive on 24 different
release sites,
***and two tracethrough deer may still be alive in Mexico.
TPWD has intensified the statewide CWD surveillance efforts, with a goal to
collect samples from more than 8,000 hunter-harvested deer, including 300
samples within a 5-mile radius of the index facility. TAHC will continue to
pursue indemnity on exposed deer located in trace-forward facilities in an
attempt to conduct a more thorough epidemiological investigation. TPWD and TAHC
have committed to reevaluate movement qualification standards that apply to deer
breeding facilities and release sites following the 2015-16 hunting season. Both
agencies are exploring ante-mortem testing protocols, and will continue to seek
guidance from experts in the field.
WILDLIFE DISEASES
515
Epidemiology of Recent CWD Cases in Ohio
Susan Skorupski, USDA-APHIS-VS
Background
Ohio has had a voluntary Chronic Wasting Disease (CWD) Herd Certification
Program for all cervidae for at least 12 years. Ohio has 331 cervidae herds in
the CWD monitoring program with 256 at Certified level. In October 2012, Ohio
White Tail Deer rule became effective. It includes several categories of white
tail deer operations. Monitored herds cannot sell or give away animals and
includes hunting preserves. Under this rule, hunting preserves cannot move live
animals from the premises and must annually sample 30 animals or 30% of
harvested deer, based on the number of deer harvested during the previous year.
Herds with Status are herds enrolled in the CWD Certification Program but not
yet at certified level. Certified Status Herds are enrolled in the CWD
monitoring program and have reached certified status. Ohio has 135 Monitored
Herds, including 24 hunting preserves, 75 Herds with Status, and 256 Certified
Status herds.
Ohio’s approach to infected animals and associated animals and herds
Infected herd – herd where a CWD infected animal resided when the test positive
sample was collected. Herd quarantined.
Exposed herd – any herd where an animal that tested CWD positive has
resided within the five years before the CWD diagnosis. Whole herd
quarantined
Herd that contains an exposed animal – whole herd quarantined unless
epidemiology information suggests the animal is of lower risk of spreading
CWD.
Exposed animal – animal that was exposed to the CWD infected animal any
time during the five years prior to when the animal died or was euthanized and
sampled/tested positive for CWD.
Recent CWD History in Ohio
a. Pennsylvania traces
In the spring of 2014, Ohio received information on traces associated with
CWD positive cases in Pennsylvania. Three Ohio herds were designated as Exposed
herds because positive deer from infected herds in Pennsylvania had been in the
Ohio herds during the previous five years. Fifty Ohio herds received 256 exposed
deer from the five Pennsylvania herds and three Ohio exposed herds. Eighty-five
of those animals were tested with Not Detected results in Ohio herds. Sixty-six
animals were traced to Out of State herds. That leaves 101 animals either
standing in quarantined herds or not tested when they died or were harvested.
Eighteen herds/preserves remain under quarantine.
b. First CWD positive found in Ohio
On October 22, 2014, National Veterinary Services Laboratory (NVSL)
confirmed a CWD positive result for a 2.5-year-old buck killed at a hunting
preserve in Holmes County Ohio on October 2, 2014. The hunting preserve had been
under quarantine since April 1, 2014 because of Pennsylvania traces and was
required to do 100% sampling of harvested deer. The positive animal
REPORT OF THE COMMITTEE
516
had official identification tracing the animal to a CWD certified
Pennsylvania herd. Records including a Certificate of Veterinary Inspection
(CVI) indicate the animal moved to Ohio March 13, 2013. Genetic testing was
conducted to support the accuracy of the trace to the Pennsylvania herd. This
herd was depopulated without indemnity April 27-29, 2015. Two hundred
twenty-four animals were depopulated at owner expense and sampled for CWD. All
tests had Not Detected results for CWD. The premises was evaluated as a
minimally contaminated facility. No cervidae have been added to the premises at
this time.
The owner of the hunting preserve business also owns or is associated with
breeding herds at other locations in Holmes County.
c. Second positive premises in Ohio
A white tail deer breeding herd owned by the same person who owned the CWD
positive hunting preserve was designated as a positive herd in the spring of
2015. A CWD positive animal was sampled on March 12, 2015 and reported on March
25, 2015. The animal was a five-year-old whitetail doe purchased from a
Wisconsin herd in February 2013. A second CWD positive animal was reported from
this herd on May 22, 2015. This animal was a 1.5- year-old natural addition
doe.
This herd was initially established in the fall of 2012 with the purchase
of a CWD certified herd from the estate of a deceased owner. In the spring and
fall of 2013, additional animals were added from at least nine Ohio herds, one
Wisconsin herd, 17 Pennsylvania herds, and three Indiana herds. This herd had
been quarantined since April 1, 2014 because of traces from several CWD exposed
or positive herds in Pennsylvania, including the herd that was the source of the
CWD positive deer in the Ohio hunting preserve. It had received over 120 animals
from these herds.
On June 15 and 16, this herd was depopulated with federal indemnity.
Samples were collected for research purposes. Two hundred forty-one animals
including 44 fawns were euthanized, sampled and tested. Sixteen additional
positive were identified. They originated from five Ohio CWD certified herds and
four Pennsylvania CWD certified herds. One of the Ohio herds was the herd that
was used to initially establish this herd. One positive animal was over 60
months of age so that Ohio herd was not designated as an exposed herd. The other
three Ohio herds were quarantined as exposed herds.
Records reviews identified 334 exposed animals associated with Ohio exposed
herds. Forty-two Ohio herds containing these animals were quarantined. They have
remained under quarantine until the quarantined animal(s) are euthanized and
tested Not Detected for CWD or 60 months have passed since animals entered the
herd. From Ohio Exposed Herd 1, 56 animals moved to 21 Ohio herds and 83 animals
moved out of state. Twentyseven animals were either already dead and tested with
CWD Not Detected results or have since been tested with CWD Not Detected
results. From Ohio Exposed Herd 2, 76 animals moved to 16 Ohio herds and 94
animals moved out of state. Twenty-five animals were either already dead and
tested with
WILDLIFE DISEASES
517
CWD Not Detected results or have since been tested with CWD Not Detected
results. From Oho Exposed Herd 3, 21 animals moved to five Ohio herds and four
animals moved out of state. Seven animals were either already dead and tested
with CWD Not Detected results or have since been tested with CWD Not Detected
results. Ohio received two exposed animals from the exposed herd in Pennsylvania
associated with this case. In summary, 334 exposed animals were identified and
traced to 40 Ohio herds. Fifty-nine of those in Ohio have been tested with Not
Detected CWD results. One hundred eighty-one have been traced out of state and
94 are still standing in 26 quarantined herds/hunting preserves.
Ohio Exposed Herd 1 has been in the CWD Certification Program since
September 2003 and has an inventory as of 48 head over one-year-old. Ohio
Exposed Herd 2 has been in the CWD Certification Program since October 2003 and
has an inventory of 93 animals. Ohio Exposed Herd 3 has been in the CWD
Certification Program since February 2009 but started with a status date of May
2001 and has an inventory of 17 deer.
In addition, Ohio received reports of 72 exposed deer from out of state
(OOS) Exposed herds traced to 18 Ohio herds. Eighteen of those animals had moved
to out of state herds. Thirty animals were tested in Ohio with Not Detected
results. Twelve animals remain in Seven quarantined herds. The summary of all
traces associated with positive cases in Ohio and Pennsylvania in 2014 – 2015
are:
Total exposed animals traced to Ohio: 661
Total tested Not Detected: 176
Total animals traced to Out of State Premises: 265
Total premises initially quarantined: 87
Total premises remaining quarantined: 40
Total Hunting Preserves quarantined: 10
USDA Cervid Health Program Updates
Randy Pritchard, USDA-APHIS, Veterinary Services (VS)
Voluntary Chronic Wasting Disease (CWD) Herd Certification Program
The APHIS National CWD Herd Certification Program (HCP) was implemented in
2014. It is a voluntary Federal-State-industry cooperative program administered
by APHIS and implemented by participating States. The program provides uniform
national herd certification standards that minimize the risk of spreading CWD in
farmed cervid populations. Participating States and herd owners must comply with
requirements for animal identification, fencing, recordkeeping,
inspections/inventories, as well as animal mortality testing and response to any
CWD-exposed, suspect, and positive herds. APHIS monitors the Approved State HCPs
to ensure consistency with Federal standards through annual reporting by the
States. With each year of successful surveillance, participating herds will
advance in status until reaching five years with no evidence of CWD, at which
time herds are certified as being low-risk for CWD. Only captive cervids from
enrolled herds certified as low risk for CWD may move interstate. Currently, 30
States participate in the voluntary CWD
REPORT OF THE COMMITTEE
518
Herd Certification Program; 29 have Approved HCPs and one has Provisional
Approved status. VS is working with the remaining State to transition it to
Approved status. FY2015 marks the second year that Approved States have
submitted their CWD HCP annual reports to APHIS. APHIS is currently reviewing
these reports.
Review of CWD Program Standards
The CWD Program Standards provide clarification and guidance on how to meet
CWD Herd Certification Program and interstate movement requirements. VS
committed to an annual review of the Program Standards by representatives of the
cervid industry and appropriate State and Federal agencies. VS planned to
perform a review in FY2015; however, this did not occur due to the response to
highly pathogenic avian influenza (HPAI). VS expects to conduct a review in
FY2016.
CWD in Farmed and Wild Cervids
Retrospective Epidemiology of CWD in Farmed Cervids: In response to a 2014
USAHA Resolution, VS asked States to include a retrospective summary of the
epidemiology of all positive herds with their annual HCP reports for FY2015.
Unfortunately, the response to HPAI delayed completion of this summary. Five
States reported information to date. A few States indicated that they did not
have the resources to devote to this request. VS will continue to gather this
data and to collect more comprehensive data in the future. Summary of CWD
detections. As of September 30, 2015, CWD has been confirmed in wild deer and
elk in 21 US States, and in farmed cervids in 16 States. In total, 23 States
have identified CWD in wild and/or farmed cervids.
CWD has been reported in 70 farmed cervid herds in the United States.
Confirmation of the disease in three free-ranging, wild white-tailed deer
in Michigan in 2015 marked the first report of CWD in the wild cervid population
in this State.
FY2015 CWD Detections in Farmed Cervids: In FY2015, CWD was identified in
eight farmed cervid herds: one white-tailed deer breeding herd in Pennsylvania,
one elk breeding herd in Utah (traced back from a hunting facility in Utah), one
white-tailed deer (WTD) breeding herd and one WTD hunting preserve in Ohio
(owned by the same producer), two WTD breeding herds in Wisconsin, one WTD and
elk herd in Texas, and a second WTD herd in Texas (traced from the first
positive herd in Texas). The positive animals in Utah, Ohio, and Texas
represented the first reported cases of CWD in captive cervids in all three of
these States.
White-Tailed Deer Breeding Herd, Pennsylvania: On October 6, 2014, the
National Veterinary Services Laboratories (NVSL) confirmed CWD in a 6- year-old
doe from a captive WTD breeding facility in Reynoldsville, Pennsylvania. The doe
was euthanized and tested because she was classified as a CWD-exposed animal
that had previously resided in two trace back exposed herds. This herd was
assembled in 2013 through the purchase of 16 animals from other HCP-certified
herds in Pennsylvania, and had been under quarantine for receiving exposed
animals from a trace back exposed herd. The remaining herd of eight WTD was
depopulated with Federal indemnity on
WILDLIFE DISEASES
519
February 18, 2015, and no additional positive animals were detected. USDA
collected samples for research purposes.
Elk Breeding Herd, Utah: On December 23, 2014, NVSL confirmed CWD in
3-year-old captive elk. The elk had been at a hunting park located in northern
Utah, where he had resided for approximately three weeks prior to being hunter
killed. All hunter-killed animals at the hunt park are required to be tested for
CWD, and this animal was sampled through routine surveillance. The elk was
traced back to its herd of origin, and that facility was quarantined. The herd
was assembled in 1999 with bulls, and later elk cows, that originated from
Colorado. Historical testing records for the herd were unavailable. The
remaining 70 elk were depopulated using Federal indemnity funds on March 3,
2015, and an additional 25 elk were confirmed as CWD-positive. USDA collected
samples for research purposes.
White-Tailed Deer Hunting Preserve, Ohio: On October 22, 2014, NVSL
confirmed CWD in a buck taken from a captive WTD deer hunting preserve in Ohio.
This was the first time that CWD had been detected in Ohio. The preserve was
tested as part of Ohio’s CWD monitoring program. The herd had been under
quarantine since April 2014 because it was a trace-forward herd associated with
a CWD-exposed herd in Pennsylvania. The positive animal was traced to its herd
of origin, a captive WTD breeding herd in Pennsylvania, through DNA identity
testing. On November 26, 2014, the Ohio State Veterinarian issued an Order of
Destruction for animals on the hunting preserve. The State executed this Order
on April 27-30, 2015. The herd of 224 WTD was depopulated and no other positives
were detected. USDA did not provide Federal indemnity.
White-Tailed Deer Breeding Herd, Ohio: On March 31, 2015, NVSL confirmed
CWD infection in a 5-year-old WTD doe from a captive breeding herd in
Holmesville, Ohio. The index animal was received from a Wisconsin WTD farm in
January 2013. The CWD-positive herd was owned by the same individual as the Ohio
hunt preserve that was found to be CWD positive in October 2014. On May 22,
2015, NVSL confirmed a second positive case in the same herd -- a yearling WTD
doe that was a natural addition in the same breeding herd. The herd had been
under quarantine since April 1, 2014 due to epidemiological linkages with two
WTD herds in Pennsylvania – one a positive herd and the other a traceback
exposed herd. USDA provided Federal indemnity and depopulated this herd on June
15 and 16, 2015. USDA collected samples for research purposes. NVSL confirmed
CWD in 16 additional animals in the herd. Of the 16 positives, one was natural
addition and the rest were purchased additions. The positive animals were
purchased from February 26, 2013 through September 24, 2013, except for one
purchased in 2012. Eleven purchased additions traced-back to three herds in
Pennsylvania and four purchased additions traced to three other herds in
Ohio.
White-Tailed Deer Breeding Herd, Wisconsin:
On October 6, 2014, NVSL confirmed CWD in a 2-year-old doe born in June of
2012 that died on a Richland County farm. The facility is within the CWD
management zone in Wisconsin. The remaining 51 deer were euthanized on November
20, 2014,
REPORT OF THE COMMITTEE
520
and seven additional positives (all males born in 2012) were found. Two of
these seven were purchased additions with the last added to the herd in January
2013. All sales from this herd were to shooting preserves. This premises was
double fenced and had been compliant in a herd certification program for over
ten years.
White-Tailed Deer Breeding Herd, Wisconsin: On June 19, 2015, NVSL
confirmed CWD in a 7-year-old female WTD from a breeding facility in Eau Claire
County. The doe was a natural addition to this breeding herd. This is the first
positive CWD case, captive or wild, in this county. The doe was found dead and
was showing no clinical signs of CWD at the time of death. Since 2003, this herd
has tested 391 animals for CWD and all had “not detected” results. In addition,
317 animals have tested “not detected” from the associated hunting preserve over
the same time period. A second positive natural addition doe from this herd was
confirmed positive by NVSL on September 10, 2015. Several escape episodes have
occurred from this herd. The herd is currently under quarantine and plans are
underway for depopulation with State indemnity.
White-Tailed Deer and Elk Breeding Herd, Texas:
On June 30, 2015, NVSL confirmed CWD in a 2-year-old WTD buck from a
captive WTD and elk breeding herd in Medina County, Texas, approximately 500
miles from previously reported positive free-ranging mule deer in far West
Texas. This was the first time that the disease had been detected in farmed
cervids in the State. The index buck was born on the premises and found dead on
June 18, 2015. Over 40 high-risk deer (i.e., pen mates, dam, others) were
euthanized and tested after the index case was found. The NVSL confirmed CWD
infection in two of those deer. Interestingly, all three of the positive deer
identified to date on this premises have the same AI sire. However, the
significance of this finding is unclear. In the past five years, records
indicate that 130 WTD from 33 facilities moved into the positive herd and 838
WTD moved out of the positive herd to 147 different herds. One positive WTD was
found in one of these traceout herds (see herd description below). Additionally,
23 elk were also moved from this herd to another herd in Texas in 2014. All
trace-outs have been intrastate except for movements to two premises in Mexico.
Premises that have received deer from the index herd are under movement
restrictions. VS is collaborating with animal health authorities in Mexico. VS
paid indemnity and depopulated this herd on September 30, 2015, and no
additional positive animals were detected. USDA collected samples for research
purposes. White-Tailed Deer Herd, Texas: On September 14, 2015 NVSL confirmed
CWD from tissues from a WTD in Lavaca County, Texas. This animal was a traceout
from the first CWD positive herd from June 30, 2015. Additional epidemiology is
ongoing.
snip...
Cervid Health Program Budget
The Cervid Health Program includes the CWD herd certification program and
the cervid TB program. It is funded through the Equine, Cervid, and Small
Ruminant Line Item. In FY2015, the Cervid Health Program was appropriated $3.0
million by Congress for cervid health activities. This funding was allocated as
follows:
Indemnity − $1.1 million for CWD and cervid TB (an additional $230,000
was provided to support herd depopulation activities in Texas).
CWD Research − $200,000 to support USDA Wildlife Services (WS) research
for development of CWD live animal diagnostic testing.
Cervid Health Program − $1.2 million for general program support
(primarily field activities).
APHIS anticipates the FY2016 Cervid Health Program funding will remain at
FY2015 levels.
Committee Business:
One resolution was proposed by a committee member titled Chronic Wasting
Disease Testing Protocol for Wild Cervidae proposing the United States Animal
Health Association (USAHA) urge the USDA to amend CFR 81.3 (b); proposing wild
cervids captured for interstate movement and release, have two forms of
identification, one of which that is official identification, must be PrP
genotyped for chronic wasting disease resistance, tested for chronic wasting
disease using a rectal biopsy test. The committee discussed and debated the
terms and science related to this resolution proposal including that currently
there is no science indicating there are “genotype resistant” cervids to
acquiring the CWD prion. The term “resistant” is miss-leading. There are only
different cervid genotypes that acquire the infectious prions at different rates
and show clinical signs at variable rates, some at prolonged periods after
acquiring the prion or they are slow to accumulate detectable levels. Since all
infected animals would be presumed to be capable of shedding the prions into the
environment, genotypes with clinical “resistance” or prolonged indication of
clinical presentation of the disease, may well potentially be considered
prolonged shedders of the prion. Additionally, there was discussion put forth by
several committee members concerning the lack of regulatory validation of the
rectal biopsy test. Also, the test can only be used on young animals and there
is significant test sensitivity and specificity variability between cervid
species when using this test. A new motion to the proposed resolution was to
table this resolution, reword the resolution potentially to be a recommendation
for USDA to provide a guidance document to the states for surveillance of CWD on
interstate translocations of wild cervids. It was proposed that this new
resolution/recommendation be discussed during the Farmed Cervid Subcommittee and
forward then to the Committee on Captive Wildlife and
WILDLIFE DISEASES
523
Alternative Livestock. The motion was proposed by member Charlie Seale and
seconded by member Sean Shaffer which was passed by committee. The Committee on
Wildlife Diseases adjourned at 5:15 p.m.
snip...
NOMINATIONS AND RESOLUTIONS 291
RESOLUTION NUMBER: 13 APPROVED SOURCE: COMMITTEE ON SCRAPIE SUBJECT MATTER:
SCRAPIE RULE BACKGROUND INFORMATION:
While the Scrapie Eradication Program has been very successful in
decreasing the prevalence of scrapie in the United States, eradication has not
yet been achieved in sheep or goats. Improved traceability and surveillance are
needed to detect the last remaining cases of scrapie, proving to our trading
partners that the United States is scrapie-free thus adding approximately $50
million in export value. Mandatory identification of sheep has allowed slaughter
surveillance to be the key in reducing the prevalence of scrapie in sheep by
85%. Slaughter surveillance of goats has been problematic because currently only
50% of mature goats are officially identified at slaughter, making it impossible
to conduct effective surveillance. A proposed rule to amend 9 Code of Federal
Regulations Parts 54 and 79 has been published. This proposed rule addresses new
standards for official identification and traceability for goats as well as
other gaps in the regulation. To succeed in the eradication of scrapie, it is
imperative that this rule be promptly finalized after appropriate review and
consideration of comments.
RESOLUTION:
The United States Animal Health Association urges the United States
Secretary of Agriculture to publish a final scrapie rule in early 2016. The
proposed rule, which provides for improved traceability for goats and addresses
other gaps in the current regulation, is a critically important element needed
to achieve scrapie eradication in the United States.
*****
snip...
REPORT OF THE COMMITTEE ON SCRAPIE
Chair: Kristine Petrini, MN Vice Chair: Cheryl Miller, IN James Averill,
MI; Scott Bender, AZ; Deborah Brennan, MS; Minden Buswell, WA; Beth Carlson, ND;
John Clifford, DC; Walter Cook, TX; Stephen Crawford, NH; Susan Culp, TX;
Ignacio dela Cruz, MP; William Edmiston, TX; Anita Edmondson, CA; Dee Ellis, TX;
Keith Forbes, NV; Larry Forgey, MO; Michael Gilsdorf, MD; William Hartmann, MN;
Carl Heckendorf, CO; Amy Hendrickson, WY; Russell Iselt, TX; Paul Jones, AL;
Susan Keller, ND; Eileen Kuhlmann, MN; James Leafstedt, SD; Mary Lis, CT; Jim
Logan, WY; Shirley McKenzie, NC; Ronald Miller, PA; Elisabeth Patton, WI; Jewell
Plumley, WV; Justin Roach, OK; Suelee Robbe-Austerman, IA; Paul Rodgers, WV;
Susan Rollo, TX; Joan Dean Rowe, CA; Ben Smith, WA; Scott Stuart, CO; Diane
Sutton, MD; Manoel Tamassia, NJ; Jeff Turner, TX; Stephen White, WA; Nora
Wineland, MO; David Winters, TX; Cindy Wolf, MN.
The Committee met on October 27, 2015 in Room 553 of the Rhode Island
Convention Center in Providence, Rhode Island from 9:00 a.m. to 12:06 p.m. There
were 18 members and 20 guests present.
Time-Specific Paper
Dr. Diane Sutton, presented a time-specific paper on the Newly Published
Proposed Revisions to Scrapie Rules 9 CFR, parts 54 and 79. Dr. Sutton
summarized the changes and explained the process for submitting comments. The
Committee discussed some of the highlights of the proposed changes. A full
summary is included at the end of this report.
Presentations and Reports
USDA-APHIS Scrapie Program Update and Scrapie Surveillance Projects Diane
Sutton, USDA-APHIS, Veterinary Services (VS)
Scrapie Eradication Program Results
The National Scrapie Eradication Program continued to make progress in
FY2015.
At the end of FY2014, the percent of cull sheep found positive at
slaughter and adjusted for face color was 0.018 percent and is currently at
0.004 percent for FY 2015. This measure has decreased by 80 percent compared to
FY2014 and by 98 percent compared to FY2003.
Three source flocks and three infected flocks were designated in FY2014.
One infected and three source flocks have been designated in FY2015, a decrease
of 30 percent.
In November 2014, the first positive goat found through regulatory
scrapie slaughter surveillance (RSSS) was identified. Based on the goats sampled
at slaughter to date, the prevalence of scrapie in US cull goats (2003 –
SCRAPIE
343
2015) was 0.0037 percent with an upper 95 percent confidence limit of
0.0097 percent.
In FY2015 there was a decrease in the number of States meeting their
sampling minimums for sheep and goats. This was likely due in part to the impact
of highly pathogenic avian influenza (HPAI) response on resources.
Slaughter Surveillance
As of September 30, 2015, 40,862 animals were sampled for scrapie testing
in FY2015:
• 38,671 RSSS samples and 2,191 on-farm samples;
• Of which 33,698 were sheep and 7,164 were goats.
Scrapie Surveillance Plan
Implementation FY2016
o States with RSSS collection sites will continue to sample all targeted
sheep and goats.
o The annual State-of-origin sampling minimum for sheep is 20 percent of
the number required to detect a scrapie prevalence of 0.1 percent with 95
percent confidence or 1 percent of the breeding flock in the State, whichever is
less. The objective is to sample sufficient sheep in a 5-year period to detect a
scrapie prevalence of 0.1 percent with 95 percent confidence or 5 percent of the
breeding flock in the State, whichever is less.
o The annual State-of-origin sampling minimum for goats is determined based
on the States’ goat scrapie case incidence.
o If a State has not had a goat scrapie case in the previous ten years, its
annual goat sampling minimum is its prorated share of 3,000 samples, based on
its proportion of the US goat population as determined by the National
Agricultural Statistics Service (NASS) Sheep and Goat annual report.
o If a State has had a goat scrapie case in the previous ten years, its
annual goat sampling minimum is determined using the same method as is used for
determining its annual sheep sampling minimum.
Note: These are minimums. Plan is to continue to collect samples from the
maximum number of targeted animals given the available budget.
ID Compliance:
All scrapie positive animals in FY2015 were traced back to their flock of
origin.
Proposed Rules Planned for Publication:
VS published revisions to nine Code of Federal Regulations (CFR) parts 54
and 79. The proposed changes are intended to improving the effectiveness and
cost efficiency of surveillance and to increase animal identification compliance
by addressing gaps in identification and by requiring States to meet reasonable
surveillance targets to remain consistent States. States must meet these targets
for VS to demonstrate geographically appropriate surveillance to meet the
criteria for freedom and have confidence that all of the remaining cases have
been found.
REPORT OF THE COMMITTEE
344
The rule would propose to:
o Give the APHIS Administrator authority to relieve requirements for sheep
and goats exposed to scrapie types, such as Nor98-like, that do not pose a
significant risk of transmission;
o Increase flexibility in how investigations can be conducted and allow the
epidemiology in a specific flock to be given more consideration in determining
flock and animal status;
o Add a genetic-based approach to regulation;
o Make goat identification requirements similar to those for sheep to
support ongoing slaughter surveillance in goats (no changes will be made in the
consistent State requirements regarding identification of goats in intrastate
commerce);
o Tighten the definition of slaughter channels;
o Expand the individual identification requirement to all sexually intact
animals unless moving as a group/lot (allows mixed-source groups moving in
slaughter channels at under 18 months);
o Limit the use of tattoos and implants to animals not moving through
markets and not in slaughter channels; and
o Reduce recordkeeping requirements by making them similar to the current
uniform methods and rules compliance guidance. APHIS is also revising its
scrapie import regulations to bring them more in line with the OIE scrapie
chapter. This will ensure that we meet OIE criteria for free status and prevent
the reintroduction of scrapie after free status is achieved.
Scrapie Flock Certification Program (SFCP) Implementation of the revised
Scrapie Flock Certification Program (SFCP) in FY 2014 has increased the efficacy
of the program while reducing program costs.
At the end of FY2015 there were 441 producers enrolled in the
program.
TSE: An Update
Linda Detwiler, Department of Pathobiology and Population Medicine,
Mississippi State University, College of Veterinary Medicine Dr. Detwiler
reviewed and discussed recent transmissible spongiform encephalopathy research
relevant to scrapie.
Update on Scrapie Research from the Animal Disease Research Unit David
Schneider, Animal Disease Research Unit, Agricultural Research Service (ARS),
USDA
The USDA-ARS unit in Pullman, Washington, conducts an integrated research
program involving studies on scrapie diagnostics, the role of prion protein
(PRNP) genetics, and modes of transmission in domestic sheep and goats. In this
update, we report on a comparison between sheep and goats on factors that affect
the diagnostic quality of rectal biopsy; progress on determination of the role
of PRNP genetics on the susceptibility, disease progression, and impact on
diagnostics in goats inoculated with classical
SCRAPIE
345
scrapie; progress in evaluating potential modes of transmission for
atypical (Nor98-like) scrapie in sheep and classical scrapie via goat’s milk;
and use of mouse models to discriminate sheep and goats with classical scrapie
versus experimental chronic wasting disease.
Biopsy of the rectal mucosa is a sensitive and safe technique used
worldwide in the live-animal diagnosis of classical scrapie infection in sheep
and goats, but which is sometimes limited when biopsy samples contain
insufficient follicles. Reported rates of biopsies with insufficient follicles
have ranged from 3% to 33%, with a significantly higher rate reported in goats
and indicating the number of follicles may depend on both procedural and animal
factors. Using live-animal biopsies obtained from a cohort of research sheep and
goats, we determined that laboratory handling had a minor effect on the number
of the follicles observed in each section. The most important factor was the
animal’s age at the time of biopsy, decreasing at a steady rate of 13 percent
per year during the first four years of the animal’s life. There was no left
versus right side difference in the age-related decline in follicle number and
the findings were the same between sheep and goats.
Regarding prion protein genetics, we continue to monitor goats of different
genotypes orally inoculated at birth with classical scrapie prions derived from
naturally infected goats. Goats with the highly susceptible genotype all
developed clinical disease within 24 months. Goats with the less susceptible or
long incubation genetics (S146 or K222) have remained clinically normal with no
evidence of prions in rectal biopsy tissues. These goats will be monitored for
the duration of the natural lifespan. In addition, a related study was completed
which demonstrates a doubly prolonged incubation period in inoculated goats
bearing the GS127 polymorphism.
Regarding our studies on modes of prion transmission, we very recently
completed and are finalizing analyses for a 7-year study on Nor98-like scrapie
in breeding ewes. Ewes were experimentally inoculated with brain homogenate
obtained from a US sheep with clinical Nor98-like scrapie. Recipient ewes were
bred annually to examine the placenta for evidence of a transmissible agent. One
recipient ewe developed an unrelated disease in her fifth year of scrapie
incubation. At postmortem examination, a Nor98-like pattern of misfolded prion
protein, PrP-Sc, accumulation was observed. Similar findings were recently
confirmed through postmortem examination of the other three ewes in the seventh
year of scrapie incubation. These results confirm that inoculation of these ewes
was successful. Not all placental tissue analyses have yet been completed, but
there has been no evidence of placental accumulation of PrP-Sc out to the sixth
year of infection.
We have recently confirmed that the classical scrapie prions which
accumulate in the placenta of goats are infectious to sheep. Similarly,
transmission to sheep has also occurred via the milk of infected goats. Thus,
both the placenta and milk of infected goats are significant transmission risks
to sheep.
Finally, we are nearing the completion of a study to determine if
transgenic mice can be used to differentiate the origin of prions in new cases
of scrapie
REPORT OF THE COMMITTEE
346
disease in sheep and goats raised in regions with endemic chronic wasting
disease (CWD) in cervids. The results show that transgenic mice bearing a
susceptible prion protein are readily susceptible to classical scrapie prions
derived from naturally infected sheep and goats but not to CWD prions derived
from naturally infected cervids. The converse was true for transgenic mice
bearing a susceptible cervid prion protein. Both types of mice were only
intermediately susceptible to CWD prions derived from experimentally infected
sheep. Thus, to date, the results suggest this bioassay model can discriminate
between these sources of prions in new cases of prion disease in small ruminants
from regions in which CWD is endemic in cervid populations.
Committee Business:
The Committee reviewed its mission statement and no alterations were
suggested. There was a discussion about whether the Committee on Scrapie and the
Committee on Sheep and Goats should be combined. The Committee members indicated
that at this time the two committees should remain separate.
The Committee reviewed its 2014 Resolution that urged the Secretary of
Agriculture to quickly publish and finalize the proposed rule amending 9 CFR
Parts 54 and 79. This proposed rule is now published and open for public
comment. The Committee passed a new resolution urging the Secretary of
Agriculture to promptly publish a final scrapie rule in early 2016 following the
appropriate review and comment period.
Note: Prior to the Committee on Scrapie meeting the following presentation
was given by Dr. Diane Sutton as part of the National Scrapie Oversight Board
meeting. A summary is included below supplemental to the Committee Report.
SFCP Participation
As of September 30, 2015 there were 441 participating flocks in the
SFCP.
o 277 Select Monitored
o 142 Export Monitored
o 22 Export Certified
In FY2015 four Export Monitored flocks advanced to Export
Certified.
48 sheep breeds and 17 goat breeds are represented in the SFCP.
As of September 30, 2015 there are active State SFCP boards in nine
States.
Canada’s Import Requirements
APHIS still anticipates a change in Canada’s import requirements, exact
timeline of publication of new requirements not yet determined.
The change will be an increase in the minimum time in status in the
Export Category for eligibility to import US sheep or Goats into Canada.
Export Monitored Flock FY 2015 Review
Export Monitored flocks in Standard or Alternative two sampling protocols
must meet sampling thresholds to reach six years of status (Standard=15;
Alternative 2=at least 50% foundation flock). In June 2015 Export
SCRAPIE
347
Monitored flocks with six or more years of status were reviewed. Ninety-six
flocks were reviewed, and of these:
o APHIS identified 28 flocks with six or more years of status that had not
met the sampling threshold;
o The status dates for these flocks were reset to five years; and
o Notification letters were sent to producers explaining their new status
dates and steps they can take to regain six years of status by January 1, 2016.
APHIS will continue to monitor flocks that are approaching six years. They
must meet threshold and notify those that need to take action to maintain their
status date.
Select Category
Participation in the Select category was lower in FY2015 than in
FY2014.
APHIS’ goal in FY2016 is to increase participation in this category,
thereby increasing the SFCP contribution to scrapie on-farm surveillance.
APHIS will also review Select Monitored flocks in FY2016 for compliance
with sampling requirements.
SFCP Standards
In FY2015, APHIS revised the SFCP Standards. The revised standards are
currently in clearance and are expected to be published in FY2016.
Updates to the SFCP Standards included the following items:
In the Select category, animals collected through Regulatory Scrapie
Slaughter Surveillance (RSSS) will count toward the sampling requirement if at
least ten animals are collected through RSSS in the same sampling period.
Sampling requirements in genetically resistant Export Monitored flocks
following the Standard sampling protocol: if there are no genetically
susceptible animals in the flock (i.e. the flock is composed entirely of QR/RR
ewes, RR rams, and no goats), the annual, 6-year, and 7-year sampling
requirements are waived (assuming all other sampling requirements are
met).
Criteria for exempting lambs born in genetically resistant flocks from
genotyping for Standard and Alternative 1 sampling protocol: if there are no
genetically susceptible animals in the flock and the owner only has mature RR
rams on the premises from that point forward lambs do not need to be genotyped.
Note: these conditions will be confirmed at each subsequent annual inspection,
and if an inspector believes at any time that one or more of the animals in the
flock may be a QQ animal, the inspector will require that the animal(s) be
officially genotyped.
How to treat “Lost to Inventory” animals in Export Monitored flocks
following the Alternative 1 sampling protocol:
o The flock owner may elect to switch to the standard sampling protocol,
and the flock’s status date will be reset to the lesser of the flock’s current
status date or 12 months of status for each test eligible animal sampled and
must meet the additional sampling
REPORT OF THE COMMITTEE
348
requirements of the standard sampling protocol to retain more than five
years in status; or
o The flock owner may elect to stay in the Alternative 1 category, and the
flock’s status date will be reset to the date the VS office was notified (or the
lost to inventory animal became known to the VS office) that the animal was lost
to inventory.
Animals from Inconsistent States not in slaughter channels must be from
either an Export Monitored/Export Certified flock or from a Select Monitored
flock in which it was born. There are no changes for animals in slaughter
channels.
Retesting animals to meet the annual sampling requirement:
o If a flock following the Standard sampling protocol has live-animal
tested all genetically susceptible test eligible animals at least once and must
test an additional animal to meet the annual sampling requirement, previously
tested animals can be repeat live-animal tested.
o If all genetically susceptible animals in the flock have been live animal
tested four times, the annual sampling requirement is waived.
Export category flocks must report the use of milk/colostrum from a lower
status flock.
Animals tested within 12 months of another animal being “Lost to
Inventory” can meet the lost to inventory sampling requirement in Export
Certified flocks if the flock had already tested 30 animals (this does not apply
to “Found Dead” animals).
How to treat previously live-animal tested “Found Dead” and “Lost to
Inventory” animals in Export Monitored flocks:
o Lost to inventory – if the animal had been tested in the previous 12
months, no change in status and no additional animals need to be tested (and if
the flock is following the Alternative 1 sampling protocol it does not have to
switch to the Standard sampling protocol).
o Found dead – APHIS will determine if the animal reasonably could have
been sampled. If so, the animal will be treated as any other found dead. If not
the animal is considered lost to inventory and will treated the same as other
lost to inventory animals.
348
SCRAPIE
349
REVIEW AND DISCUSSION OF NEWLY PUBLISHED REVISIONS TO SCRAPIE RULES 9 CFR,
PARTS 54 AND 7
Diane Sutton
USDA-APHIS-Veterinary Services (VS)
Overview
The US Department of Agriculture’s (USDA) Animal and Plant Health
Inspection Service (APHIS) is proposing changes to its existing scrapie
regulations. Scrapie is a degenerative and eventually fatal prion disease of
sheep and goats, and APHIS regulations help prevent its spread and support its
eventual eradication.
This is a synopsis of the proposed rule and should not be considered
definitive. Please read the entire proposed rule
to review all the proposed changes as well as APHIS’ reasons for the
proposed changes. Also, please read the draft “Scrapie Program Standards, Volume
1: National Scrapie Eradication Program” which is also posted at the link above.
The rule proposes to:
1. Remove the low-risk commercial goat exemption and treat sheep and goats
the same with respect to official identification requirements, the only
differences are the allowed state exemptions which have not been changed.
2. Simplify the way the identification and movement requirements are
presented and clarify the requirements. Also, adds tag replacement and use
requirements from the ADT rule. Recommend reading proposed §79.2 and 79.3 in
their entirety.
3. Add “Free” to “Scrapie Flock Certification Program” to read “Scrapie
Free Flock Certification Program”
4. Change the noncompliant definition so that it now reads: Noncompliant
flock. (1) Any source, infected, or exposed flock or flock under investigation
whose owner declines to enter into a flock plan or post-exposure management and
monitoring plan agreement within 30 days of being so designated, or whose owner
is not in compliance with either agreement;
(2) Any exposed flock or flock under investigation whose owner fails to
make animals available for testing within 60 days of notification, or as
mutually agreed, or whose owner fails to submit required postmortem
samples;
(3) Any flock whose owner has misrepresented, or who employs a person who
has misrepresented, the scrapie status of an animal or any other information on
a certificate, permit, owner statement, or other official document within the
last 5 years; or
(4) Any flock whose owner or manager has moved, or who employs a person who
has moved, an animal in violation of this chapter within the last 5 years.
5. Remove concept of “separate contemporary lambing group”.
REPORT OF THE COMMITTEE
350
6. Change certificate to Interstate Certificate of Veterinary Inspection
(ICVI). See proposed § 79.5 for ICVI requirements. Adds requirement for breeding
animals that official genotype be included on the ICVI if known.
7. Change definition of flock sire to read: Flock sire. A sexually intact
male animal that has produced offspring in the preceding 12 months or that was
used for breeding during the current breeding cycle.
8. Change definition of scrapie positive animal to add ELISA
Scrapie-positive animal. An animal for which a diagnosis of scrapie has been
made by the National Veterinary Services Laboratories or another laboratory
authorized by the Administrator to conduct scrapie tests in accordance with this
chapter, through:
(1) Histopathological examination of central nervous system (CNS) tissues
from the animal for characteristic microscopic lesions of scrapie;
(2) The use of proteinase-resistant protein analysis methods including but
not limited to immunohistochemistry, and/or ELISA, and/or western blotting on
CNS and/or peripheral tissue samples from a live or a dead animal for which a
given method or combination of methods has been approved by the Administrator
for use on that tissue;
(3) Bioassay;
(4) Scrapie associated fibrils (SAF) detected by electron microscopy;
or
(5) Any other test method approved by the Administrator in accordance with
§54.10 of this chapter.
9. Add the concept of “classification or reclassification investigation”
and moves details for conducting them to the APHIS website in the program
standards. See proposed § 79.4 and the draft program standards for more
information.
Classification or reclassification investigation. An epidemiological
investigation conducted or directed by a DSE for the purpose of designating or
redesignating the status of a flock or animal. In conducting such an
investigation, the DSE will evaluate the available records for flocks and
individual animals and conduct or direct any testing needed to assess the status
of a flock or animal. The status of an animal or flock will be determined based
on the applicable definitions in this section and, when needed to make a
designation under § 79.4 of this chapter, official genotype test results,
exposure risk, scrapie type involved, and/or results of official scrapie testing
on live or dead animals
10. Changes definition of destroy, removes slaughter option for indemnified
animals
Destroyed. Euthanized and the carcass disposed of by means authorized by
the Administrator that will prevent its use as feed or food,
SCRAPIE
351
or moved to a quarantined research facility if the movement has been
approved by the Administrator.
11. Change exposed animal definition:
a. Adds embryo explicitly
b. Sets criteria for setting date of infection
c. Adds concept of further designation based on genotype and exposure
risk.
Exposed animal. Any animal or embryo that: (1) Has been in a flock or in an
enclosure off the premises of the flock with a scrapie-positive female animal,
(2) resides in a noncompliant flock, or (3) has resided on the premises of a
flock before or while it was designated an infected or source flock and before a
flock plan was completed. An animal shall not be designated an exposed animal if
it only resided on the premises before the date that infection was most likely
introduced to the premises as determined by a Federal or State representative.
If the probable date of infection cannot be determined based on the
epidemiologic investigation, a date 2 years before the birth of the oldest
scrapie-positive animal(s) will be used. If the actual birth date is unknown,
the date of birth will be estimated based on examination of the teeth and any
available records. If an age estimate cannot be made, the animal will be assumed
to have been 48 months of age on the date samples were collected for scrapie
diagnosis. Exposed animals will be further designated as genetically resistant
exposed sheep, genetically less susceptible exposed sheep, genetically
susceptible exposed animals, or low-risk exposed animals. An animal will no
longer be an exposed animal if it is redesignated in accordance with §
79.4.
12. Redefine exposed flock (divides old definition into Flock Under
Investigation and Exposed Flock and references redesignation section: Exposed
flock. (1) Any flock that was designated an infected or source flock that has
completed a flock plan and that retained a female genetically susceptible
exposed animal; (2) Any flock under investigation that retains a female
genetically susceptible exposed animal or a suspect animal, or whose owner
declines to complete genotyping and live-animal and/or post-mortem scrapie
testing required by the APHIS or State representative investigating the flock;
or (3) Any noncompliant flock or any flock for which a PEMMP is required that is
not in compliance with the conditions of the PEMMP. A flock will no longer be an
exposed flock if it is redesignated in accordance with § 79.4 of this
chapter.
Flock under investigation. Any flock in which an APHIS or State
representative has determined that a scrapie-suspect animal, high-risk animal,
or scrapie-positive animal resides or may have resided. A flock will no longer
be a flock under investigation if it is redesignated in accordance with § 79.4
of this chapter.
REPORT OF THE COMMITTEE
352
13. Add definitions for genetically less susceptible exposed sheep,
genetically resistant exposed sheep, genetically resistant sheep, genetically
susceptible animal, and genetically susceptible exposed animal.
Genetically less susceptible exposed sheep. Any sheep or sheep embryo that
is:
(1) An exposed sheep or sheep embryo of genotype AA QR, unless it is
epidemiologically linked to a scrapie-positive RR or AA QR sheep or to a scrapie
type to which AA QR sheep are not less susceptible where Q represents any
genotype other than R at codon 171; or
(2) An exposed sheep or sheep embryo of genotype AV QR, unless it is
epidemiologically linked to a scrapie-positive RR or QR sheep, to a flock that
the DSE has determined may be affected by valine associated scrapie (based on an
evaluation of the genotypes of the scrapie-positive animals linked to the
flock), or to another scrapie type to which AV QR sheep are not less susceptible
where Q represents any genotype other than R at codon 171 and V represents any
genotype other than A at codon 136; or
(3) An exposed sheep or sheep embryo of a genotype that has been exposed to
a scrapie type to which the Administrator has determined that genotype is less
susceptible.
Genetically resistant exposed sheep. Any exposed sheep or sheep embryo of
genotype RR unless it is epidemiologically linked to a scrapie-positive RR sheep
or to a scrapie type to which RR sheep are not resistant.
Genetically resistant sheep. Any sheep or sheep embryo of genotype RR
unless it is epidemiologically linked to a scrapie-positive RR sheep or to a
scrapie type that affects RR sheep.
Genetically susceptible animal. Any goat or goat embryo, sheep or sheep
embryo of a genotype other than RR or QR, or sheep or sheep embryo of
undetermined genotype where Q represents any genotype other than R at codon
171.
Genetically susceptible exposed animal. Excluding low-risk exposed animals,
any exposed animal or embryo that is also: (1) A genetically susceptible
animal.
(2) A sheep or sheep embryo of genotype AV QR that is epidemiologically
linked to a scrapie-positive RR or QR sheep, to a flock that the DSE has
determined may be affected by valine associated scrapie (based on an evaluation
of the genotypes of the scrapie-positive animals linked to the flock), or to a
scrapie type to which AV QR sheep are susceptible where Q represents any
genotype other than R at codon 171 and V represents any genotype other than A at
codon 136.
(3) A sheep or sheep embryo of genotype AA QR that is epidemiologically
linked to a scrapie-positive RR or AA QR sheep or to
SCRAPIE
353
a scrapie type to which AA QR sheep are susceptible where Q represents any
genotype other than R at codon 171; or
(4) A sheep or sheep embryo of genotype RR that is epidemiologically linked
to a scrapie-positive RR sheep or to a scrapie type to which RR sheep are
susceptible.
14. High-risk animal redefined as. The female offspring or embryo of a
scrapie-positive female animal, or any suspect animal, or a female genetically
susceptible exposed animal, or any exposed animal that the Administrator
determines to be a potential risk based on the scrapie type, the epidemiology of
the flock or flocks with which it is epidemiologically linked, including
genetics of the positive sheep, the prevalence of scrapie in the flock, any
history of recurrent infection, and other flock characteristics. An animal will
no longer be a high-risk animal if it is redesignated in accordance with § 79.4
of this chapter. This in concert with the new low-risk exposed animal definition
below gives a lot of flexibility in handling infected/source flocks and exposed
animals minimizing the need to revise the regulations as scientific knowledge
increases. It also allows APHIS to not restrict animals exposed to Nor98-like
scrapie and to at some point if warranted by new scientific evidence establish a
genetic based approach for goats. Low-risk exposed animal. Any exposed animal to
which the DSE has determined one or more of the following applies:
(1) The positive animal that was the source of exposure was not born in the
flock and did not lamb in the flock or in an enclosure where the exposed animal
resided;
(2) The Administrator and State representative concur that the animal is
unlikely to be infected due to factors such as, but not limited to, where the
animal resided or the time period the animal resided in the flock;
(3) The exposed animal is male and was not born in an infected or source
flock;
(4) The exposed animal is a castrated male;
(5) The exposed animal is an embryo of a genetically resistant exposed
sheep or a genetically less susceptible exposed sheep unless placed in a
recipient that was a genetically susceptible exposed animal; or,
(6) The animal was exposed to a scrapie type and/or is of a genotype that
the Administrator has determined poses low risk of scrapie transmission.
15. Change the first paragraph of the suspect animal definition to
read:
(1) A mature sheep or goat as evidenced by eruption of the first incisor
that has been condemned by FSIS or a State inspection authority for central
nervous system (CNS) signs, or that exhibits any of the following clinical signs
of scrapie and has been determined to be suspicious for scrapie by an accredited
veterinarian or a State or USDA representative, based on one or more of the
following signs and
REPORT OF THE COMMITTEE
354
the severity of the signs: (i) Weakness of any kind including, but not
limited to, stumbling, falling down, or having difficulty rising, not including
those with visible traumatic injuries and no other signs of scrapie; (ii)
behavioral abnormalities; (iii) significant weight loss despite retention of
appetite or in an animal with adequate dentition; (iv) increased sensitivity to
noise and sudden movement; (v) tremors; (vi) star gazing; (vii) head pressing;
(viii) bilateral gait abnormalities such as but not limited to incoordination,
ataxia, high stepping gait of forelimbs, bunny-hop movement of rear legs, or
swaying of back end, but not including abnormalities involving only one leg or
one front and one back leg; (ix) repeated intense rubbing with bare areas or
damaged wool in similar locations on both sides of the animal’s body or, if on
the head, both sides of the poll; (x) abraded, rough, thickened, or
hyperpigmented areas of skin in areas of wool/hair loss in similar locations on
both sides of the animal’s body or, if on the head, both sides of the poll; or
(xi) other signs of CNS disease. An animal will no longer be a suspect animal if
it is redesignated in accordance with §
79.4 of this chapter.
16. Add definition of tamper-resistant sampling kit and changes definition
of Official genotype test to allow sampling using an APHIS approved tamper
evident eartag for official genotyping. Note: APHIS is not aware of
tamper-evident versions of these devices being commercially available.
17. Add definition of owner/hauler statement in place of previous owner
statement.
Owner/hauler statement. A signed written statement by the owner or hauler
that includes:
(1) The name, address, and phone number of the owner and, if different, the
hauler;
(2) The date the animals were moved;
(3) The flock identification number or PIN assigned to the flock or
premises of the animals;
(4) If moving individually unidentified animals, the group/lot
identification number and any information required to officially identify the
animals;
(5) The number of animals;
(6) The species, breed, and class of animals. If breed is unknown, for
sheep the face color and for goats the type (milk, fiber, or meat) must be
recorded instead; and
(7) The name and address of point of origin, if different from the owner’s
address, and the destination.
18. Add definition:
Restricted animal sale or restricted livestock facility. A sale where any
animals in slaughter channels are maintained separate from other animals not in
slaughter channels and are sold in lots that consist entirely of animals sold
for slaughter only or a livestock facility at which
SCRAPIE
355
all animals are in slaughter channels and where the sale or facility
manager maintains a copy of, or maintains a record of, the information from, the
owner/hauler statement for all animals entering and leaving the sale or
facility. A restricted animal sale may be held at a livestock facility that is
not restricted.
19. Tighten up slaughter channels through revised definition and
requirement for an owner hauler statement and addition of §79.3(g).
Slaughter channels. Animals in slaughter channels include any animal that
is sold, transferred, or moved either directly to or through a restricted animal
sale or restricted livestock facility to a slaughter establishment that is under
continuous inspection by the Food Safety and Inspection Service or under State
inspection that the Food Safety and Inspection Service has recognized as at
least equal to Federal inspection or to a custom exempt slaughter establishment
as defined by FSIS for immediate slaughter or to an individual for immediate
slaughter for personal use or to a terminal feedlot. Any animal sold at an
unrestricted sale is not in slaughter channels. Animals in slaughter channels
must be accompanied by an owner/hauler statement completed in accordance with §
79.3(g) of this chapter. Animals in slaughter channels may not be held in the
same enclosure with sexually intact animals from another flock of origin that
are not in slaughter channels. When selling animals that do not meet the
requirements to move as breeding animals, owners must note on the bill of sale
that the animals are sold only for slaughter.
79.3(g) Animals moved to slaughter. Once an animal enters slaughter
channels the animal may not be removed from slaughter channels. An animal is in
slaughter channels if it was sold through a restricted animal sale, resided in a
terminal feedlot, was sold with a bill of sale marked for slaughter only, was
identified with an identification device or tattoo marked “slaughter only” or
“MEAT” or was moved in a manner not permitted for other classes of animals.
Animals in slaughter channels may move either directly to a slaughter
establishment that is under continuous inspection by the Food Safety and
Inspection Service or under State inspection that the Food Safety and Inspection
Service has recognized as at least equal to Federal inspection or to a custom
exempt slaughter establishment as defined by FSIS for immediate slaughter or to
an individual for immediate slaughter for personal use, to a terminal feedlot,
or may move indirectly to such a destination through a restricted animal sale or
restricted livestock facility. Once an animal has entered slaughter channels it
may only be officially identified with an official blue eartag marked with the
words “Meat” or “Slaughter Only" or an ear tattoo reading "Meat." Animals in
slaughter channels must be accompanied by an owner/hauler statement indicating
the owner’s name and address; the name and address of the person or livestock
facility from which and where they were acquired, if different from the owner;
the slaughter establishment,
REPORT OF THE COMMITTEE
356
restricted animal sale, restricted livestock facility or terminal feedlot
to which they are being moved, and a statement that the animals are in slaughter
channels. A copy of the owner/hauler statement must be provided to the slaughter
establishment, restricted animal sale, restricted livestock facility or terminal
feedlot to which the animals are moved. Any bill of sale regarding the animals
must indicate that the animals were sold for slaughter only.
20. Revises Terminal feedlot definition by revising paragraph 1 to include
removal of organic material before use by other sheep or goats, by adding
paragraph 2, and revising paragraph 3 (now 4) to increase the record retention
requirement to 5 years and reiterate that the owner hauler statement or the
information contained therein must be retained: Terminal feedlot. (1) A dry lot
approved by a State or APHIS representative or an accredited veterinarian who is
authorized to perform this function where animals in the terminal feedlot are
separated from all other animals by at least 30 feet at all times or are
separated by a solid wall through, over, or under which fluids cannot pass and
contact cannot occur and must be cleaned of all organic material prior to being
used to contain sheep or goats that are not in slaughter channels, where only
castrated males are maintained with female animals and from which animals are
moved only to another terminal feedlot or directly to slaughter; or
(2) A dry lot approved by a State or APHIS representative or an accredited
veterinarian authorized to perform this function where only animals that either
are not pregnant based on the animal being male, an owner certification that any
female animals have not been exposed to a male in the preceding 6 months, an
ICVI issued by an accredited veterinarian stating the animals are open, or the
animals are under 6 months of age at time of receipt, where only castrated males
are maintained with female animals, and all animals in the terminal feedlot are
separated from all other animals such that physical contact cannot occur and
from which animals are moved only to another terminal feedlot or directly to
slaughter; or
(3) A pasture when approved by and maintained under the supervision of the
State and in which only nonpregnant animals are permitted based on the animal
being male, an owner certification that any female animals have not been exposed
to a male in the preceding 6 months, or an ICVI issued by an accredited
veterinarian stating the animals are open, or the animals are under 6 months of
age at time of receipt, where only castrated males are maintained with female
animals, where there is no direct fence-to-fence contact with another flock, and
from which animals are moved only to another terminal feedlot or directly to
slaughter.
(4) Records of all animals entering and leaving a terminal feedlot must be
maintained for 5 years after the animal leaves the feedlot and must meet the
requirements of § 79.2 of this chapter,
SCRAPIE
357
including either a copy of the required owner/hauler statements for animals
entering and leaving the facility or the information required to be on the
statements. Records must be made available for inspection and copying by an
APHIS or State representative upon request.
21. In the indemnity sections proposed § 54.3 adds:
a. Prohibitions:
No indemnity will be paid for any animal, or the progeny of any animal,
that has been moved or handled by the owner in violation of the requirements of
the Animal Health Protection Act or the regulations promulgated thereunder. No
indemnity will be paid for an animal added to the premises while a flock is
under investigation or while it is an infected or source flock other than
natural additions. No indemnity will be paid for natural additions born more
than 60 days after the owner is notified they are eligible for indemnity unless
the Administrator makes a determination that the dam could not be removed within
the allowed time as a result of conditions outside the control of the owner. No
indemnity will be paid unless the owner has signed and is in compliance with the
requirements of a flock plan or PEMMP as described in § 54.8.
b. Allows partial indemnity if cleaning and disinfection cannot be
completed due weather or other factors outside the control of the owner make
immediate disinfection impractical.
c. Moves specific instructions for calculating indemnity to the program
standards which includes specific language on late gestation and early lambing
premiums as well as allows for the use of available price reports rather than
specifying particular ones, which may become unavailable. See proposed § 54.6
and draft program standards for details.
22. Add language stating that APHIS may pay full disposal costs for
indemnified animals
23. Add use of an EPA approved product should one be approved or new
exempted products
24. Update section § 54.8 Requirements for flocks under investigation and
flocks subject to flock plans and post-exposure management and monitoring plans
(PEMMPs)
a. Reorganized and reworded for clarity
b. Adds flocks under investigation to the requirements for official
identification
c. Requires official identification on all animals in a flock under a flock
plan or PEMMP
d. Specifically allows APHIS to establish policies for retention of
high-risk animals.
e. Gives more flexibility on when a PEMMP will be used
25. Update section § 54.10 Program approval of tests for scrapie
a. Adds information on appeals
REPORT OF THE COMMITTEE
358
b. Moves test use guidelines to the APHIS website. See draft program
standards for details.
26. Update section § 54.11 Approval of laboratories to run official scrapie
tests and official genotype tests
a. Adds ability for NVSL to waive tissue retention times in an SOP
b. Adds additional information on appeals
c. Adds that NVSL may recoup costs associated with laboratory approval from
the approved laboratories
27. Change low-risk commercial sheep to low-risk commercial flock to
include goats, but limits this exception to animals moving for slaughter
28. Require submission of tagging records by individuals who tag animals
for others such as markets and veterinarians through a website or by other
mutually agreed methods.
29. Revise information required to be maintained about animal
dispositions/acquisitions and records of animals tagged. Remove requirement to
record tags that are on animals when acquired unless an ICVI is required.
30. Add meeting surveillance targets as a requirement for remaining a
consistent state and requires States to conduct of facilitate surveillance in
State inspected mature sheep and goat slaughter establishments (see proposed §
79.6).
31. Simplify the requirements for inconsistent states and includes the
option to use genotyping for movement of breeding sheep in addition to
enrollment in SFCP (see proposed § 79.3(j)).
32. Move the Consistent State List to the website in the program standards
and provides for notice and comment for changing the list. Specifically, the
definition is changed to read:
Consistent State. (1) A State that the Administrator has determined
conducts an active State scrapie control program that meets the requirements of
§79.6 or effectively enforces a State-designed plan that the Administrator
determines is at least as effective in controlling scrapie as the requirements
of § 79.6.
(2) A list of Consistent States can be found on the Internet at http://www.aphis.usda.gov/animal-health/scrapie.
(3) When the Administrator determines that a State should be added to or
removed from the list of Consistent States, APHIS will publish a notice in the
Federal Register advising the public of the Administrator's determination,
providing the reasons for that determination, and soliciting public comments.
After considering any comments we receive, APHIS will publish a second notice
either advising the public that the Administrator has decided to add or remove
the State from the list of Consistent States or notifying the public that the
Administrator has decided not to make any changes to the list of Consistent
States, depending on the information presented in the comments.
SCRAPIE
359
33. Add/revise definitions for flock identification (ID) number, Premises
identification number (PIN) and group/lot number
Flock identification (ID) number. A nationally unique number assigned by a
State or Federal animal health authority to a group of animals that are managed
as a unit on one or more premises and are under the same ownership. The flock ID
number must begin with the State postal abbreviation, must have no more than
nine alphanumeric characters, and must not contain the characters “I”, “O”, or
"Q" other than as part of the State postal abbreviation or another standardized
format authorized by the administrator and issued through the National Scrapie
Database. Flock identification numbers will be linked in the National Scrapie
Database to one or more PINs and may be used in conjunction with an animal
number unique within the flock to provide a unique official identification
number for an animal, or may be used in conjunction with the date and a sequence
number to provide a GIN for a group of animals when group identification is
permitted.
Premises identification number (PIN). This term has the meaning set forth
in § 86.1 of this subchapter. APHIS may also maintain historical and/or State
premises numbers and link them to the premises identification number in records
and databases. Such secondary or historical numbers are typically the State's
two-letter postal abbreviation followed by a number assigned by the State.
Group/lot identification number (GIN). The identification number used to
uniquely identify a unit of animals that is managed together as one group. The
format of the GIN may be either as defined in § 71.1 of this chapter, or the
flock identification number followed by a six-digit representation of the date
on which the group or lot of animals was assembled (MM/DD/YY). If more than one
group is created on the same date a sequential number will be added to the end
of the GIN. If a flock identification number is used, the flock identification
number, date, and sequential number will be separated by hyphens.
34. Revise definitions of Animal identification number (AIN), Officially
identified, Official identification device or method and Official Eartag for
clarity to specific the use of devices approved and distributed in accordance
the scrapie rules and methods approved for use in sheep and goats by
APHIS.
35. Explicitly allows an appeal of designation decisions see proposed §
79.4(c)(3). Draft rules of practice may be found in the draft program
standards.
Prohibit transferring official eartags without the permission of APHIS or
the State or applying official sheep and goat tags to animals other than sheep
or goats. See proposed § 79.2 (b)(5)(d&e)
36. Does not allow use of back tags as official ID.
37. Provide for eartagging compliance agreements. See proposed § 79.3
(k).
REPORT OF THE COMMITTEE
360
38. Allow APHIS through the program standards or other web posting to
establish the requirements for official identification devices and methods
including:
a. Establishing allowed colors and limiting certain colors to certain uses.
For example only “slaughter only” official sheep and goat eartags can be blue
and all “slaughter only” official sheep and goat eartags must be blue. Specifies
that yellow metal official tags will be used for permanently exposed animals and
that red metal official tags will be used for animals that have tested positive
for scrapie.
b. Requirements for use of tattoos. Proposed changes:
i. Not allowed as a sole means of official identification on animals in
slaughter channels or moving through livestock markets
ii. Registry tattoos must be issued by a registry that has agreed to
cooperate with APHIS in tracing scrapie positive and exposed animals or the
registry tattoo prefix must be provide to APHIS for entry into the National
Scrapie Database.
c. Requirements for use of electronic implants. Proposed changes:
i. Not allowed as a sole means of official identification on animals in
slaughter channels or moving through livestock markets
ii. If used as the sole form of official identification must be tattooed
with “E” for implants in the ear or “ET” for implants in the tail
iii. If used in an unregistered animal must also be tattooed with the flock
identification number.
d. Specifies that eartags must be placed in the ear.
See the draft program standards (link) or the extract of materials (link)
referred to in the proposed rule available on the web for more detailed
information.
360
Specialist Commission Reports
A. Scientific Commission for Animal Diseases (SCAD) – The SCAD addresses
technical issues, and makes science based recommendations to the Terrestrial
Animal Health Standards (Code) Commission for improving and updating the various
Code Chapters. The President of the SCAD summarized the activities of the
Commission during the previous year. These included:
a. Overseeing and directing the work of 21 different expert ad hoc
groups;
b. Amending and finalizing the chapters on:
snip...
Bovine spongiform encephalopathy (BSE), making a clear distinction
between classical and atypical BSE, and clarifying that it is only the classical
form for which status is granted, and that findings of atypical BSE do not
affect status;
snip...
241
s. Bovine Spongiform Encephalopathy (Chapter 11.4) – this chapter was
updated to recognize the distinction between “classical BSE” and “atypical BSE.”
New Zealand, on behalf of the Quads countries (New Zealand, Australia, United
States, and Canada), made an intervention. Specifically, the Quads are concerned
that once again changes to a current Terrestrial Animal Health Code chapter are
being proposed for adoption without Member Countries being given the appropriate
opportunity to consider the changes carefully and offer comment to the
Terrestrial Animal Health Standards Commission. While acknowledging that there
may be occasions when changes to Code chapters must be made with urgency, this
was not such an occasion. The Quads recognized the need to make a distinction
between the occurrence of a case of “classical” BSE and a case of “atypical”
BSE, and welcomed the recognition that a case of “atypical” BSE, an uncommon,
spontaneously occurring condition, should not negatively affect a country’s BSE
risk status. However, the changes proposed have broader implications. With the
normal cycle of Member Country comments on proposed changes, countries would
have time to recognise the implications for surveillance and information
gathering systems and be prepared when the changes are adopted after the normal
process of consultation and comment. The Quads also pointed to another problem
with rushing this revised text through. A very important distinction is made
between “classical” and “atypical” BSE. However, nowhere in the Code or Manual
is there a case definition for either condition. Before the Code recommends
different responses to these two conditions, the OIE Member Countries should be
provided with definitive case
REPORT OF THE COMMITTEE
246
definitions so as to avoid ambiguity and dispute over BSE status. Since the
occurrence of “atypical” BSE has been recognised for several years now, the
Quads suggested that there was no need for urgency to make changes to the Code
and the normal cycle of Member Countries’ scrutiny, comment and consultation
should be followed. The EU, however, did have an urgency to get these changes
through (likely because they have been detecting “atypical” cases of BSE and did
not want these to influence their status, since the Code does not currently make
such a distinction). A compromise was reached by not adopting the proposed
changes, but adding a short sentence at the end of the introductory paragraph of
the chapter which reads: “For the purpose of official BSE status recognition,
BSE excludes ‘atypical BSE’ as it is a condition believed to occur spontaneously
in all cattle populations at a very low rate.” Countries can now review the
proposed changes and submit any comments before the next meeting of the Code
Commission in September 2015.
246
PRION 2016 CONFERENCE TOKYO
SCRAPIE WS-01: Prion diseases in animals and zoonotic potential 2016
Prion. 10:S15-S21. 2016 ISSN: 1933-6896 printl 1933-690X online
Taylor & Francis
Prion 2016 Animal Prion Disease Workshop Abstracts
WS-01: Prion diseases in animals and zoonotic potential
Juan Maria Torres a, Olivier Andreoletti b, J uan-Carlos Espinosa a.
Vincent Beringue c. Patricia Aguilar a,
Natalia Fernandez-Borges a. and Alba Marin-Moreno a
"Centro de Investigacion en Sanidad Animal ( CISA-INIA ). Valdeolmos,
Madrid. Spain; b UMR INRA -ENVT 1225 Interactions Holes Agents Pathogenes. ENVT.
Toulouse. France: "UR892. Virologie lmmunologie MolécuIaires, Jouy-en-Josas.
France
Dietary exposure to bovine spongiform encephalopathy (BSE) contaminated
bovine tissues is considered as the origin of variant Creutzfeldt Jakob (vCJD)
disease in human. To date, BSE agent is the only recognized zoonotic prion.
Despite the variety of Transmissible Spongiform Encephalopathy (TSE) agents that
have been circulating for centuries in farmed ruminants there is no apparent
epidemiological link between exposure to ruminant products and the occurrence of
other form of TSE in human like sporadic Creutzfeldt Jakob Disease (sCJD).
However, the zoonotic potential of the diversity of circulating TSE agents has
never been systematically assessed. The major issue in experimental assessment
of TSEs zoonotic potential lies in the modeling of the ‘species barrier‘, the
biological phenomenon that limits TSE agents’ propagation from a species to
another. In the last decade, mice genetically engineered to express normal forms
of the human prion protein has proved essential in studying human prions
pathogenesis and modeling the capacity of TSEs to cross the human species
barrier.
To assess the zoonotic potential of prions circulating in farmed
ruminants, we study their transmission ability in transgenic mice expressing
human PrPC (HuPrP-Tg). Two lines of mice expressing different forms of the human
PrPC (129Met or 129Val) are used to determine the role of the Met129Val
dimorphism in susceptibility/resistance to the different agents.
These transmission experiments confirm the ability of BSE prions to
propagate in 129M- HuPrP-Tg mice and demonstrate that Met129 homozygotes may be
susceptible to BSE in sheep or goat to a greater degree than the BSE agent in
cattle and that these agents can convey molecular properties and
neuropathological indistinguishable from vCJD. However homozygous 129V mice are
resistant to all tested BSE derived prions independently of the originating
species suggesting a higher transmission barrier for 129V-PrP variant.
Transmission data also revealed that several scrapie prions propagate in
HuPrP-Tg mice with efficiency comparable to that of cattle BSE. While the
efficiency of transmission at primary passage was low, subsequent passages
resulted in a highly virulent prion disease in both Met129 and Val129 mice.
Transmission of the different scrapie isolates in these mice leads to the
emergence of prion strain phenotypes that showed similar characteristics to
those displayed by MM1 or VV2 sCJD prion. These results demonstrate that scrapie
prions have a zoonotic potential and raise new questions about the possible link
between animal and human prions.
*** Transmission data also revealed that several scrapie prions propagate
in HuPrP-Tg mice with efficiency comparable to that of cattle BSE. While the
efficiency of transmission at primary passage was low, subsequent passages
resulted in a highly virulent prion disease in both Met129 and Val129 mice.
Transmission of the different scrapie isolates in these mice leads to the
emergence of prion strain phenotypes that showed similar characteristics to
those displayed by MM1 or VV2 sCJD prion. These results demonstrate that scrapie
prions have a zoonotic potential and raise new questions about the possible link
between animal and human prions.
Research Project: TRANSMISSION, DIFFERENTIATION, AND PATHOBIOLOGY OF
TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
Title: Transmission of scrapie prions to primate after an extended silent
incubation period
Authors
item Comoy, Emmanuel - item Mikol, Jacqueline - item Luccantoni-Freire,
Sophie - item Correia, Evelyne - item Lescoutra-Etchegaray, Nathalie - item
Durand, Valérie - item Dehen, Capucine - item Andreoletti, Olivier - item
Casalone, Cristina - item Richt, Juergen item Greenlee, Justin item Baron,
Thierry - item Benestad, Sylvie - item Hills, Bob - item Brown, Paul - item
Deslys, Jean-Philippe -
Submitted to: Scientific Reports Publication Type: Peer Reviewed Journal
Publication Acceptance Date: May 28, 2015 Publication Date: June 30, 2015
Citation: Comoy, E.E., Mikol, J., Luccantoni-Freire, S., Correia, E.,
Lescoutra-Etchegaray, N., Durand, V., Dehen, C., Andreoletti, O., Casalone, C.,
Richt, J.A., Greenlee, J.J., Baron, T., Benestad, S., Brown, P., Deslys, J.
2015. Transmission of scrapie prions to primate after an extended silent
incubation period. Scientific Reports. 5:11573.
Interpretive Summary: The transmissible spongiform encephalopathies (also
called prion diseases) are fatal neurodegenerative diseases that affect animals
and humans. The agent of prion diseases is a misfolded form of the prion protein
that is resistant to breakdown by the host cells. Since all mammals express
prion protein on the surface of various cells such as neurons, all mammals are,
in theory, capable of replicating prion diseases. One example of a prion
disease, bovine spongiform encephalopathy (BSE; also called mad cow disease),
has been shown to infect cattle, sheep, exotic undulates, cats, non-human
primates, and humans when the new host is exposed to feeds or foods contaminated
with the disease agent. The purpose of this study was to test whether non-human
primates (cynomologous macaque) are susceptible to the agent of sheep scrapie.
After an incubation period of approximately 10 years a macaque developed
progressive clinical signs suggestive of neurologic disease. Upon postmortem
examination and microscopic examination of tissues, there was a widespread
distribution of lesions consistent with a transmissible spongiform
encephalopathy. This information will have a scientific impact since it is the
first study that demonstrates the transmission of scrapie to a non-human primate
with a close genetic relationship to humans. This information is especially
useful to regulatory officials and those involved with risk assessment of the
potential transmission of animal prion diseases to humans. Technical Abstract:
Classical bovine spongiform encephalopathy (c-BSE) is an animal prion disease
that also causes variant Creutzfeldt-Jakob disease in humans. Over the past
decades, c-BSE's zoonotic potential has been the driving force in establishing
extensive protective measures for animal and human health.
*** In complement to the recent demonstration that humanized mice are
susceptible to scrapie, we report here the first observation of direct
transmission of a natural classical scrapie isolate to a macaque after a 10-year
incubation period. Neuropathologic examination revealed all of the features of a
prion disease: spongiform change, neuronal loss, and accumulation of PrPres
throughout the CNS.
*** This observation strengthens the questioning of the harmlessness of
scrapie to humans, at a time when protective measures for human and animal
health are being dismantled and reduced as c-BSE is considered controlled and
being eradicated.
*** Our results underscore the importance of precautionary and protective
measures and the necessity for long-term experimental transmission studies to
assess the zoonotic potential of other animal prion strains.
Transmission of scrapie prions to primate after an extended silent
incubation period
Emmanuel E. Comoy , Jacqueline Mikol , Sophie Luccantoni-Freire , Evelyne
Correia , Nathalie Lescoutra-Etchegaray , Valérie Durand , Capucine Dehen ,
Olivier Andreoletti , Cristina Casalone , Juergen A. Richt , Justin J. Greenlee
, Thierry Baron , Sylvie L. Benestad , Paul Brown & Jean-Philippe Deslys
Scientific Reports 5, Article number: 11573 (2015) doi:10.1038/srep11573
Download Citation Epidemiology Neurological manifestations Prion diseases
Received:16 February 2015Accepted:28 May 2015
***Moreover, sporadic disease has never been observed in breeding colonies
or primate research laboratories, most notably among hundreds of animals over
several decades of study at the National Institutes of Health25, and in nearly
twenty older animals continuously housed in our own facility.***
Tuesday, December 16, 2014
Evidence for zoonotic potential of ovine scrapie prions
Hervé Cassard,1, n1 Juan-Maria Torres,2, n1 Caroline Lacroux,1, Jean-Yves
Douet,1, Sylvie L. Benestad,3, Frédéric Lantier,4, Séverine Lugan,1, Isabelle
Lantier,4, Pierrette Costes,1, Naima Aron,1, Fabienne Reine,5, Laetitia
Herzog,5, Juan-Carlos Espinosa,2, Vincent Beringue5, & Olivier Andréoletti1,
Affiliations Contributions Corresponding author Journal name: Nature
Communications Volume: 5, Article number: 5821 DOI: doi:10.1038/ncomms6821
Received 07 August 2014 Accepted 10 November 2014 Published 16 December 2014
Article tools Citation Reprints Rights & permissions Article metrics
Abstract
Although Bovine Spongiform Encephalopathy (BSE) is the cause of variant
Creutzfeldt Jakob disease (vCJD) in humans, the zoonotic potential of scrapie
prions remains unknown. Mice genetically engineered to overexpress the human
prion protein (tgHu) have emerged as highly relevant models for gauging the
capacity of prions to transmit to humans. These models can propagate human
prions without any apparent transmission barrier and have been used used to
confirm the zoonotic ability of BSE. Here we show that a panel of sheep scrapie
prions transmit to several tgHu mice models with an efficiency comparable to
that of cattle BSE. The serial transmission of different scrapie isolates in
these mice led to the propagation of prions that are phenotypically identical to
those causing sporadic CJD (sCJD) in humans. These results demonstrate that
scrapie prions have a zoonotic potential and raise new questions about the
possible link between animal and human prions.
snip...
Do our transmission results in tgHu imply that sheep scrapie is the cause
of sCJD cases in humans? This question challenges well-established dogma that
sCJD is a spontaneous disorder unrelated to animal prion disease. In our
opinion, our data on their own do not unequivocally establish a causative link
between natural exposure to sheep scrapie and the subsequent appearance of sCJD
in humans. However, our studies clearly point out the need to re-consider this
possibility. Clarification on this topic will be aided by informed and modern
epidemiological studies to up-date previous analysis that was performed at the
end of the last century3, 4. The value of such an approach is highlighted by the
implementation in the year 2000 of large-scale active animal TSE surveillance
programs around the world that provided an informed epidemiological-based view
of the occurrence and geographical spread of prion disease in small ruminant
populations51. The fact that both Australia and New-Zealand, two countries that
had been considered for more than 50 years as TSE-free territories, were finally
identified positive for atypical scrapie in their sheep flocks provides an
example of how prion dogma can be reversed52. However, the incubation period for
prion disease in humans after exposure to prions via the peripheral route, such
as in iatrogenic CJD transmission and Kuru, can exceed several decades53, 54. In
this context, it will be a challenge to combine epidemiological data collected
contemporarily in animal populations and humans to investigate the existence of
a causative link between prion disease occurrence in these different hosts.
Furthermore, it is crucial to bear in mind that sporadic sCJD in humans is a
rare disease (1–2 individuals per million of the population per year) and that
scrapie has been circulating in small ruminants populations used for food
purposes for centuries. Consequently, it is our opinion that even if a causative
link was established between sheep scrapie exposure and the occurrence of
certain sCJD cases, it would be wrong to consider small ruminant TSE agents as a
new major threat for public health. Despite this, it remains clear that our data
provide a new impetus to establish the true zoonotic potential of sheep scrapie
prions.
Subject terms: Biological sciences• Medical research At a glance
Thursday, August 04, 2016
MEETING ON THE FEASIBILITY OF CARRYING OUT EPIDEMIOLOGICAL STUDIES ON
CREUTZFELDT JAKOB DISEASE 1978 THE SCRAPIE FILES IN CONFIDENCE CONFIDENTIAL SCJD
SEE CONFIDENTIAL SCRAPIE FILES ;
BE SURE TO SEE THIS NEXT ONE WITH FIGURES...TSS
STUDIES ON CREUTZFELDT-JAKOB DISEASE
i enclose a list of ICD categories showing the numbers of deaths attributed
to each (as underlying cause) in England and Hales in 1975.
ICD NO...Number of Certificates examined
xxxxx...18...15 mentioned C-J
xxxxx...122...1 mentioned C-J with dimentia, 24 mentioned Alzheimer’s
disease, 1 mentioned Pick’s disease.
xxxxx...22...4 mentioned Myoclonic epilepsy
xxxxx...384...none mentioned Corticostrionigral degeneration
xxxxx...2...none mentioned Corticostrionigral degeneration
snip...
1979
SILENCE ON CJD AND SCRAPIE
1980
SILENCE ON CJD AND SCRAPIE
*** 1981 NOVEMBER
1: J Infect Dis 1980 Aug;142(2):205-8
Oral transmission of kuru, Creutzfeldt-Jakob disease, and scrapie to
nonhuman primates.
Gibbs CJ Jr, Amyx HL, Bacote A, Masters CL, Gajdusek DC.
Kuru and Creutzfeldt-Jakob disease of humans and scrapie disease of sheep
and goats were transmitted to squirrel monkeys (Saimiri sciureus) that were
exposed to the infectious agents only by their nonforced consumption of known
infectious tissues. The asymptomatic incubation period in the one monkey exposed
to the virus of kuru was 36 months; that in the two monkeys exposed to the virus
of Creutzfeldt-Jakob disease was 23 and 27 months, respectively; and that in the
two monkeys exposed to the virus of scrapie was 25 and 32 months, respectively.
Careful physical examination of the buccal cavities of all of the monkeys failed
to reveal signs or oral lesions. One additional monkey similarly exposed to kuru
has remained asymptomatic during the 39 months that it has been under
observation.
snip...
The successful transmission of kuru, Creutzfeldt-Jakob disease, and
scrapie by natural feeding to squirrel monkeys that we have reported provides
further grounds for concern that scrapie-infected meat may occasionally give
rise in humans to Creutzfeldt-Jakob disease.
PMID: 6997404
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6997404&dopt=Abstract
12/10/76
AGRICULTURAL RESEARCH COUNCIL REPORT OF THE ADVISORY COMMITTE ON SCRAPIE
Office Note CHAIRMAN: PROFESSOR PETER WILDY
snip...
A The Present Position with respect to Scrapie A] The Problem Scrapie is a
natural disease of sheep and goats. It is a slow and inexorably progressive
degenerative disorder of the nervous system and it ia fatal. It is enzootic in
the United Kingdom but not in all countries. The field problem has been reviewed
by a MAFF working group (ARC 35/77). It is difficult to assess the incidence in
Britain for a variety of reasons but the disease causes serious financial loss;
it is estimated that it cost Swaledale breeders alone $l.7 M during the five
years 1971-1975. A further inestimable loss arises from the closure of certain
export markets, in particular those of the United States, to British sheep. It
is clear that scrapie in sheep is important commercially and for that reason
alone effective measures to control it should be devised as quickly as possible.
Recently the question has again been brought up as to whether scrapie is
transmissible to man. This has followed reports that the disease has been
transmitted to primates.
One particularly lurid speculation (Gajdusek 1977) conjectures that the
agents of scrapie, kuru, Creutzfeldt-Jakob disease and transmissible
encephalopathy of mink are varieties of a single "virus". The U.S. Department of
Agriculture concluded that it could "no longer justify or permit scrapie-blood
line and scrapie-exposed sheep and goats to be processed for human or animal
food at slaughter or rendering plants" (ARC 84/77)" The problem is emphasised by
the finding that some strains of scrapie produce lesions identical to the once
which characterise the human dementias" Whether true or not. the hypothesis that
these agents might be transmissible to man raises two considerations. First, the
safety of laboratory personnel requires prompt attention. Second, action such as
the "scorched meat" policy of USDA makes the solution of the acrapie problem
urgent if the sheep industry is not to suffer grievously.
snip...
76/10.12/4.6
*** 1976 Scrapie Research USDA worried about Scrapie and sCJD in man...tss
Nature. 1972 Mar 10;236(5341):73-4.
Transmission of scrapie to the cynomolgus monkey (Macaca fascicularis).
Gibbs CJ Jr, Gajdusek DC. Nature 236, 73 - 74 (10 March 1972);
doi:10.1038/236073a0
Transmission of Scrapie to the Cynomolgus Monkey (Macaca fascicularis)
C. J. GIBBS jun. & D. C. GAJDUSEK National Institute of Neurological
Diseases and Stroke, National Institutes of Health, Bethesda, Maryland
SCRAPIE has been transmitted to the cynomolgus, or crab-eating, monkey
(Macaca fascicularis) with an incubation period of more than 5 yr from the time
of intracerebral inoculation of scrapie-infected mouse brain. The animal
developed a chronic central nervous system degeneration, with ataxia, tremor and
myoclonus with associated severe scrapie-like pathology of intensive astroglial
hypertrophy and proliferation, neuronal vacuolation and status spongiosus of
grey matter. The strain of scrapie virus used was the eighth passage in Swiss
mice (NIH) of a Compton strain of scrapie obtained as ninth intracerebral
passage of the agent in goat brain, from Dr R. L. Chandler (ARC, Compton,
Berkshire).
Nature. 1972 Mar 10;236(5341):73-4.
Transmission of scrapie to the cynomolgus monkey (Macaca fascicularis).
Gibbs CJ Jr, Gajdusek DC. Nature 236, 73 - 74 (10 March 1972);
doi:10.1038/236073a0
Transmission of Scrapie to the Cynomolgus Monkey (Macaca fascicularis)
C. J. GIBBS jun. & D. C. GAJDUSEK National Institute of Neurological
Diseases and Stroke, National Institutes of Health, Bethesda, Maryland
SCRAPIE has been transmitted to the cynomolgus, or crab-eating, monkey
(Macaca fascicularis) with an incubation period of more than 5 yr from the time
of intracerebral inoculation of scrapie-infected mouse brain. The animal
developed a chronic central nervous system degeneration, with ataxia, tremor and
myoclonus with associated severe scrapie-like pathology of intensive astroglial
hypertrophy and proliferation, neuronal vacuolation and status spongiosus of
grey matter. The strain of scrapie virus used was the eighth passage in Swiss
mice (NIH) of a Compton strain of scrapie obtained as ninth intracerebral
passage of the agent in goat brain, from Dr R. L. Chandler (ARC, Compton,
Berkshire).
why do we not want to do TSE transmission studies on chimpanzees $
IN CONFIDENCE
TRANSMISSION TO CHIMPANZEES
snip...
5. A positive result from a chimpanzee challenged severely would likely
create alarm in some circles even if the result could not be interpreted for
man. I have a view that all these agents could be transmitted provided a large
enough dose by appropriate routes was given and the animals kept long enough.
Until the mechanisms of the species barrier are more clearly understood it might
be best to retain that hypothesis.
snip...
R. BRADLEY
full text ;
RB3.20
IN CONFIDENCE
TRANSMISSION TO CHIMPANZEE
1. Kuru and CJD have been successfully transmitted to chimpanzees but
scrapie and TME have not.
2. We cannot say that scrapie will not transmit to chimpanzees. There are
several scrapie strains and I am not aware that all have been tried (that would
have to be from mouse passaged material). Nor has a wide enough range of field
isolates subsequently strain typed in mice been inoculated by the appropriate
routes (i/c, i/p and i v);
3. I believe the proposed experiment to determine transmissibility, if
conducted, would only show the susceptibility or resistance of the chimpanzee to
infection/disease by the routes used and the result could not be interpreted for
the predictability of the susceptibility for man. Proposals for prolonged oral
exposure of chimpanzees to milk from cattle were suggested a long while ago and
rejected.
4. In view of Dr Gibbs‘ probable use of Chimpazees Mr Wells‘ comments
(enclosed) are pertinent. I have yet to receive a direct communication from Dr
Schellekers but before any collaboration or provision of material we should
identify the Gibbs' proposals and objectives.
5. A positive result from a chimpanzee challenged severely would likely
create alarm in some circles even if the result could not be interpreted for
man. I have a view that all these agents could be transmitted provided a large
enough dose by appropriate routes was given and the animals kept long enough.
Until the mechanisms of the species barrier are more clearly understood it might
be best to retain that hypothesis.
A negative result would take a lifetime to determine but that would be a
shorter period than might be available for human exposure and it would still not
answer the question regarding mans' susceptibility. In the meantime no doubt the
negativity would be used defensively. It would however be counterproductive if
the experiment finally became positive- We may learn more about public reactions
following next Monday‘s meeting. CVO (+ Mr. Wells’ comments)
Dr. T W A Little
Dr. B J Shreeve
R Bradley September 1990
90/9.23/1/1
Saturday, April 23, 2016
SCRAPIE WS-01: Prion diseases in animals and zoonotic potential 2016
TOKYO
Prion. 10:S15-S21. 2016 ISSN: 1933-6896 printl 1933-690X
Tuesday, June 07, 2016
*** Comparison of two US sheep scrapie isolates supports identification as
separate strains ***
Research Project: TRANSMISSION, DIFFERENTIATION, AND PATHOBIOLOGY OF
TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
THIS IS most important as well, and you may not be aware of this, if not,
you and your colleagues should please take note ‘After a natural route of
exposure, 100% of white-tailed deer were susceptible to scrapie’, and below this
as well, I am now beginning to question the Red Deer Ataxia back in the 70s and
80s, as I did the infamous ‘hound ataxia’.
*** After a natural route of exposure, 100% of white-tailed deer were
susceptible to scrapie. ***
2011
*** After a natural route of exposure, 100% of white-tailed deer were
susceptible to scrapie. ***
Primary transmission of CWD versus scrapie prions from small ruminants to
ovine and cervid PrP transgenic mice
Authors: Sally A. Madsen-Bouterse1, David A. Schneider2, Dongyue Zhuang3,
Rohana P. Dassanayake4, Aru Balachandran5, Gordon B. Mitchell6, Katherine I.
O'Rourke7 VIEW AFFILIATIONS
Published Ahead of Print: 08 July, 2016 Journal of General Virology doi:
10.1099/jgv.0.000539 Published Online: 08/07/2016
Development of mice expressing either ovine (Tg338) or cervid (TgElk) prion
protein (PrP) have aided in characterization of scrapie and chronic wasting
disease (CWD), respectively. Experimental inoculation of sheep with CWD prions
has demonstrated the potential for interspecies transmission but, infection with
CWD versus classical scrapie prions may be difficult to differentiate using
validated diagnostic platforms. In this study, mouse bioassay in Tg338 and TgElk
was utilized to evaluate transmission of CWD versus scrapie prions from small
ruminants. Mice (>5/homogenate) were inoculated with brain homogenates from
clinically affected sheep or goats with naturally-acquired classical scrapie,
white-tailed deer with naturally-acquired CWD (WTD-CWD), or sheep with
experimentally-acquired CWD derived from elk (sheep-passaged-CWD). Survival time
(time to clinical disease) and attack rates (brain accumulation of protease
resistant PrP, PrPres) were determined. Inoculation with classical scrapie
prions resulted in clinical disease and 100% attack rates in Tg338, but no
clinical disease at endpoint (>300 days post inoculation, dpi) and low attack
rates (6.8%) in TgElk. Inoculation with WTD-CWD prions yielded no clinical
disease or brain PrPres accumulation in Tg338 at endpoint (>500dpi) but rapid
onset of clinical disease (~121dpi) and 100% attack rate in TgElk.
Sheep-passaged-CWD resulted in transmission to both mouse lines with 100% attack
rates at endpoint in Tg338 and an attack rate of ~73% in TgElk with some culled
due to clinical disease. These primary transmission observations demonstrate the
potential of bioassay in Tg338 and TgElk to help differentiate possible
infection with CWD versus classical scrapie prions in sheep and goats.
P.97: Scrapie transmits to white-tailed deer by the oral route and has a
molecular profile similar to chronic wasting disease and distinct from the
scrapie inoculum
Justin Greenlee1, S Jo Moore1, Jodi Smith1, M Heather West Greenlee2, and
Robert Kunkle1
1National Animal Disease Center; Ames, IA USA;
2Iowa State University; Ames, IA USA
The purpose of this work was to determine susceptibility of white-tailed
deer (WTD) to the agent of sheep scrapie and to compare the resultant PrPSc to
that of the original inoculum and chronic wasting disease (CWD). We inoculated
WTD by a natural route of exposure (concurrent oral and intranasal (IN); n D 5)
with a US scrapie isolate. All scrapie-inoculated deer had evidence of PrPSc
accumulation. PrPSc was detected in lymphoid tissues at preclinical time points,
and deer necropsied after 28 months post-inoculation had clinical signs,
spongiform encephalopathy, and widespread distribution of PrPSc in neural and
lymphoid tissues. Western blotting (WB) revealed PrPSc with 2 distinct molecular
profiles. WB on cerebral cortex had a profile similar to the original scrapie
inoculum, whereas WB of brainstem, cerebellum, or lymph nodes revealed PrPSc
with a higher profile resembling CWD. Homogenates with the 2 distinct profiles
from WTD with clinical scrapie were further passaged to mice expressing cervid
prion protein and intranasally to sheep and WTD. In cervidized mice, the 2
inocula have distinct incubation times. Sheep inoculated intranasally with WTD
derived scrapie developed disease, but only after inoculation with the inoculum
that had a scrapie-like profile. The WTD study is ongoing, but deer in both
inoculation groups are positive for PrPSc by rectal mucosal biopsy. In summary,
this work demonstrates that WTD are susceptible to the agent of scrapie, 2
distinct molecular profiles of PrPSc are present in the tissues of affected
deer, and inoculum of either profile readily passes to deer.
2012
PO-039: A comparison of scrapie and chronic wasting disease in white-tailed
deer
Justin Greenlee, Jodi Smith, Eric Nicholson US Dept. Agriculture;
Agricultural Research Service, National Animal Disease Center; Ames, IA USA
snip...
The results of this study suggest that there are many similarities in the
manifestation of CWD and scrapie in WTD after IC inoculation including early and
widespread presence of PrPSc in lymphoid tissues, clinical signs of depression
and weight loss progressing to wasting, and an incubation time of 21-23 months.
Moreover, western blots (WB) done on brain material from the obex region have a
molecular profile similar to CWD and distinct from tissues of the cerebrum or
the scrapie inoculum. However, results of microscopic and IHC examination
indicate that there are differences between the lesions expected in CWD and
those that occur in deer with scrapie: amyloid plaques were not noted in any
sections of brain examined from these deer and the pattern of immunoreactivity
by IHC was diffuse rather than plaque-like.
*** After a natural route of exposure, 100% of WTD were susceptible to
scrapie.
Deer developed clinical signs of wasting and mental depression and were
necropsied from 28 to 33 months PI. Tissues from these deer were positive for
PrPSc by IHC and WB. Similar to IC inoculated deer, samples from these deer
exhibited two different molecular profiles: samples from obex resembled CWD
whereas those from cerebrum were similar to the original scrapie inoculum. On
further examination by WB using a panel of antibodies, the tissues from deer
with scrapie exhibit properties differing from tissues either from sheep with
scrapie or WTD with CWD. Samples from WTD with CWD or sheep with scrapie are
strongly immunoreactive when probed with mAb P4, however, samples from WTD with
scrapie are only weakly immunoreactive. In contrast, when probed with mAb’s 6H4
or SAF 84, samples from sheep with scrapie and WTD with CWD are weakly
immunoreactive and samples from WTD with scrapie are strongly positive. This
work demonstrates that WTD are highly susceptible to sheep scrapie, but on first
passage, scrapie in WTD is differentiable from CWD.
Scrapie in Deer: Comparisons and Contrasts to Chronic Wasting Disease (CWD)
Justin J. Greenlee of the Virus and Prion Diseases Research Unit, National
Animal Disease Center, ARS, USDA, Ames, IA provided a presentation on scrapie
and CWD in inoculated deer. Interspecies transmission studies afford the
opportunity to better understand the potential host range and origins of prion
diseases. We inoculated white-tailed deer intracranially (IC) and by a natural
route of exposure (concurrent oral and intranasal inoculation) with a US scrapie
isolate. All deer inoculated by the intracranial route had evidence of PrPSc
accumulation and those necropsied after 20 months post-inoculation (PI) (3/5)
had clinical signs, spongiform encephalopathy, and widespread distribution of
PrPSc in neural and lymphoid tissues. A single deer that was necropsied at 15.6
months PI did not have clinical signs, but had widespread distribution of PrPSc.
This highlights the facts that 1) prior to the onset of clinical signs PrPSc is
widely distributed in the CNS and lymphoid tissues and 2) currently used
diagnostic methods are sufficient to detect PrPSc prior to the onset of clinical
signs. The results of this study suggest that there are many similarities in the
manifestation of CWD and scrapie in white-tailed deer after IC inoculation
including early and widespread presence of PrPSc in lymphoid tissues, clinical
signs of depression and weight loss progressing to wasting, and an incubation
time of 21-23 months. Moreover, western blots (WB) done on brain material from
the obex region have a molecular profile consistent with CWD and distinct from
tissues of the cerebrum or the scrapie inoculum. However, results of microscopic
and IHC examination indicate that there are differences between the lesions
expected in CWD and those that occur in deer with scrapie: amyloid plaques were
not noted in any sections of brain examined from these deer and the pattern of
immunoreactivity by IHC was diffuse rather than plaque-like. After a natural
route of exposure, 100% of white-tailed deer were susceptible to scrapie. Deer
developed clinical signs of wasting and mental depression and were necropsied
from 28 to 33 months PI. Tissues from these deer were positive for scrapie by
IHC and WB. Tissues with PrPSc immunoreactivity included brain, tonsil,
retropharyngeal and mesenteric lymph nodes, hemal node, Peyer’s patches, and
spleen. While two WB patterns have been detected in brain regions of deer
inoculated by the natural route, unlike the IC inoculated deer, the pattern
similar to the scrapie inoculum predominates.
White-tailed Deer are Susceptible to Scrapie by Natural Route of Infection
Jodi D. Smith, Justin J. Greenlee, and Robert A. Kunkle; Virus and Prion
Research Unit, National Animal Disease Center, USDA-ARS
Interspecies transmission studies afford the opportunity to better
understand the potential host range and origins of prion diseases. Previous
experiments demonstrated that white-tailed deer are susceptible to sheep-derived
scrapie by intracranial inoculation. The purpose of this study was to determine
susceptibility of white-tailed deer to scrapie after a natural route of
exposure. Deer (n=5) were inoculated by concurrent oral (30 ml) and intranasal
(1 ml) instillation of a 10% (wt/vol) brain homogenate derived from a sheep
clinically affected with scrapie. Non-inoculated deer were maintained as
negative controls. All deer were observed daily for clinical signs. Deer were
euthanized and necropsied when neurologic disease was evident, and tissues were
examined for abnormal prion protein (PrPSc) by immunohistochemistry (IHC) and
western blot (WB). One animal was euthanized 15 months post-inoculation (MPI)
due to an injury. At that time, examination of obex and lymphoid tissues by IHC
was positive, but WB of obex and colliculus were negative. Remaining deer
developed clinical signs of wasting and mental depression and were necropsied
from 28 to 33 MPI. Tissues from these deer were positive for scrapie by IHC and
WB. Tissues with PrPSc immunoreactivity included brain, tonsil, retropharyngeal
and mesenteric lymph nodes, hemal node, Peyer’s patches, and spleen. This work
demonstrates for the first time that white-tailed deer are susceptible to sheep
scrapie by potential natural routes of inoculation. In-depth analysis of tissues
will be done to determine similarities between scrapie in deer after
intracranial and oral/intranasal inoculation and chronic wasting disease
resulting from similar routes of inoculation.
see full text ;
*** How Did CWD Get Way Down In Medina County, Texas?
DISCUSSION Observations of natural outbreaks of scrapie indicated that the
disease spread from flock to flock by the movement of infected, but apparently
normal, sheep which were incubating the disease.
There was no evidence that the disease spread to adjacent flocks in the
absent of such movements or that vectors or other host species were involved in
the spread of scrapie to sheep or goats; however, these possibilities should be
kept open...
*** Infectious agent of sheep scrapie may persist in the environment for at
least 16 years ***
Gudmundur Georgsson1, Sigurdur Sigurdarson2 and Paul Brown3
Saturday, May 28, 2016
*** Infection and detection of PrPCWD in soil from CWD infected farm in
Korea Prion 2016 Tokyo ***
Monday, May 02, 2016
*** Zoonotic Potential of CWD Prions: An Update Prion 2016 Tokyo ***
2015
O.05: Transmission of prions to primates after extended silent incubation
periods: Implications for BSE and scrapie risk assessment in human populations
Emmanuel Comoy, Jacqueline Mikol, Valerie Durand, Sophie Luccantoni,
Evelyne Correia, Nathalie Lescoutra, Capucine Dehen, and Jean-Philippe Deslys
Atomic Energy Commission; Fontenay-aux-Roses, France
Prion diseases (PD) are the unique neurodegenerative proteinopathies
reputed to be transmissible under field conditions since decades. The
transmission of Bovine Spongiform Encephalopathy (BSE) to humans evidenced that
an animal PD might be zoonotic under appropriate conditions. Contrarily, in the
absence of obvious (epidemiological or experimental) elements supporting a
transmission or genetic predispositions, PD, like the other proteinopathies, are
reputed to occur spontaneously (atpical animal prion strains, sporadic CJD
summing 80% of human prion cases). Non-human primate models provided the first
evidences supporting the transmissibiity of human prion strains and the zoonotic
potential of BSE. Among them, cynomolgus macaques brought major information for
BSE risk assessment for human health (Chen, 2014), according to their
phylogenetic proximity to humans and extended lifetime. We used this model to
assess the zoonotic potential of other animal PD from bovine, ovine and cervid
origins even after very long silent incubation periods.
*** We recently observed the direct transmission of a natural classical
scrapie isolate to macaque after a 10-year silent incubation period,
***with features similar to some reported for human cases of sporadic CJD,
albeit requiring fourfold long incubation than BSE. Scrapie, as recently evoked
in humanized mice (Cassard, 2014),
***is the third potentially zoonotic PD (with BSE and L-type BSE),
***thus questioning the origin of human sporadic cases. We will present an
updated panorama of our different transmission studies and discuss the
implications of such extended incubation periods on risk assessment of animal PD
for human health.
===============
***thus questioning the origin of human sporadic cases***
===============
***our findings suggest that possible transmission risk of H-type BSE to
sheep and human. Bioassay will be required to determine whether the PMCA
products are infectious to these animals.
==============
PRION 2016 TOKYO
Zoonotic Potential of CWD Prions: An Update
Ignazio Cali1, Liuting Qing1, Jue Yuan1, Shenghai Huang2, Diane Kofskey1,3,
Nicholas Maurer1, Debbie McKenzie4, Jiri Safar1,3,5, Wenquan Zou1,3,5,6,
Pierluigi Gambetti1, Qingzhong Kong1,5,6
1Department of Pathology, 3National Prion Disease Pathology Surveillance
Center, 5Department of Neurology, 6National Center for Regenerative Medicine,
Case Western Reserve University, Cleveland, OH 44106, USA.
4Department of Biological Sciences and Center for Prions and Protein
Folding Diseases, University of Alberta, Edmonton, Alberta, Canada,
2Encore Health Resources, 1331 Lamar St, Houston, TX 77010
Chronic wasting disease (CWD) is a widespread and highly transmissible
prion disease in free-ranging and captive cervid species in North America. The
zoonotic potential of CWD prions is a serious public health concern, but the
susceptibility of human CNS and peripheral organs to CWD prions remains largely
unresolved. We reported earlier that peripheral and CNS infections were detected
in transgenic mice expressing human PrP129M or PrP129V. Here we will present an
update on this project, including evidence for strain dependence and influence
of cervid PrP polymorphisms on CWD zoonosis as well as the characteristics of
experimental human CWD prions.
PRION 2016 TOKYO
In Conjunction with Asia Pacific Prion Symposium 2016
PRION 2016 Tokyo
Prion 2016
Prion 2016
Purchase options Price * Issue Purchase USD 198.00
Cervid to human prion transmission
Kong, Qingzhong
Case Western Reserve University, Cleveland, OH, United States
Abstract
Prion disease is transmissible and invariably fatal. Chronic wasting
disease (CWD) is the prion disease affecting deer, elk and moose, and it is a
widespread and expanding epidemic affecting 22 US States and 2 Canadian
provinces so far. CWD poses the most serious zoonotic prion transmission risks
in North America because of huge venison consumption (>6 million deer/elk
hunted and consumed annually in the USA alone), significant prion infectivity in
muscles and other tissues/fluids from CWD-affected cervids, and usually high
levels of individual exposure to CWD resulting from consumption of the affected
animal among often just family and friends. However, we still do not know
whether CWD prions can infect humans in the brain or peripheral tissues or
whether clinical/asymptomatic CWD zoonosis has already occurred, and we have no
essays to reliably detect CWD infection in humans. We hypothesize that:
(1) The classic CWD prion strain can infect humans at low levels in the
brain and peripheral lymphoid tissues;
(2) The cervid-to-human transmission barrier is dependent on the cervid
prion strain and influenced by the host (human) prion protein (PrP) primary
sequence;
(3) Reliable essays can be established to detect CWD infection in
humans;and
(4) CWD transmission to humans has already occurred. We will test these
hypotheses in 4 Aims using transgenic (Tg) mouse models and complementary in
vitro approaches.
Aim 1 will prove that the classical CWD strain may infect humans in brain
or peripheral lymphoid tissues at low levels by conducting systemic bioassays in
a set of "humanized" Tg mouse lines expressing common human PrP variants using a
number of CWD isolates at varying doses and routes. Experimental "human CWD"
samples will also be generated for Aim 3.
Aim 2 will test the hypothesis that the cervid-to-human prion transmission
barrier is dependent on prion strain and influenced by the host (human) PrP
sequence by examining and comparing the transmission efficiency and phenotypes
of several atypical/unusual CWD isolates/strains as well as a few prion strains
from other species that have adapted to cervid PrP sequence, utilizing the same
panel of humanized Tg mouse lines as in Aim 1.
Aim 3 will establish reliable essays for detection and surveillance of CWD
infection in humans by examining in details the clinical, pathological,
biochemical and in vitro seeding properties of existing and future experimental
"human CWD" samples generated from Aims 1-2 and compare them with those of
common sporadic human Creutzfeldt-Jakob disease (sCJD) prions.
Aim 4 will attempt to detect clinical CWD-affected human cases by examining
a significant number of brain samples from prion-affected human subjects in the
USA and Canada who have consumed venison from CWD-endemic areas utilizing the
criteria and essays established in Aim 3. The findings from this proposal will
greatly advance our understandings on the potential and characteristics of
cervid prion transmission in humans, establish reliable essays for CWD zoonosis
and potentially discover the first case(s) of CWD infection in humans.
Public Health Relevance There are significant and increasing human exposure
to cervid prions because chronic wasting disease (CWD, a widespread and highly
infectious prion disease among deer and elk in North America) continues
spreading and consumption of venison remains popular, but our understanding on
cervid-to-human prion transmission is still very limited, raising public health
concerns. This proposal aims to define the zoonotic risks of cervid prions and
set up and apply essays to detect CWD zoonosis using mouse models and in vitro
methods. The findings will greatly expand our knowledge on the potentials and
characteristics of cervid prion transmission in humans, establish reliable
essays for such infections and may discover the first case(s) of CWD infection
in humans.
Funding Agency Agency National Institute of Health (NIH)
Institute National Institute of Neurological Disorders and Stroke (NINDS)
Type Research Project (R01)
Project # 1R01NS088604-01A1
Application # 9037884
Study Section Cellular and Molecular Biology of Neurodegeneration Study
Section (CMND)
Program Officer Wong, May
Project Start 2015-09-30
Project End 2019-07-31
Budget Start 2015-09-30
Budget End 2016-07-31
Support Year 1
Fiscal Year 2015
Total Cost $337,507
Indirect Cost $118,756
Institution
Name Case Western Reserve University
Department Pathology
Type Schools of Medicine
DUNS # 077758407
City Cleveland
State OH
Country United States
Zip Code 44106
===========================================================
We hypothesize that:
(1) The classic CWD prion strain can infect humans at low levels in the
brain and peripheral lymphoid tissues;
(2) The cervid-to-human transmission barrier is dependent on the cervid
prion strain and influenced by the host (human) prion protein (PrP) primary
sequence;
(3) Reliable essays can be established to detect CWD infection in
humans;and
(4) *** CWD transmission to humans has already occurred. *** We will test
these hypotheses in 4 Aims using transgenic (Tg) mouse models and complementary
in vitro approaches.
============================================================
Key Molecular Mechanisms of TSEs
Zabel, Mark D.
Colorado State University-Fort Collins, Fort Collins, CO, United States
Abstract Prion diseases, or transmissible spongiform encephalopathies (TSEs),
are fatal neurodegenerative diseases affecting humans, cervids, bovids, and
ovids. The absolute requirement of PrPC expression to generate prion diseases
and the lack of instructional nucleic acid define prions as unique infectious
agents. Prions exhibit species-specific tropism, inferring that unique prion
strains exist that preferentially infct certain host species and confront
transmission barriers to heterologous host species. However, transmission
barriers are not absolute. Scientific consensus agrees that the sheep TSE
scrapie probably breached the transmission barrier to cattle causing bovine
spongiform encephalopathy that subsequently breached the human transmission
barrier and likely caused several hundred deaths by a new-variant form of the
human TSE Creutzfeldt-Jakob disease in the UK and Europe. The impact to human
health, emotion and economies can still be felt in areas like farming, blood and
organ donations and the threat of a latent TSE epidemic. This precedent raises
the real possibility of other TSEs, like chronic wasting disease of cervids,
overcoming similar human transmission barriers. A groundbreaking discovery made
last year revealed that mice infected with heterologous prion strains facing
significant transmission barriers replicated prions far more readily in spleens
than brains6. Furthermore, these splenic prions exhibited weakened transmission
barriers and expanded host ranges compared to neurogenic prions. These data
question conventional wisdom of avoiding neural tissue to avoid prion
xenotransmission, when more promiscuous prions may lurk in extraneural tissues.
Data derived from work previously funded by NIH demonstrate that Complement
receptors CD21/35 bind prions and high density PrPC and differentially impact
prion disease depending on the prion isolate or strain used. Recent advances in
live animal and whole organ imaging have led us to generate preliminary data to
support novel, innovative approaches to assessing prion capture and transport.
We plan to test our unifying hypothesis for this proposal that CD21/35 control
the processes of peripheral prion capture, transport, strain selection and
xenotransmission in the following specific aims. 1. Assess the role of CD21/35
in splenic prion strain selection and host range expansion. 2. Determine whether
CD21/35 and C1q differentially bind distinct prion strains 3. Monitor the
effects of CD21/35 on prion trafficking in real time and space 4. Assess the
role of CD21/35 in incunabular prion trafficking
Public Health Relevance Transmissible spongiform encephalopathies, or prion
diseases, are devastating illnesses that greatly impact public health,
agriculture and wildlife in North America and around the world. The impact to
human health, emotion and economies can still be felt in areas like farming,
blood and organ donations and the threat of a latent TSE epidemic. This
precedent raises the real possibility of other TSEs, like chronic wasting
disease (CWD) of cervids, overcoming similar human transmission barriers. Early
this year Canada reported its first case of BSE in over a decade audits first
case of CWD in farmed elk in three years, underscoring the need for continued
vigilance and research. Identifying mechanisms of transmission and zoonoses
remains an extremely important and intense area of research that will benefit
human and other animal populations.
Funding Agency Agency National Institute of Health (NIH)
Institute National Institute of Allergy and Infectious Diseases (NIAID)
Type High Priority, Short Term Project Award (R56)
Project # 1R56AI122273-01A1
Application # 9211114
Study Section Cellular and Molecular Biology of Neurodegeneration Study
Section (CMND)
Program Officer Beisel, Christopher E
Project Start 2016-02-16
Project End 2017-01-31
Budget Start 2016-02-16
Budget End 2017-01-31
Support Year 1
Fiscal Year 2016
Total Cost
Indirect Cost Institution Name Colorado State University-Fort Collins
Department Microbiology/Immun/Virology
Type Schools of Veterinary Medicine
DUNS # 785979618 City Fort Collins
State CO
Country United States
Zip Code 80523
PMCA Detection of CWD Infection in Cervid and Non-Cervid Species
Hoover, Edward Arthur
Colorado State University-Fort Collins, Fort Collins, CO, United States
Abstract Chronic wasting disease (CWD) of deer and elk is an emerging highly
transmissible prion disease now recognized in 18 States, 2 Canadian provinces,
and Korea. We have shown that Infected deer harbor and shed high levels of
infectious prions in saliva, blood, urine, and feces, and in the tissues
generating those body fluids and excreta, thereby leading to facile transmission
by direct contact and environmental contamination. We have also shown that CWD
can infect some non-cervid species, thus the potential risk CWD represents to
domestic animal species and to humans remains unknown. Whether prions borne in
blood, saliva, nasal fluids, milk, or excreta are generated or modified in the
proximate peripheral tissue sites, may differ in subtle ways from those
generated in brain, or may be adapted for mucosal infection remain open
questions. The increasing parallels in the pathogenesis between prion diseases
and human neurodegenerative conditions, such as Alzheimer's and Parkinson's
diseases, add relevance to CWD as a transmissible protein misfolding disease.
The overall goal of this work is to elucidate the process of CWD prion
transmission from mucosal secretory and excretory tissue sites by addressing
these questions: (a) What are the kinetics and magnitude of CWD prion shedding
post-exposure? (b) Are excreted prions biochemically distinct, or not, from
those in the CNS? (c) Are peripheral epithelial or CNS tissues, or both, the
source of excreted prions? and (d) Are excreted prions adapted for horizontal
transmission via natural/trans-mucosal routes? The specific aims of this
proposal are: (1) To determine the onset and consistency of CWD prion shedding
in deer and cervidized mice; (2); To compare the biochemical and biophysical
properties of excretory vs. CNS prions; (3) To determine the capacity of
peripheral tissues to support replication of CWD prions; (4) To determine the
protease- sensitive infectious fraction of excreted vs. CNS prions; and (5) To
compare the mucosal infectivity of excretory vs. CNS prions. Understanding the
mechanisms that enable efficient prion dissemination and shedding will help
elucidate how horizontally transmissible prions evolve and succeed, and is the
basis of this proposal. Understanding how infectious misfolded proteins (prions)
are generated, trafficked, shed, and transmitted will aid in preventing,
treating, and managing the risks associated with these agents and the diseases
they cause.
Public Health Relevance Chronic wasting disease (CWD) of deer and elk is an
emergent highly transmissible prion disease now recognized throughout the USA as
well as in Canada and Korea. We have shown that infected deer harbor and shed
high levels of infectious prions in saliva, blood, urine, and feces thereby
leading to transmission by direct contact and environmental contamination. In
that our studies have also shown that CWD can infect some non-cervid species,
the potential risk CWD may represents to domestic animal species and humans
remains unknown. The increasing parallels in the development of major human
neurodegenerative conditions, such as Alzheimer's and Parkinson's diseases, and
prion diseases add relevance to CWD as a model of a transmissible protein
misfolding disease. Understanding how infectious misfolded proteins (prions) are
generated and transmitted will aid in interrupting, treating, and managing the
risks associated with these agents and the diseases they cause.
Funding Agency Agency National Institute of Health (NIH)
Institute National Institute of Neurological Disorders and Stroke (NINDS)
Type Research Project (R01)
Project # 4R01NS061902-07
Application # 9010980
Study Section Cellular and Molecular Biology of Neurodegeneration Study
Section (CMND)
Program Officer Wong, May Project Start 2009-09-30
Project End 2018-02-28
Budget Start 2016-03-01
Budget End 2017-02-28
Support Year 7
Fiscal Year 2016
Total Cost $409,868
Indirect Cost $134,234 Institution Name Colorado State University-Fort
Collins
Department Microbiology/Immun/Virology
Type Schools of Veterinary Medicine
DUNS # 785979618 City Fort Collins
State CO
Country United States
Zip Code 80523
LOOKING FOR CWD IN HUMANS AS nvCJD or as an ATYPICAL CJD, LOOKING IN ALL
THE WRONG PLACES $$$
*** These results would seem to suggest that CWD does indeed have zoonotic
potential, at least as judged by the compatibility of CWD prions and their human
PrPC target. Furthermore, extrapolation from this simple in vitro assay suggests
that if zoonotic CWD occurred, it would most likely effect those of the PRNP
codon 129-MM genotype and that the PrPres type would be similar to that found in
the most common subtype of sCJD (MM1).***
PRION 2015 CONFERENCE FT. COLLINS CWD RISK FACTORS TO HUMANS
*** LATE-BREAKING ABSTRACTS PRION 2015 CONFERENCE ***
O18
Zoonotic Potential of CWD Prions
Liuting Qing1, Ignazio Cali1,2, Jue Yuan1, Shenghai Huang3, Diane Kofskey1,
Pierluigi Gambetti1, Wenquan Zou1, Qingzhong Kong1 1Case Western Reserve
University, Cleveland, Ohio, USA, 2Second University of Naples, Naples, Italy,
3Encore Health Resources, Houston, Texas, USA
*** These results indicate that the CWD prion has the potential to infect
human CNS and peripheral lymphoid tissues and that there might be asymptomatic
human carriers of CWD infection.
==================
***These results indicate that the CWD prion has the potential to infect
human CNS and peripheral lymphoid tissues and that there might be asymptomatic
human carriers of CWD infection.***
==================
P.105: RT-QuIC models trans-species prion transmission
Kristen Davenport, Davin Henderson, Candace Mathiason, and Edward Hoover
Prion Research Center; Colorado State University; Fort Collins, CO USA
Conversely, FSE maintained sufficient BSE characteristics to more
efficiently convert bovine rPrP than feline rPrP. Additionally, human rPrP was
competent for conversion by CWD and fCWD.
***This insinuates that, at the level of protein:protein interactions, the
barrier preventing transmission of CWD to humans is less robust than previously
estimated.
================
***This insinuates that, at the level of protein:protein interactions, the
barrier preventing transmission of CWD to humans is less robust than previously
estimated.***
================
*** PRICE OF CWD TSE PRION POKER GOES UP 2014 ***
Transmissible Spongiform Encephalopathy TSE PRION update January 2, 2014
*** chronic wasting disease, there was no absolute barrier to conversion of
the human prion protein.
*** Furthermore, the form of human PrPres produced in this in vitro assay
when seeded with CWD, resembles that found in the most common human prion
disease, namely sCJD of the MM1 subtype.
*** These results would seem to suggest that CWD does indeed have zoonotic
potential, at least as judged by the compatibility of CWD prions and their human
PrPC target. Furthermore, extrapolation from this simple in vitro assay suggests
that if zoonotic CWD occurred, it would most likely effect those of the PRNP
codon 129-MM genotype and that the PrPres type would be similar to that found in
the most common subtype of sCJD (MM1).***
*** The potential impact of prion diseases on human health was greatly
magnified by the recognition that interspecies transfer of BSE to humans by beef
ingestion resulted in vCJD. While changes in animal feed constituents and
slaughter practices appear to have curtailed vCJD, there is concern that CWD of
free-ranging deer and elk in the U.S. might also cross the species barrier.
Thus, consuming venison could be a source of human prion disease. Whether BSE
and CWD represent interspecies scrapie transfer or are newly arisen prion
diseases is unknown. Therefore, the possibility of transmission of prion disease
through other food animals cannot be ruled out. There is evidence that vCJD can
be transmitted through blood transfusion. There is likely a pool of unknown size
of asymptomatic individuals infected with vCJD, and there may be asymptomatic
individuals infected with the CWD equivalent. These circumstances represent a
potential threat to blood, blood products, and plasma supplies.
***********CJD REPORT 1994 increased risk for consumption of veal and
venison and lamb***********
CREUTZFELDT JAKOB DISEASE SURVEILLANCE IN THE UNITED KINGDOM THIRD ANNUAL
REPORT AUGUST 1994
Consumption of venison and veal was much less widespread among both cases
and controls. For both of these meats there was evidence of a trend with
increasing frequency of consumption being associated with increasing risk of
CJD. (not nvCJD, but sporadic CJD...tss)
These associations were largely unchanged when attention was restricted to
pairs with data obtained from relatives. ...
Table 9 presents the results of an analysis of these data.
There is STRONG evidence of an association between ‘’regular’’ veal eating
and risk of CJD (p = .0.01).
Individuals reported to eat veal on average at least once a year appear to
be at 13 TIMES THE RISK of individuals who have never eaten veal.
There is, however, a very wide confidence interval around this estimate.
There is no strong evidence that eating veal less than once per year is
associated with increased risk of CJD (p = 0.51).
The association between venison eating and risk of CJD shows similar
pattern, with regular venison eating associated with a 9 FOLD INCREASE IN RISK
OF CJD (p = 0.04).
There is some evidence that risk of CJD INCREASES WITH INCREASING FREQUENCY
OF LAMB EATING (p = 0.02).
The evidence for such an association between beef eating and CJD is weaker
(p = 0.14). When only controls for whom a relative was interviewed are included,
this evidence becomes a little STRONGER (p = 0.08).
snip...
It was found that when veal was included in the model with another
exposure, the association between veal and CJD remained statistically
significant (p = < 0.05 for all exposures), while the other exposures ceased
to be statistically significant (p = > 0.05).
snip...
In conclusion, an analysis of dietary histories revealed statistical
associations between various meats/animal products and INCREASED RISK OF CJD.
When some account was taken of possible confounding, the association between
VEAL EATING AND RISK OF CJD EMERGED AS THE STRONGEST OF THESE ASSOCIATIONS
STATISTICALLY. ...
snip...
In the study in the USA, a range of foodstuffs were associated with an
increased risk of CJD, including liver consumption which was associated with an
apparent SIX-FOLD INCREASE IN THE RISK OF CJD. By comparing the data from 3
studies in relation to this particular dietary factor, the risk of liver
consumption became non-significant with an odds ratio of 1.2 (PERSONAL
COMMUNICATION, PROFESSOR A. HOFMAN. ERASMUS UNIVERSITY, ROTTERDAM). (???...TSS)
snip...see full report ;
CJD9/10022
October 1994
Mr R.N. Elmhirst Chairman British Deer Farmers Association Holly Lodge
Spencers Lane BerksWell Coventry CV7 7BZ
Dear Mr Elmhirst,
CREUTZFELDT-JAKOB DISEASE (CJD) SURVEILLANCE UNIT REPORT
Thank you for your recent letter concerning the publication of the third
annual report from the CJD Surveillance Unit. I am sorry that you are
dissatisfied with the way in which this report was published.
The Surveillance Unit is a completely independant outside body and the
Department of Health is committed to publishing their reports as soon as they
become available. In the circumstances it is not the practice to circulate the
report for comment since the findings of the report would not be amended. In
future we can ensure that the British Deer Farmers Association receives a copy
of the report in advance of publication.
The Chief Medical Officer has undertaken to keep the public fully informed
of the results of any research in respect of CJD. This report was entirely the
work of the unit and was produced completely independantly of the the
Department.
The statistical results reqarding the consumption of venison was put into
perspective in the body of the report and was not mentioned at all in the press
release. Media attention regarding this report was low key but gave a realistic
presentation of the statistical findings of the Unit. This approach to
publication was successful in that consumption of venison was highlighted only
once by the media ie. in the News at one television proqramme.
I believe that a further statement about the report, or indeed statistical
links between CJD and consumption of venison, would increase, and quite possibly
give damaging credence, to the whole issue. From the low key media reports of
which I am aware it seems unlikely that venison consumption will suffer
adversely, if at all.
http://web.archive.org/web/20030511010117/http://www.bseinquiry.gov.uk/files/yb/1994/10/00003001.pdf
Monday, May 02, 2016
*** Zoonotic Potential of CWD Prions: An Update Prion 2016 Tokyo ***
*** PRION 2014 CONFERENCE CHRONIC WASTING DISEASE CWD
*** PPo3-7: Prion Transmission from Cervids to Humans is Strain-dependent
*** Here we report that a human prion strain that had adopted the cervid
prion protein (PrP) sequence through passage in cervidized transgenic mice
efficiently infected transgenic mice expressing human PrP,
*** indicating that the species barrier from cervid to humans is prion
strain-dependent and humans can be vulnerable to novel cervid prion strains.
PPo2-27:
Generation of a Novel form of Human PrPSc by Inter-species Transmission of
Cervid Prions
*** Our findings suggest that CWD prions have the capability to infect
humans, and that this ability depends on CWD strain adaptation, implying that
the risk for human health progressively increases with the spread of CWD among
cervids.
PPo2-7:
Biochemical and Biophysical Characterization of Different CWD Isolates
*** The data presented here substantiate and expand previous reports on the
existence of different CWD strains.
Envt.07:
Pathological Prion Protein (PrPTSE) in Skeletal Muscles of Farmed and Free
Ranging White-Tailed Deer Infected with Chronic Wasting Disease
***The presence and seeding activity of PrPTSE in skeletal muscle from
CWD-infected cervids suggests prevention of such tissue in the human diet as a
precautionary measure for food safety, pending on further clarification of
whether CWD may be transmissible to humans.
>>>CHRONIC WASTING DISEASE , THERE WAS NO ABSOLUTE BARRIER TO
CONVERSION OF THE HUMAN PRION PROTEIN<<<
*** PRICE OF CWD TSE PRION POKER GOES UP 2014 ***
Transmissible Spongiform Encephalopathy TSE PRION update January 2, 2014
Wednesday, January 01, 2014
Molecular Barriers to Zoonotic Transmission of Prions
*** chronic wasting disease, there was no absolute barrier to conversion of
the human prion protein.
*** Furthermore, the form of human PrPres produced in this in vitro assay
when seeded with CWD, resembles that found in the most common human prion
disease, namely sCJD of the MM1 subtype.
Using in vitro prion replication for high sensitive detection of prions and
prionlike proteins and for understanding mechanisms of transmission.
Claudio Soto
Mitchell Center for Alzheimer's diseases and related Brain disorders,
Department of Neurology, University of Texas Medical School at Houston.
Prion and prion-like proteins are misfolded protein aggregates with the
ability to selfpropagate to spread disease between cells, organs and in some
cases across individuals. I n T r a n s m i s s i b l e s p o n g i f o r m
encephalopathies (TSEs), prions are mostly composed by a misfolded form of the
prion protein (PrPSc), which propagates by transmitting its misfolding to the
normal prion protein (PrPC). The availability of a procedure to replicate prions
in the laboratory may be important to study the mechanism of prion and
prion-like spreading and to develop high sensitive detection of small quantities
of misfolded proteins in biological fluids, tissues and environmental samples.
Protein Misfolding Cyclic Amplification (PMCA) is a simple, fast and efficient
methodology to mimic prion replication in the test tube. PMCA is a platform
technology that may enable amplification of any prion-like misfolded protein
aggregating through a seeding/nucleation process. In TSEs, PMCA is able to
detect the equivalent of one single molecule of infectious PrPSc and propagate
prions that maintain high infectivity, strain properties and species
specificity. Using PMCA we have been able to detect PrPSc in blood and urine of
experimentally infected animals and humans affected by vCJD with high
sensitivity and specificity. Recently, we have expanded the principles of PMCA
to amplify amyloid-beta (Aβ) and alphasynuclein (α-syn) aggregates implicated in
Alzheimer's and Parkinson's diseases, respectively. Experiments are ongoing to
study the utility of this technology to detect Aβ and α-syn aggregates in
samples of CSF and blood from patients affected by these diseases.
=========================
***Recently, we have been using PMCA to study the role of environmental
prion contamination on the horizontal spreading of TSEs. These experiments have
focused on the study of the interaction of prions with plants and
environmentally relevant surfaces. Our results show that plants (both leaves and
roots) bind tightly to prions present in brain extracts and excreta (urine and
feces) and retain even small quantities of PrPSc for long periods of time.
Strikingly, ingestion of prioncontaminated leaves and roots produced disease
with a 100% attack rate and an incubation period not substantially longer than
feeding animals directly with scrapie brain homogenate. Furthermore, plants can
uptake prions from contaminated soil and transport them to different parts of
the plant tissue (stem and leaves). Similarly, prions bind tightly to a variety
of environmentally relevant surfaces, including stones, wood, metals, plastic,
glass, cement, etc. Prion contaminated surfaces efficiently transmit prion
disease when these materials were directly injected into the brain of animals
and strikingly when the contaminated surfaces were just placed in the animal
cage. These findings demonstrate that environmental materials can efficiently
bind infectious prions and act as carriers of infectivity, suggesting that they
may play an important role in the horizontal transmission of the disease.
========================
Since its invention 13 years ago, PMCA has helped to answer fundamental
questions of prion propagation and has broad applications in research areas
including the food industry, blood bank safety and human and veterinary disease
diagnosis.
see ;
with CWD TSE Prions, I am not sure there is any absolute yet, other than
what we know with transmission studies, and we know tse prion kill, and tse
prion are bad. science shows to date, that indeed soil, dirt, some better than
others, can act as a carrier. same with objects, farm furniture. take it with
how ever many grains of salt you wish, or not. if load factor plays a role in
the end formula, then everything should be on the table, in my opinion. see
;
***Recently, we have been using PMCA to study the role of environmental
prion contamination on the horizontal spreading of TSEs. These experiments have
focused on the study of the interaction of prions with plants and
environmentally relevant surfaces. Our results show that plants (both leaves and
roots) bind tightly to prions present in brain extracts and excreta (urine and
feces) and retain even small quantities of PrPSc for long periods of time.
Strikingly, ingestion of prioncontaminated leaves and roots produced disease
with a 100% attack rate and an incubation period not substantially longer than
feeding animals directly with scrapie brain homogenate. Furthermore, plants can
uptake prions from contaminated soil and transport them to different parts of
the plant tissue (stem and leaves). Similarly, prions bind tightly to a variety
of environmentally relevant surfaces, including stones, wood, metals, plastic,
glass, cement, etc. Prion contaminated surfaces efficiently transmit prion
disease when these materials were directly injected into the brain of animals
and strikingly when the contaminated surfaces were just placed in the animal
cage. These findings demonstrate that environmental materials can efficiently
bind infectious prions and act as carriers of infectivity, suggesting that they
may play an important role in the horizontal transmission of the disease.
Since its invention 13 years ago, PMCA has helped to answer fundamental
questions of prion propagation and has broad applications in research areas
including the food industry, blood bank safety and human and veterinary disease
diagnosis.
see ;
Oral Transmissibility of Prion Disease Is Enhanced by Binding to Soil
Particles
Author Summary
Transmissible spongiform encephalopathies (TSEs) are a group of incurable
neurological diseases likely caused by a misfolded form of the prion protein.
TSEs include scrapie in sheep, bovine spongiform encephalopathy (‘‘mad cow’’
disease) in cattle, chronic wasting disease in deer and elk, and
Creutzfeldt-Jakob disease in humans. Scrapie and chronic wasting disease are
unique among TSEs because they can be transmitted between animals, and the
disease agents appear to persist in environments previously inhabited by
infected animals. Soil has been hypothesized to act as a reservoir of
infectivity and to bind the infectious agent. In the current study, we orally
dosed experimental animals with a common clay mineral, montmorillonite, or whole
soils laden with infectious prions, and compared the transmissibility to unbound
agent. We found that prions bound to montmorillonite and whole soils remained
orally infectious, and, in most cases, increased the oral transmission of
disease compared to the unbound agent. The results presented in this study
suggest that soil may contribute to environmental spread of TSEs by increasing
the transmissibility of small amounts of infectious agent in the
environment.
tse prion soil
Saturday, May 28, 2016
*** Infection and detection of PrPCWD in soil from CWD infected farm in
Korea Prion 2016 Tokyo ***
Wednesday, December 16, 2015
Objects in contact with classical scrapie sheep act as a reservoir for
scrapie transmission
The sources of dust borne prions are unknown but it seems reasonable to
assume that faecal, urine, skin, parturient material and saliva-derived prions
may contribute to this mobile environmental reservoir of infectivity. This work
highlights a possible transmission route for scrapie within the farm
environment, and this is likely to be paralleled in CWD which shows strong
similarities with scrapie in terms of prion dissemination and disease
transmission. The data indicate that the presence of scrapie prions in dust is
likely to make the control of these diseases a considerable challenge.
>>>Particle-associated PrPTSE molecules may migrate from locations
of deposition via transport processes affecting soil particles, including
entrainment in and movement with air and overland flow. <<<
Fate of Prions in Soil: A Review
Christen B. Smith, Clarissa J. Booth, and Joel A. Pedersen*
Several reports have shown that prions can persist in soil for several
years. Significant interest remains in developing methods that could be applied
to degrade PrPTSE in naturally contaminated soils. Preliminary research suggests
that serine proteases and the microbial consortia in stimulated soils and
compost may partially degrade PrPTSE. Transition metal oxides in soil (viz.
manganese oxide) may also mediate prion inactivation. Overall, the effect of
prion attachment to soil particles on its persistence in the environment is not
well understood, and additional study is needed to determine its implications on
the environmental transmission of scrapie and CWD.
P.161: Prion soil binding may explain efficient horizontal CWD transmission
Conclusion. Silty clay loam exhibits highly efficient prion binding,
inferring a durable environmental reservoir, and an efficient mechanism for
indirect horizontal CWD transmission.
>>>Another alternative would be an absolute prohibition on the
movement of deer within the state for any purpose. While this alternative would
significantly reduce the potential spread of CWD, it would also have the
simultaneous effect of preventing landowners and land managers from implementing
popular management strategies involving the movement of deer, and would deprive
deer breeders of the ability to engage in the business of buying and selling
breeder deer. Therefore, this alternative was rejected because the department
determined that it placed an avoidable burden on the regulated
community.<<<
Wednesday, December 16, 2015
Objects in contact with classical scrapie sheep act as a reservoir for
scrapie transmission
Objects in contact with classical scrapie sheep act as a reservoir for
scrapie transmission
Timm Konold1*, Stephen A. C. Hawkins2, Lisa C. Thurston3, Ben C. Maddison4,
Kevin C. Gough5, Anthony Duarte1 and Hugh A. Simmons1
1 Animal Sciences Unit, Animal and Plant Health Agency Weybridge,
Addlestone, UK, 2 Pathology Department, Animal and Plant Health Agency
Weybridge, Addlestone, UK, 3 Surveillance and Laboratory Services, Animal and
Plant Health Agency Penrith, Penrith, UK, 4 ADAS UK, School of Veterinary
Medicine and Science, University of Nottingham, Sutton Bonington, UK, 5 School
of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington,
UK
Classical scrapie is an environmentally transmissible prion disease of
sheep and goats. Prions can persist and remain potentially infectious in the
environment for many years and thus pose a risk of infecting animals after
re-stocking. In vitro studies using serial protein misfolding cyclic
amplification (sPMCA) have suggested that objects on a scrapie affected sheep
farm could contribute to disease transmission. This in vivo study aimed to
determine the role of field furniture (water troughs, feeding troughs, fencing,
and other objects that sheep may rub against) used by a scrapie-infected sheep
flock as a vector for disease transmission to scrapie-free lambs with the prion
protein genotype VRQ/VRQ, which is associated with high susceptibility to
classical scrapie. When the field furniture was placed in clean accommodation,
sheep became infected when exposed to either a water trough (four out of five)
or to objects used for rubbing (four out of seven). This field furniture had
been used by the scrapie-infected flock 8 weeks earlier and had previously been
shown to harbor scrapie prions by sPMCA. Sheep also became infected (20 out of
23) through exposure to contaminated field furniture placed within pasture not
used by scrapie-infected sheep for 40 months, even though swabs from this
furniture tested negative by PMCA. This infection rate decreased (1 out of 12)
on the same paddock after replacement with clean field furniture. Twelve grazing
sheep exposed to field furniture not in contact with scrapie-infected sheep for
18 months remained scrapie free. The findings of this study highlight the role
of field furniture used by scrapie-infected sheep to act as a reservoir for
disease re-introduction although infectivity declines considerably if the field
furniture has not been in contact with scrapie-infected sheep for several
months. PMCA may not be as sensitive as VRQ/VRQ sheep to test for environmental
contamination.
snip...
Discussion
Classical scrapie is an environmentally transmissible disease because it
has been reported in naïve, supposedly previously unexposed sheep placed in
pastures formerly occupied by scrapie-infected sheep (4, 19, 20). Although the
vector for disease transmission is not known, soil is likely to be an important
reservoir for prions (2) where – based on studies in rodents – prions can adhere
to minerals as a biologically active form (21) and remain infectious for more
than 2 years (22). Similarly, chronic wasting disease (CWD) has re-occurred in
mule deer housed in paddocks used by infected deer 2 years earlier, which was
assumed to be through foraging and soil consumption (23).
Our study suggested that the risk of acquiring scrapie infection was
greater through exposure to contaminated wooden, plastic, and metal surfaces via
water or food troughs, fencing, and hurdles than through grazing. Drinking from
a water trough used by the scrapie flock was sufficient to cause infection in
sheep in a clean building. Exposure to fences and other objects used for rubbing
also led to infection, which supported the hypothesis that skin may be a vector
for disease transmission (9). The risk of these objects to cause infection was
further demonstrated when 87% of 23 sheep presented with PrPSc in lymphoid
tissue after grazing on one of the paddocks, which contained metal hurdles, a
metal lamb creep and a water trough in contact with the scrapie flock up to 8
weeks earlier, whereas no infection had been demonstrated previously in sheep
grazing on this paddock, when equipped with new fencing and field furniture.
When the contaminated furniture and fencing were removed, the infection rate
dropped significantly to 8% of 12 sheep, with soil of the paddock as the most
likely source of infection caused by shedding of prions from the
scrapie-infected sheep in this paddock up to a week earlier.
This study also indicated that the level of contamination of field
furniture sufficient to cause infection was dependent on two factors: stage of
incubation period and time of last use by scrapie-infected sheep. Drinking from
a water trough that had been used by scrapie sheep in the predominantly
pre-clinical phase did not appear to cause infection, whereas infection was
shown in sheep drinking from the water trough used by scrapie sheep in the later
stage of the disease. It is possible that contamination occurred through
shedding of prions in saliva, which may have contaminated the surface of the
water trough and subsequently the water when it was refilled. Contamination
appeared to be sufficient to cause infection only if the trough was in contact
with sheep that included clinical cases. Indeed, there is an increased risk of
bodily fluid infectivity with disease progression in scrapie (24) and CWD (25)
based on PrPSc detection by sPMCA. Although ultraviolet light and heat under
natural conditions do not inactivate prions (26), furniture in contact with the
scrapie flock, which was assumed to be sufficiently contaminated to cause
infection, did not act as vector for disease if not used for 18 months, which
suggest that the weathering process alone was sufficient to inactivate prions.
PrPSc detection by sPMCA is increasingly used as a surrogate for
infectivity measurements by bioassay in sheep or mice. In this reported study,
however, the levels of PrPSc present in the environment were below the limit of
detection of the sPMCA method, yet were still sufficient to cause infection of
in-contact animals. In the present study, the outdoor objects were removed from
the infected flock 8 weeks prior to sampling and were positive by sPMCA at very
low levels (2 out of 37 reactions). As this sPMCA assay also yielded 2 positive
reactions out of 139 in samples from the scrapie-free farm, the sPMCA assay
could not detect PrPSc on any of the objects above the background of the assay.
False positive reactions with sPMCA at a low frequency associated with de novo
formation of infectious prions have been reported (27, 28). This is in contrast
to our previous study where we demonstrated that outdoor objects that had been
in contact with the scrapie-infected flock up to 20 days prior to sampling
harbored PrPSc that was detectable by sPMCA analysis [4 out of 15 reactions
(12)] and was significantly more positive by the assay compared to analogous
samples from the scrapie-free farm. This discrepancy could be due to the use of
a different sPMCA substrate between the studies that may alter the efficiency of
amplification of the environmental PrPSc. In addition, the present study had a
longer timeframe between the objects being in contact with the infected flock
and sampling, which may affect the levels of extractable PrPSc. Alternatively,
there may be potentially patchy contamination of this furniture with PrPSc,
which may have been missed by swabbing. The failure of sPMCA to detect
CWD-associated PrP in saliva from clinically affected deer despite confirmation
of infectivity in saliva-inoculated transgenic mice was associated with as yet
unidentified inhibitors in saliva (29), and it is possible that the sensitivity
of sPMCA is affected by other substances in the tested material. In addition,
sampling of amplifiable PrPSc and subsequent detection by sPMCA may be more
difficult from furniture exposed to weather, which is supported by the
observation that PrPSc was detected by sPMCA more frequently in indoor than
outdoor furniture (12). A recent experimental study has demonstrated that
repeated cycles of drying and wetting of prion-contaminated soil, equivalent to
what is expected under natural weathering conditions, could reduce PMCA
amplification efficiency and extend the incubation period in hamsters inoculated
with soil samples (30). This seems to apply also to this study even though the
reduction in infectivity was more dramatic in the sPMCA assays than in the sheep
model. Sheep were not kept until clinical end-point, which would have enabled us
to compare incubation periods, but the lack of infection in sheep exposed to
furniture that had not been in contact with scrapie sheep for a longer time
period supports the hypothesis that prion degradation and subsequent loss of
infectivity occurs even under natural conditions.
In conclusion, the results in the current study indicate that removal of
furniture that had been in contact with scrapie-infected animals should be
recommended, particularly since cleaning and decontamination may not effectively
remove scrapie infectivity (31), even though infectivity declines considerably
if the pasture and the field furniture have not been in contact with
scrapie-infected sheep for several months. As sPMCA failed to detect PrPSc in
furniture that was subjected to weathering, even though exposure led to
infection in sheep, this method may not always be reliable in predicting the
risk of scrapie infection through environmental contamination. These results
suggest that the VRQ/VRQ sheep model may be more sensitive than sPMCA for the
detection of environmentally associated scrapie, and suggest that extremely low
levels of scrapie contamination are able to cause infection in susceptible sheep
genotypes.
Keywords: classical scrapie, prion, transmissible spongiform
encephalopathy, sheep, field furniture, reservoir, serial protein misfolding
cyclic amplification
Wednesday, December 16, 2015
*** Objects in contact with classical scrapie sheep act as a reservoir for
scrapie transmission ***
Monday, May 02, 2016
*** Zoonotic Potential of CWD Prions: An Update Prion 2016 Tokyo ***
***at present, no cervid PrP allele conferring absolute resistance to prion
infection has been identified.
P-145 Estimating chronic wasting disease resistance in cervids using real
time quaking- induced conversion
Nicholas J Haley1, Rachel Rielinqer2, Kristen A Davenport3, W. David
Walter4, Katherine I O'Rourke5, Gordon Mitchell6, Juergen A Richt2
1 Department of Microbiology and Immunology, Midwestern University, United
States; 2Department of Diagnostic Medicine and Pathobiology, Kansas State
University; 3Prion Research Center; Colorado State University; 4U.S. Geological
Survey, Pennsylvania Cooperative Fish and Wildlife Research Unit; 5Agricultural
Research Service, United States Department of Agriculture; 6Canadian Food
Inspection Agency, National and OlE Reference Laboratory for Scrapie and CWO
In mammalian species, the susceptibility to prion diseases is affected, in
part, by the sequence of the host's prion protein (PrP). In sheep, a gradation
from scrapie susceptible to resistant has been established both in vivo and in
vitro based on the amino acids present at PrP positions 136, 154, and 171, which
has led to global breeding programs to reduce the prevalence of scrapie in
domestic sheep. In cervids, resistance is commonly characterized as a delayed
progression of chronic wasting disease (CWD); at present, no cervid PrP allele
conferring absolute resistance to prion infection has been identified. To model
the susceptibility of various naturally-occurring and hypothetical cervid PrP
alleles in vitro, we compared the amplification rates and efficiency of various
CWD isolates in recombinant PrPC using real time quaking-induced conversion. We
hypothesized that amplification metrics of these isolates in cervid PrP
substrates would correlate to in vivo susceptibility - allowing susceptibility
prediction for alleles found at 10 frequency in nature, and that there would be
an additive effect of multiple resistant codons in hypothetical alleles. Our
studies demonstrate that in vitro amplification metrics predict in vivo
susceptibility, and that alleles with multiple codons, each influencing
resistance independently, do not necessarily contribute additively to
resistance. Importantly, we found that the white-tailed deer 226K substrate
exhibited the slowest amplification rate among those evaluated, suggesting that
further investigation of this allele and its resistance in vivo are warranted to
determine if absolute resistance to CWD is possible.
***at present, no cervid PrP allele conferring absolute resistance to prion
infection has been identified.
PRION 2016 CONFERENCE TOKYO
Prion protein gene sequence and chronic wasting disease susceptibility in
white-tailed deer (Odocoileus virginianus)
Adam L Brandt, Amy C Kelly, Michelle L Green, Paul Shelton, Jan Novakofski
& Nohra E Mateus-Pinilla To cite this article: Adam L Brandt, Amy C Kelly,
Michelle L Green, Paul Shelton, Jan Novakofski & Nohra E Mateus-Pinilla
(2015) Prion protein gene sequence and chronic wasting disease susceptibility in
white-tailed deer (Odocoileus virginianus), Prion, 9:6, 449-462, DOI:
10.1080/19336896.2015.1115179 To link to this article: http://dx.doi.org/10.1080/19336896.2015.1115179
Prion, 9:449–462, 2015 Published with license by Taylor & Francis
Group, LLC ISSN: 1933-6896 print / 1933-690X online DOI:
10.1080/19336896.2015.1115179
RESEARCH PAPER Prion protein gene sequence and chronic wasting disease
susceptibility in white-tailed deer (Odocoileus virginianus) Adam L Brandt1, Amy
C Kelly1, Michelle L Green1,2, Paul Shelton3, Jan Novakofski2,*, and Nohra E
Mateus-Pinilla1,2 1Illinois Natural History Survey; University of Illinois at
Urbana-Champaign; Urbana, IL USA; 2Department of Animal Sciences; University of
Illinois at Urbana-Champaign; Urbana, IL USA; 3Illinois Department of Natural
Resources; Division of Wildlife Resources; Springfield, IL USA
ABSTRACT.
The sequence of the prion protein gene (PRNP) affects susceptibility to
spongiform encephalopathies, or prion diseases in many species. In white-tailed
deer, both coding and noncoding single nucleotide polymorphisms have been
identified in this gene that correlate to chronic wasting disease (CWD)
susceptibility. Previous studies examined individual nucleotide or amino acid
mutations; here we examine all nucleotide polymorphisms and their combined
effects on CWD. A 626 bp region of PRNP was examined from 703 free-ranging
white-tailed deer. Deer were sampled between 2002 and 2010 by hunter harvest or
government culling in Illinois and Wisconsin. Fourteen variable nucleotide
positions were identified (4 new and 10 previously reported). We identified 68
diplotypes comprised of 24 predicted haplotypes, with the most common diplotype
occurring in 123 individuals. Diplotypes that were found exclusively among
positive or negative animals were rare, each occurring in less than 1% of the
deer studied. Only one haplotype (C, odds ratio 0.240) and 2 diplotypes (AC and
BC, odds ratios of 0.161 and 0.108 respectively) has significant associations
with CWD resistance. Each contains mutations (one synonymous nucleotide 555C/T
and one nonsynonymous nucleotide 286G/A) at positions reported to be
significantly associated with reduced CWD susceptibility. Results suggest that
deer populations with higher frequencies of haplotype C or diplotypes AC and BC
might have a reduced risk for CWD infection – while populations with lower
frequencies may have higher risk for infection. Understanding the genetic basis
of CWD has improved our ability to assess herd susceptibility and direct
management efforts within CWD infected areas.
Adam L Brandt, Amy C Kelly, Michelle L Green, Paul Shelton, Jan
Novakofski, and Nohra E Mateus-Pinilla *Correspondence to: Jan Novakofski;
Email: jnova@illinois.edu Received September 21, 2015; Revised October 23, 2015;
Accepted October 23, 2015. Color versions of one or more of the figures in the
article can be found online atwww.tandfonline.com/kprn. This is an Open Access
article distributed under the terms of the Creative Commons
Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),
which permits unrestricted non-commercial use, distribution, and reproduction in
any medium, provided the original work is properly cited. The moral rights of
the named author(s) have been asserted.
DISCUSSION
In this study, we find reduced susceptibility to CWD infection among
white-tailed deer with haplotype C (Table 2). We still observed individual deer
positive for CWD with this haplotype, demonstrating a reduced susceptibility
rather than a complete genetic resistance as is seen with other TSEs (e.g.,
scrapie36,37). This haplotype had 2 different polymorphisms, 1 synonymous and 1
non-synonymous, both reported to be associated with decreased infection; nt286A
(aa96S) and nt555T.10,26,29,30 Other haplotypes have similar mutations at nt286
and nt555 (e.g., haplotypes I, Q, and S); though, within the CWD infection area
these haplotypes are not found at all (haplotype Q), occur infrequently (f <
0.01, haplotypes I and S), or are found exclusively among positive deer
(haplotype I). A number of other haplotypes have the same mutations at either
nt286 or nt555; again most are absent (haplotypes H, V, W and X), infrequent (f
< 0.01, haplotypes N and P), or are found abundantly among positive deer
(haplotype B) in the CWD infection area (Table 2). Rarity of these haplotypes
prevents any meaningful association with changes in susceptibility (Table 2).
The effects of mutations at nt286 and nt555 alone or in concert are unclear as
other haplotypes with these polymorphisms occur infrequently and with varied
susceptibility. An even larger sampling may be necessary to resolve this
interaction.
Neither haplotypes with aa95H (nt285C) had a significantly reduced
susceptibility to CWD (Table 2). Some previous studies reported the occurrence
of this mutation among CWD negative deer only, which was interpreted as CWD
resistance.26,29 In this study and in the study by Kelly et al.10 the aa95H
mutation was found among deer positive for CWD; however, we find in a larger
sampling (ND240) the frequency of aa95H to be lower than that found by Kelly et
al.10 and not significantly associated with resistance. We cannot preclude the
importance of this mutation given that a significant difference in disease
susceptibility may be possible with an even larger sample size providing greater
statistical power (data not shown).
The presence of aa96S has been associated with slowed disease progression,
longer life span among captive deer,26,27 and does not appear to affect the rate
at which prions are shed from infected individuals.38 Additionally, CWD infected
mule deer have been found to excrete pathogenic prions while asymptomatic. 39
This contributes to concerns that wild deer with aa96S may be shedding
infectious prions into the environment for longer periods of time than deer
lacking the mutation, but are not symptomatic or detectable by
immunohistochemical procedures. On the other hand, studies using epidemiological
modeling suggest that deer with aa96S under certain conditions may have a
selective advantage for CWD resistance over those without.40 With our data, we
are unable to make accurate conclusions about detection, longevity, or increased
risks of exposure to infectious prions. Nonetheless, our results do corroborate
the importance of the polymorphism at G96S in reduced CWD susceptibility (Table
5).26,30
Kelly et al.10 found a negative correlation between the number of
nucleotide deviations from the PRNP consensus sequence and CWD infection. The
database derived consensus sequence reported is the same as the most common
haplotype (haplotype A) in this study (Table 1). Haplotype C has 2 deviations
from haplotype A; other haplotypes were found containing more deviations but
were exceedingly rare (Table 1). These haplotypes (namely haplotypes I, N, Q, S,
and X) were largely absent among CWD positive deer (only 2 positive deer were
found each with a single copy of haplotype I) and their combined frequency was
less than 1%. An increased number of polymorphisms may improve resistance to
CWD, but the large sample size of this study (ND703) suggests that haplotypes
with more than 2 nucleotide deviations are rare and would not be likely to have
an appreciable effect on resistance or susceptibility within the
population.
Examination of PRNP diplotypes revealed that individuals with at least one
copy of haplotype C (specifically AC and BC) were less likely to test positive
for CWD (Table 4). Other diplotypes containing at least one copy of haplotype C
(mutations at aa96S and nt555T) had a low frequency of occurrence (<1 41="" a="" account="" additional="" address="" age="" all="" always="" analyses="" and="" animals.="" animals="" any="" are="" area.="" area="" as="" association="" at="" attempted="" available="" average="" avoid="" background.29="" basis="" be="" been="" between="" bias.="" but="" by="" c="" cases="" circumstances="" conditions="" confounding="" control="" controlled="" could="" counties="" county="" cwd.="" cwd="" decreasing="" deer43-45="" deer="" design="" determining="" diplotypes="" disease="" distances="" div="" due="" examined="" experimental="" exposed="" factor="" factors="" family="" for="" found="" free="" frequency="" frequent="" from="" genetic="" geographic="" greater="" groups="" haplotype="" harvest.="" have="" herd="" home="" hunter="" i.e.="" ideal="" identified="" illinois="" immunity="" in="" increase="" increasing="" indication="" individually="" infected="" infection="" inheritance="" is="" less="" likelihood="" likely="" locations="" low="" management="" match="" matched-case="" may="" minimize="" more="" multiple="" nature="" negative="" nonetheless="" not="" obtainable="" of="" on="" one="" or="" origin="" originating="" other="" outside="" over="" paired-case="" paired="" perfectly="" play="" population-level="" positive="" possible="" potential="" prnp="" randomly="" range="" ranging="" relatedness="" relationship="" resistance="" restricted="" results="" role="" samples="" sampling="" selected="" sequence="" sex="" significant="" similar="" spurious="" statistical="" status="" strong="" studies="" study="" studying="" suggesting="" susceptibility.="" susceptibility="" than="" that="" the="" therefore="" these="" they="" this="" though="" through="" throughout="" time="" to="" under="" use="" vital="" was="" were="" when="" whitetailed="" with="" without="">
1>
Tuesday, August 02, 2016
1>
The PRNP gene is variable within all species with some mutations affecting
susceptibility to TSEs.46-48 Scrapie infection in sheep is the classic example
of genetic resistance to a prion disease, where individuals with 2 copies of
amino acid sequence V136, R154, Q171 are susceptible to scrapie, and those with
2 copies of the sequence A136, R154, R171 are resistant. 36,37 Changes in the
protein coding sequence have been shown to affect the ability of pathogenic
prions to convert normal prion proteins31; accordingly, many studies have
heavily examined the amino acid variations associated with CWD. Synonymous or
silent mutations are often overlooked, but may have a greater effect on protein
expression and conformation than expected.49-53Other studies have found
significant associations between individual synonymous mutations and CWD
susceptibility. 10,28 The specific mechanisms involved between nucleotide
variation (specifically synonymous mutations) and CWD are not known, but the
rate at which PrPC conformations that are more favorable to PrPSC conversion are
produced may be slowed by the presence of certain synonymous mutations.51 Due to
the low frequency of haplotypes with similar mutations as haplotype C, we cannot
accurately conclude whether or not the specific combination of mutations or any
one mutation alone is responsible for reduced CWD susceptibility. Nevertheless,
haplotype and diplotype analyses provide more insight in gene-disease
association than those restricted to alleles and genotypes54 which are unable to
detect additive effects.
A solid understanding of the genetics of CWD in white-tailed deer is vital
to improve management of CWD on the landscape. Most TSEs are found in domestic
or captive animals where management of infected individuals is feasible. For
example, scrapie infected flocks can be handled through a process generally
involving genetic testing, removal and destruction of infected or suspect
animals, followed by decontamination of facilities and equipment.55 Containment
of free ranging deer in wild populations potentially infected with CWD and
decontamination of the environment is not reasonably possible. The long term
effects of CWD are not yet known but it is conceivable that an unmanaged
infected population would be gradually extirpated as the disease progresses
56,57 or at least reduced to low densities with high disease prevalence.58,59
Either outcome would have severe ecological effects (e.g., deer play a major
role in affecting plant communities60 and as a prey source61,62) as well as
negative economic impacts to hunting. Overall disease prevalence has remained at
relatively low levels in Illinois compared to Wisconsin. 11 It is important to
note that at the time of sampling, CWD had been found in 6 Illinois counties and
has since been detected in 14.9 Complete eradication of CWD among free ranging
white-tailed deer may not be possible; however, an active containment effort in
Illinois appears to have prevented significant increases in prevalence.9,11,12
Further examination of PRNP haplotype and diplotype frequencies across northern
Illinois and southern Wisconsin in conjunction with population structure and
movement45,63,64 will be useful in identifying localities with greater or
reduced susceptibility risk. Effectiveness of CWD containment efforts can be
aided through genetic testing and redirecting management resources.
snip...
CWD TESTING
Other diagnostic tests and technologies that allow more rapid testing of
larger numbers of samples continue to be developed. A rectal associated mucosal
lymphoid tissue (RAMALT) biopsy (live-animal) test has been developed by
researchers and appears to hold promise for future use in certain CWD monitoring
or management situations in farmed cervids. This technique utilizes the current
IHC testing technologies described above.
*** The RAMALT is not currently approved as an official test for CWD.
Seeded amplification of chronic wasting disease prions in nasal brushings
and recto-anal mucosa associated lymphoid tissues from elk by real time
quaking-induced conversion
Nicholas J. Haley#,a, Chris Siepkera, Laura L. Hoon-Hanksb, Gordon
Mitchellc, W. David Walterd, Matteo Mancae, Ryan J. Monellof, Jenny G. Powersf,
Margaret A. Wildf, Edward A. Hooverb, Byron Caugheye and Jürgen A. Richta +
Author Affiliations
Department of Diagnostic Medicine and Pathobiology, College of Veterinary
Medicine, Kansas State University (KSU), Manhattan, KS, USAa Department of
Microbiology, Immunology and Pathology, College of Veterinary Medicine and
Biomedical Sciences, Colorado State University, Fort Collins, CO, USAb Canadian
Food Inspection Agency, National and OIE Reference Laboratory for Scrapie and
CWD, Ottawa Laboratory Fallowfield, Ottawa, ON, Canadac U.S. Geological Survey,
Pennsylvania Cooperative Fish and Wildlife Research Unit, The Pennsylvania State
University, University Park, PA, USAd TSE/Prion Biochemistry Section, Laboratory
of Persistent Viral Diseases, Rocky Mountain Laboratories (RML), National
Institute of Allergy and Infectious Diseases, Hamilton, MT, USAe National Park
Service, Biological Resources Division, 1201 Oak Ridge Drive, Suite 200, Fort
Collins, Colorado 80525, USAf
ABSTRACT
Chronic wasting disease (CWD), a transmissible spongiform encephalopathy of
cervids, was first documented nearly fifty years ago in Colorado and Wyoming,
and has since been detected across North America and to the Republic of Korea.
The expansion of this disease makes the development of sensitive diagnostic
assays and antemortem sampling techniques crucial for the mitigation of spread;
this is especially true in cases of relocation/reintroduction, or prevalence
studies in large or protected herds where depopulation may be contraindicated.
This study sought to evaluate the sensitivity of the real-time quaking-induced
conversion (RT-QuIC) assay in recto-anal mucosa associated lymphoid tissue
(RAMALT) biopsies and nasal brushings collected antemortem. These findings were
compared to results from ante- and postmortem samples evaluated using
immunohistochemistry (IHC). RAMALT samples were collected from populations of
farmed and free-ranging Rocky Mountain elk (Cervus elaphus nelsoni, n=323), with
nasal brushes collected from a subpopulation of these animals (n=205). We
hypothesized the sensitivity of RT-QuIC would be comparable to IHC in RAMALT,
and would correspond to IHC of postmortem tissues. We found RAMALT sensitivity
(77.3%) to be highly correlative between RT-QuIC and IHC. Sensitivity was lower
when testing nasal brushings (34%), though both RAMALT and nasal brush
sensitivities were dependent on both PRNP genotype and disease progression
determined by obex score. These data suggest that RT-QuIC, like IHC, is a
relatively sensitive assay for detection of CWD prions in RAMALT biopsies, and
with further investigation has potential for large scale and rapid automated
testing for CWD in antemortem samples.
FOOTNOTES
↵#Corresponding author (e-mail: nicholas.j.haley@gmail.com) Copyright ©
2016, American Society for Microbiology. All Rights Reserved. http://jcm.asm.org/content/early/2016/02/11/JCM.02700-15.abstract
Saturday, February 20, 2016
Seeded amplification of chronic wasting disease prions in nasal brushings
and recto-anal mucosa associated lymphoid tissues from elk by real time
quaking-induced conversion
Sunday, February 14, 2016
Antemortem detection of chronic wasting disease prions in nasal brush
collections and rectal biopsies from white-tailed deer by real time
quaking-induced conversion
Research Project: TRANSMISSION, DIFFERENTIATION, AND PATHOBIOLOGY OF
TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
Title: Antemortem detection of chronic wasting disease prions in nasal
brush collections and rectal biopsies from white-tailed deer by real time
quaking-induced conversion
Authors
item Haley, Nicholas - item Siepker, Chris - item Walter, W. David - item
Thomsen, Bruce - item Greenlee, Justin item Lehmkuhl, Aaron - item Richt, Jürgen
-
Submitted to: Journal of Clinical Microbiology Publication Type: Peer
Reviewed Journal Publication Acceptance Date: November 27, 2015 Publication
Date: February 10, 2016 Citation: Haley, N.J., Siepker, C., Walter, W.D.,
Thomsen, B.V., Greenlee, J.J., Lehmkuhl, A.D., Richt, J.A. 2016. Antemortem
detection of chronic wasting disease prions in nasal brush collections and
rectal biopsy specimens from white-tailed deer by real time quaking-induced
conversion. Journal of Clinical Microbiology. 54(4):1108-1116.
Interpretive Summary: Chronic Wasting Disease (CWD), a fatal
neurodegenerative disease that occurs in farmed and wild cervids (deer and elk)
of North America, is a transmissible spongiform encephalopathy (TSE). TSEs are
caused by infectious proteins called prions that are resistant to various
methods of decontamination and environmental degradation. Early diagnosis of CWD
in wild and captive herds would be very helpful to controlling the spread of
CWD, for which there are not yet any preventative or treatment measures
available. The purpose of this study was to test a laboratory method of prion
detection (real-time Quaking Induced Conversion; RT-QuIC) that has the potential
to detect very low levels of infectious prions in samples collected from live
animals against the gold standard diagnostic where abnormal prion in tissues is
stained on a microscope slide. This study reports that RT-QuIC detects more
cases of CWD than standard methods, but also can identify a small number of
animals without CWD as being positive. In the case of CWD, where it is likely
that large numbers of animals within a herd may be positive, misidentifying a
negative as a positive may have less of an impact than in the case of other
prion diseases such as bovine spongiform encephalopathy considering that this
test allows testing much larger numbers of samples with a faster turn around
time than traditional methods. This information could have an impact on
regulatory and wildlife officials developing plans to reduce or eliminate CWD
and cervid farmers that want to ensure that their herd remains CWD-free.
Technical Abstract: Chronic wasting disease (CWD), a transmissible
spongiform encephalopathy of cervids, was first documented nearly fifty years
ago in Colorado and Wyoming and has since spread to cervids in 23 states, 2
Canadian provinces, and the Republic of Korea. The increasing expansion of this
disease makes the development of sensitive diagnostic assays and antemortem
sampling techniques crucial for the mitigation of spread; this is especially
true in cases of relocation/reintroduction of farmed or free-ranging deer and
elk, or surveillance studies in private or protected herds where depopulation
may be contraindicated. This study sought to evaluate the sensitivity of the
real-time quaking-induced conversion (RT-QuIC) assay in samples collected
antemortem. Antemortem findings were then compared to results from ante- and
postmortem samples evaluated using the current gold standard diagnostic assay,
immunohistochemistry (IHC). Recto-anal mucosal associated lymphoid tissue
(RAMALT) biopsies and nasal brush collections from three separate herds of
farmed white-tailed deer (n=409) were evaluated, along with standard postmortem
microscopic analysis of brainstem at the level of the obex and retropharyngeal
lymph nodes. We hypothesized the sensitivity of RT-QuIC would be comparable to
IHC in antemortem tissues, and would correlate with both genotype and stage of
clinical disease. Our results showed that RAMALT testing by RT-QuIC had the
highest sensitivity (69.8%) when compared to postmortem testing. This data
suggests that RT-QuIC, like IHC, is a fairly sensitive assay for detection of
CWD prions in rectal biopsies and other antemortem samples, and with further
investigation has potential for large scale and rapid automated testing for CWD
diagnosis.
Research Project: TRANSMISSION, DIFFERENTIATION, AND PATHOBIOLOGY OF
TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
Title: Clinical stage of infection is critical in the antemortem diagnosis
of chronic wasting disease in deer and elk
Authors
item Siepker, Chris - item Haley, Nicholas - item Walter, W. David - item
Hoon-Hanks, Laura - item Monello, Ryan - item Powers, Jenny - item Greenlee,
Justin item Thomsen, Bruce - item Lehmkuhl, Aaron - item Mitchell, Gordon - item
Nichols, Tracy - item Hoover, Edward - item Richt, Juergen -
Submitted to: Prion Publication Type: Abstract Only Publication Acceptance
Date: March 5, 2015 Publication Date: N/A
Technical Abstract: Chronic wasting disease (CWD) is an efficiently
transmitted spongiform encephalopathy of cervids (e.g. deer, elk, and moose),
and is the only known prion disease affecting both free-ranging wildlife and
captive animals. The antemortem detection of CWD and other prion diseases has
proven difficult, due in part to difficulties in identifying an appropriate
peripheral tissue specimen and complications with conventional test sensitivity.
At present, biopsies of the recto-anal mucosal-associated lymphoid tissues
(RAMALT) have shown promising sensitivity and are practical to collect in live
animals. Nasal brush collections have likewise proven both sensitive and
practical for identification of prion infections in humans. In this study, we
evaluated both RAMALT and nasal brush collections by real time quaking-induced
conversion (RT-QuIC), and compared our findings to RAMALT immunohistochemistry
as well as conventional postmortem evaluation of obex and retropharyngeal lymph
node tissues from over 700 captive and free-ranging deer and elk in areas with
endemic CWD. We correlated our results with various clinical findings, including
pathological stage of infection as determined by obex scoring, PrP genotype,
age, and sex. While the sensitivity of RAMALT RT-QuIC analyses exceeded that of
RAMALT IHC (69-80% vs. >44%) and nasal brush collections (15-30%), the
sensitivity of both biopsy and nasal brush analyses were dependent primarily on
clinical stage of disease, although PrP genotype was also an important predictor
of sample positivity. ***Our findings further demonstrate the potential and
limitations of antemortem sample analyses by RT-QuIC in the identification and
management of prion diseases.
*** CHRONIC WASTING DISEASE TESTING PROTOCAL FOR WILD CERVIDAE proposing
the United States Animal Health Association (USAHA) urge the USDA to amend CFR
81.3 ***
Committee Business:
One resolution was proposed by a committee member titled CHRONIC WASTING
DISEASE TESTING PROTOCAL FOR WILD CERVIDAE proposing the United States Animal
Health Association (USAHA) urge the USDA to amend CFR 81.3 (b); proposing wild
cervids captured for interstate movement and release, have two forms of
identification, one of which that is official identification, must be PrP
genotyped for Chronic Wasting Disease resistance, tested for Chronic Wasting
Disease using a rectal biopsy test. The committee discussed and debated the
terms and science related to this resolution proposal including that currently
there is no science indicating there are “genotype resistant” cervids to
acquiring the CWD prion. The term “resistant” is miss-leading. There are only
different cervid genotypes that acquire the infectious prions at different rates
and show clinical signs at variable rates, some at prolonged periods after
acquiring the prion or they are slow to accumulate detectable levels.. Since all
infected animals would be presumed to be capable of shedding the prions into the
environment, genotypes with clinical “resistance” or prolonged indication of
clinical presentation of the disease, may well potentially be considered
prolonged shedders of the prion. Additionally there was discussion put forth by
several committee members concerning the lack of regulatory validation of the
rectal biopsy test. Also, the test can only be used on young animals and there I
significant test sensitivity and specificity variability between cervid species
when using this test. A new motion to the proposed resolution was to table this
resolution, reword the resolution potentially to be a recommendation for USDA to
provide a guidance document to the states for surveillance of CWD on interstate
translocations od wild cervids. It was proposed that this new
resolution/recommendation be discussed during the Farmed Cervid Subcommittee and
forward then to the Captive Wildlfie and Alternative Livestock committee. The
motion was proposed by member Charlie Seale and seconded by member Sean Shaffer
which was passed by committee. The Committee on Wildlife Diseases adjourned at
515 PM.
Tuesday, September 22, 2015
*** Host Determinants of Prion Strain Diversity Independent of Prion
Protein Genotype
Friday, August 28, 2015
*** Chronic Wasting Disease CWD TSE Prion Diagnostics and subclinical
infection
Monday, July 18, 2016
Texas Parks Wildlife Dept TPWD HIDING TSE (CWD) in Deer Herds, Farmers
Sampling Own Herds, Rapid Testing, False Negatives, a Recipe for Disaster
Tuesday, August 02, 2016
Chronic wasting disease of deer – is the battle to keep Europe free already
lost?
Tuesday, April 12, 2016
The first detection of Chronic Wasting Disease (CWD) in Europe free-ranging
reindeer from the Nordfjella population in South-Norway.
Tuesday, June 14, 2016
*** Chronic Wasting Disease (CWD) in a moose from Selbu in Sør-Trøndelag
Norway ***
Thursday, July 07, 2016
Norway reports a third case Chronic Wasting Disease CWD TSE Prion in 2nd
Norwegian moose
14/06/2016 - Norway reports a third case
Saturday, July 16, 2016
Chronic wasting Disease in Deer (CWD or Spongiform Encephalopathy) The
British Deer Society 07/04/2016
Red Deer Ataxia or Chronic Wasting Disease CWD TSE PRION?
could this have been cwd in the UK back in 1970’S ???
SEE FULL TEXT ;
Wednesday, August 10, 2016
Arkansas Chronic Wasting Disease CWD TSE Prion Potentially Trucked in from
Missouri, what about Florida and ?
Wednesday, July 27, 2016
Arkansas CWD 101 positive cases documented to date, Biologists to take
additional samples in in southern Pope County, Aug. 1-5
Saturday, July 09, 2016
Texas Intrastate – within state movement of all Cervid or Trucking Chronic
Wasting Disease CWD TSE Prion Moratorium
Friday, July 01, 2016
*** TEXAS Thirteen new cases of chronic wasting disease (CWD) were
confirmed at a Medina County captive white-tailed deer breeding facility on June
29, 2016***
Tuesday, August 02, 2016
TEXAS TPWD Sets Public Hearings on Deer Movement Rule Proposals in Areas
with CWD Rule Terry S. Singeltary Sr. comment submission
Friday, July 29, 2016
IOWA CHRONIC WASTING DISEASE CWD TSE PRION TOTAL TO DATE 304 CASES WILD AND
CAPTIVE REPORT UPDATE JULY 2016
Friday, August 05, 2016
MINNESOTA CHRONIC WASTING DISEASE SURVEILLANCE AND TESTING CWD TSE PRION
UPDATE
Monday, August 01, 2016
Florida Fish and Wildlife Conservation Commission CWD TSE Prion
Surveillance Monitoring Programs and Testing
Tuesday, July 19, 2016
MONTANA CHRONIC WASTING DISEASE CWD TSE PRION UPDATE STILL SHOWS ONLY 9
CAPTIVE CASES CONFIRMED FROM Philipsburg Kesler Game game since 1999
Sunday, July 17, 2016
Virginia Chronic Wasting Disease CWD As of March 2016 has diagnosed 13
CWD-positive white-tailed deer
Sunday, July 17, 2016
West Virginia Chronic Wasting Disease CWD has been found in 195
white-tailed deer As of June 2016
Sunday, May 08, 2016
WISCONSIN CHRONIC WASTING DISEASE CWD TSE PRION SPIRALING FURTHER INTO THE
ABYSS UPDATE
Tuesday, March 08, 2016
Oklahoma Chronic Wasting Disease CWD of Deer and Elk Surveillance, Testing,
and Preparedness
Wednesday, April 27, 2016
WYOMING GAME AND FISH DEPARTMENT CHRONIC WASTING DISEASE MANAGEMENT PLAN
APRIL 22, 2016
Sunday, July 17, 2016
*** CHRONIC WASTING DISEASE CWD TSE PRION GLOBAL REPORT UPDATE JULY 17 2016
***
Friday, February 05, 2016
*** Report of the Committee on Wildlife Diseases FY2015 CWD TSE PRION
Detections in Farmed Cervids and Wild ***
Friday, August 14, 2015
*** Susceptibility of cattle to the agent of chronic wasting disease from
elk after intracranial inoculation ***
Chronic Wasting Disease Susceptibility of Four North American Rodents
Chad J. Johnson1*, Jay R. Schneider2, Christopher J. Johnson2, Natalie A.
Mickelsen2, Julia A. Langenberg3, Philip N. Bochsler4, Delwyn P. Keane4, Daniel
J. Barr4, and Dennis M. Heisey2 1University of Wisconsin School of Veterinary
Medicine, Department of Comparative Biosciences, 1656 Linden Drive, Madison WI
53706, USA 2US Geological Survey, National Wildlife Health Center, 6006
Schroeder Road, Madison WI 53711, USA 3Wisconsin Department of Natural
Resources, 101 South Webster Street, Madison WI 53703, USA 4Wisconsin Veterinary
Diagnostic Lab, 445 Easterday Lane, Madison WI 53706, USA *Corresponding author
email: cjohnson@svm.vetmed.wisc.edu
We intracerebrally challenged four species of native North American rodents
that inhabit locations undergoing cervid chronic wasting disease (CWD)
epidemics. The species were: deer mice (Peromyscus maniculatus), white-footed
mice (P. leucopus), meadow voles (Microtus pennsylvanicus), and red-backed voles
(Myodes gapperi). The inocula were prepared from the brains of hunter-harvested
white-tailed deer from Wisconsin that tested positive for CWD. Meadow voles
proved to be most susceptible, with a median incubation period of 272 days.
Immunoblotting and immunohistochemistry confirmed the presence of PrPd in the
brains of all challenged meadow voles. Subsequent passages in meadow voles lead
to a significant reduction in incubation period. The disease progression in
red-backed voles, which are very closely related to the European bank vole (M.
glareolus) which have been demonstrated to be sensitive to a number of TSEs, was
slower than in meadow voles with a median incubation period of 351 days. We
sequenced the meadow vole and red-backed vole Prnp genes and found three amino
acid (AA) differences outside of the signal and GPI anchor sequences. Of these
differences (T56-, G90S, S170N; read-backed vole:meadow vole), S170N is
particularly intriguing due its postulated involvement in "rigid loop" structure
and CWD susceptibility. Deer mice did not exhibit disease signs until nearly 1.5
years post-inoculation, but appear to be exhibiting a high degree of disease
penetrance. White-footed mice have an even longer incubation period but are also
showing high penetrance. Second passage experiments show significant shortening
of incubation periods. Meadow voles in particular appear to be interesting lab
models for CWD. These rodents scavenge carrion, and are an important food source
for many predator species. Furthermore, these rodents enter human and domestic
livestock food chains by accidental inclusion in grain and forage. Further
investigation of these species as potential hosts, bridge species, and
reservoirs of CWD is required.
Veterinary Pathology Onlinevet.sagepub.com Published online before print
February 27, 2014, doi: 10.1177/0300985814524798 Veterinary Pathology February
27, 2014 0300985814524798
Lesion Profiling and Subcellular Prion Localization of Cervid Chronic
Wasting Disease in Domestic Cats
D. M. Seelig1⇑ A. V. Nalls1 M. Flasik2 V. Frank1 S. Eaton2 C. K. Mathiason1
E. A. Hoover1 1Department of Microbiology, Immunology, and Pathology, Colorado
State University, Fort Collins, CO, USA 2Department of Biomedical Sciences,
Colorado State University, Fort Collins, CO, USA D. M. Seelig, University of
Minnesota, Department of Veterinary Clinical Sciences, Room 339 VetMedCtrS,
6192A (Campus Delivery Code), 1352 Boyd Ave, St Paul, MN 55108, USA. Email
address: dseelig@umn.edu
Abstract
Chronic wasting disease (CWD) is an efficiently transmitted, fatal, and
progressive prion disease of cervids with an as yet to be fully clarified host
range. While outbred domestic cats (Felis catus) have recently been shown to be
susceptible to experimental CWD infection, the neuropathologic features of the
infection are lacking. Such information is vital to provide diagnostic power in
the event of natural interspecies transmission and insights into host and strain
interactions in interspecies prion infection. Using light microscopy and
immunohistochemistry, we detail the topographic pattern of neural spongiosis
(the “lesion profile”) and the distribution of misfolded prion protein in the
primary and secondary passage of feline CWD (FelCWD). We also evaluated cellular
and subcellular associations between misfolded prion protein (PrPD) and central
nervous system neurons and glial cell populations. From these studies, we (1)
describe the novel neuropathologic profile of FelCWD, which is distinct from
either cervid CWD or feline spongiform encephalopathy (FSE), and (2) provide
evidence of serial passage-associated interspecies prion adaptation. In
addition, we demonstrate through confocal analysis the successful
co-localization of PrPD with neurons, astrocytes, microglia, lysosomes, and
synaptophysin, which, in part, implicates each of these in the neuropathology of
FelCWD. In conclusion, this work illustrates the simultaneous role of both host
and strain in the development of a unique FelCWD neuropathologic profile and
that such a profile can be used to discriminate between FelCWD and FSE.
prion chronic wasting disease immunohistochemistry interspecies cat feline
spongiform encephalopathy transmissible spongiform encephalopathy adaptation
species barrier
Monday, August 8, 2011 Susceptibility of Domestic Cats to CWD Infection
Oral.29: Susceptibility of Domestic Cats to CWD Infection
Amy Nalls, Nicholas J. Haley, Jeanette Hayes-Klug, Kelly Anderson, Davis M.
Seelig, Dan S. Bucy, Susan L. Kraft, Edward A. Hoover and Candace K. Mathiason†
Colorado State University; Fort Collins, CO USA†Presenting author; Email:
ckm@lamar.colostate.edu
Domestic and non-domestic cats have been shown to be susceptible to one
prion disease, feline spongiform encephalopathy (FSE), thought to be transmitted
through consumption of bovine spongiform encephalopathy (BSE) contaminated meat.
Because domestic and free ranging felids scavenge cervid carcasses, including
those in CWD affected areas, we evaluated the susceptibility of domestic cats to
CWD infection experimentally. Groups of n = 5 cats each were inoculated either
intracerebrally (IC) or orally (PO) with CWD deer brain homogenate. Between
40–43 months following IC inoculation, two cats developed mild but progressive
symptoms including weight loss, anorexia, polydipsia, patterned motor behaviors
and ataxia—ultimately mandating euthanasia. Magnetic resonance imaging (MRI) on
the brain of one of these animals (vs. two age-matched controls) performed just
before euthanasia revealed increased ventricular system volume, more prominent
sulci, and T2 hyperintensity deep in the white matter of the frontal hemisphere
and in cortical grey distributed through the brain, likely representing
inflammation or gliosis. PrPRES and widely distributed peri-neuronal vacuoles
were demonstrated in the brains of both animals by immunodetection assays. No
clinical signs of TSE have been detected in the remaining primary passage cats
after 80 months pi. Feline-adapted CWD was sub-passaged into groups (n=4 or 5)
of cats by IC, PO, and IP/SQ routes. Currently, at 22 months pi, all five IC
inoculated cats are demonstrating abnormal behavior including increasing
aggressiveness, pacing, and hyper responsiveness.
*** Two of these cats have developed rear limb ataxia. Although the limited
data from this ongoing study must be considered preliminary, they raise the
potential for cervid-to-feline transmission in nature.
AD.63:
Susceptibility of domestic cats to chronic wasting disease
Amy V.Nalls,1 Candace Mathiason,1 Davis Seelig,2 Susan Kraft,1 Kevin
Carnes,1 Kelly Anderson,1 Jeanette Hayes-Klug1 and Edward A. Hoover1 1Colorado
State University; Fort Collins, CO USA; 2University of Minnesota; Saint Paul, MN
USA
Domestic and nondomestic cats have been shown to be susceptible to feline
spongiform encephalopathy (FSE), almost certainly caused by consumption of
bovine spongiform encephalopathy (BSE)-contaminated meat. Because domestic and
free-ranging nondomestic felids scavenge cervid carcasses, including those in
areas affected by chronic wasting disease (CWD), we evaluated the susceptibility
of the domestic cat (Felis catus) to CWD infection experimentally. Cohorts of 5
cats each were inoculated either intracerebrally (IC) or orally (PO) with
CWD-infected deer brain. At 40 and 42 mo post-inoculation, two IC-inoculated
cats developed signs consistent with prion disease, including a stilted gait,
weight loss, anorexia, polydipsia, patterned motor behaviors, head and tail
tremors, and ataxia, and progressed to terminal disease within 5 mo. Brains from
these two cats were pooled and inoculated into cohorts of cats by IC, PO, and
intraperitoneal and subcutaneous (IP/SC) routes. Upon subpassage, feline-adapted
CWD (FelCWD) was transmitted to all IC-inoculated cats with a decreased
incubation period of 23 to 27 mo. FelCWD was detected in the brains of all the
symptomatic cats by western blotting and immunohistochemistry and abnormalities
were seen in magnetic resonance imaging, including multifocal T2 fluid
attenuated inversion recovery (FLAIR) signal hyper-intensities, ventricular size
increases, prominent sulci, and white matter tract cavitation. Currently, 3 of 4
IP/SQ and 2 of 4 PO inoculared cats have developed abnormal behavior patterns
consistent with the early stage of feline CWD.
*** These results demonstrate that CWD can be transmitted and adapted to
the domestic cat, thus raising the issue of potential cervid-to- feline
transmission in nature.
www.landesbioscience.com
PO-081: Chronic wasting disease in the cat— Similarities to feline
spongiform encephalopathy (FSE)
FELINE SPONGIFORM ENCEPHALOPATHY FSE
Wednesday, October 17, 2012
Prion Remains Infectious after Passage through Digestive System of American
Crows (Corvus brachyrhynchos)
Prion
Volume 9, Issue 4, 2015
Porcine prion protein amyloid
DOI:10.1080/19336896.2015.1065373Per Hammarströma & Sofie Nyströma*
pages 266-277
Received: 1 Jun 2015 Accepted: 17 Jun 2015 Accepted author version posted
online: 28 Jul 2015
© 2015 The Author(s). Published with license by Taylor & Francis Group,
LLC Additional license information
ABSTRACT
Mammalian prions are composed of misfolded aggregated prion protein (PrP)
with amyloid-like features. Prions are zoonotic disease agents that infect a
wide variety of mammalian species including humans. Mammals and by-products
thereof which are frequently encountered in daily life are most important for
human health. It is established that bovine prions (BSE) can infect humans while
there is no such evidence for any other prion susceptible species in the human
food chain (sheep, goat, elk, deer) and largely prion resistant species (pig) or
susceptible and resistant pets (cat and dogs, respectively). PrPs from these
species have been characterized using biochemistry, biophysics and neurobiology.
Recently we studied PrPs from several mammals in vitro and found evidence for
generic amyloidogenicity as well as cross-seeding fibril formation activity of
all PrPs on the human PrP sequence regardless if the original species was
resistant or susceptible to prion disease. Porcine PrP amyloidogenicity was
among the studied. Experimentally inoculated pigs as well as transgenic mouse
lines overexpressing porcine PrP have, in the past, been used to investigate the
possibility of prion transmission in pigs. The pig is a species with
extraordinarily wide use within human daily life with over a billion pigs
harvested for human consumption each year. Here we discuss the possibility that
the largely prion disease resistant pig can be a clinically silent carrier of
replicating prions.
SNIP...
CONCLUDING REMARKS Should the topic of porcine PrP amyloid be more of a
worry than of mere academic interest? Well perhaps. Prions are particularly
insidious pathogens. A recent outbreak of peripheral neuropathy in human,
suggests that exposure to aerosolized porcine brain is deleterious for human
health.43,44 Aerosolization is a known vector for prions at least under
experimental conditions.45-47 where a mere single exposure was enough for
transmission in transgenic mice. HuPrP is seedable with BoPrP seeds and even
more so with PoPrP seed (Fig. 1), indicating that humans could be infected by
porcine APrP prions while neurotoxicity associated with spongiform
encephalopathy if such a disease existed is even less clear. Importantly
transgenic mice over-expressing PoPrP are susceptible to BSE and BSE passaged
through domestic pigs implicating that efficient downstream neurotoxicity
pathways in the mouse, a susceptible host for prion disease neurotoxicity is
augmenting the TSE phenotype.25,26 Prions in silent carrier hosts can be
infectious to a third species. Data from Collinge and coworkers.21 propose that
species considered to be prion free may be carriers of replicating prions.
Especially this may be of concern for promiscuous prion strains such as
BSE.19,48 It is rather established that prions can exist in both replicating and
neurotoxic conformations.49,50 and this can alter the way in which new host
organisms can react upon cross-species transmission.51 The na€ıve host can
either be totally resistant to prion infection as well as remain non-infectious,
become a silent non-symptomatic but infectious carrier of disease or be
afflicted by disease with short or long incubation time. The host can harbor
and/or propagate the donor strain or convert the strain conformation to adapt it
to the na€ıve host species. The latter would facilitate infection and shorten
the incubation time in a consecutive event of intra-species transmission. It may
be advisable to avoid procedures and exposure without proper biosafety
precautions as the knowledge of silence carrier species is poor. One case of
iatrogenic CJD in recipient of porcine dura mater graft has been reported in the
literature.52 The significance of this finding is still unknown. The low public
awareness in this matter is exemplified by the practice of using proteolytic
peptide mixtures prepared from porcine brains (Cerebrolysin) as a nootropic
drug. While Cerebrolysin may be beneficial for treatment of severe diseases such
as vascular dementia,53 a long term follow-up of such a product for recreational
use is recommended.
Friday, August 21, 2015
Porcine prion protein amyloid or mad pig disease PSE Porcine Spongiform
Encephalopathy ?
*** Docket No. FDA-2003-D-0432 (formerly 03D-0186) Use of Material from
Deer and Elk in Animal Feed Singeltary Submission ***
Transmission of scrapie prions to primate after an extended silent
incubation period
Emmanuel E. Comoy , Jacqueline Mikol , Sophie Luccantoni-Freire , Evelyne
Correia , Nathalie Lescoutra-Etchegaray , Valérie Durand , Capucine Dehen ,
Olivier Andreoletti , Cristina Casalone , Juergen A. Richt , Justin J. Greenlee
, Thierry Baron , Sylvie L. Benestad , Paul Brown & Jean-Philippe Deslys
Scientific Reports 5, Article number: 11573 (2015) doi:10.1038/srep11573
Download Citation Epidemiology Neurological manifestations Prion diseases
Received:16 February 2015Accepted:28 May 2015
SPONTANEOUS ATYPICAL BOVINE SPONGIFORM ENCEPHALOPATHY
***Moreover, sporadic disease has never been observed in breeding colonies
or primate research laboratories, most notably among hundreds of animals over
several decades of study at the National Institutes of Health25, and in nearly
twenty older animals continuously housed in our own facility.***
Tuesday, August 9, 2016
Concurrence with OIE Risk Designations for Bovine Spongiform Encephalopathy
[Docket No. APHIS-2015-0055]
Saturday, July 23, 2016
BOVINE SPONGIFORM ENCEPHALOPATHY BSE TSE PRION SURVEILLANCE, TESTING, AND
SRM REMOVAL UNITED STATE OF AMERICA UPDATE JULY 2016
Tuesday, July 26, 2016
Atypical Bovine Spongiform Encephalopathy BSE TSE Prion UPDATE JULY 2016
Saturday, July 16, 2016
Importation of Sheep, Goats, and Certain Other Ruminants [Docket No.
APHIS-2009-0095]RIN 0579-AD10
WITH great disgust and concern, I report to you that the OIE, USDA, APHIS,
are working to further legalize the trading of Transmissible Spongiform
Encephalopathy TSE Pion disease around the globe.
THIS is absolutely insane. it’s USDA INC.
Thursday, August 4, 2016
Secretary's Advisory Committee on Animal Health [Docket No.
APHIS-2016-0046] TSE PRION DISEASE
see BSE TSE SRM breaches being served up to humans as appetizers...
Monday, June 20, 2016
Specified Risk Materials SRMs BSE TSE Prion Program
Tuesday, July 12, 2016
Chronic Wasting Disease CWD, Scrapie, Bovine Spongiform Encephalopathy BSE,
TSE, Prion Zoonosis Science History
*** see history of NIH may destroy human brain collection ***
Thursday, February 25, 2016
U.S. Food & Drug Administration (FDA) FDA/CFSAN Cosmetics Update:
Cosmetics Program; Import and Domestic and Transmissible Spongiform
Encephalopathy TSE Prion Disease Risk Factors
***WARNING TO ALL CONSUMERS AND COUNTRIES AROUND THE WORLD***
***Note: FDA labs do not conduct BSE analysis and thus no sampling guidance
is issued for BSE. ***
Sunday, July 24, 2016
Chronic Wasting Disease Prions in Elk Antler Velvet and Marketing of this
Product in Nutritional Supplements for Humans?
Research Project: TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES: THE ROLE OF
GENETICS, STRAIN VARIATION, AND ENVIRONMENTAL CONTAMINATION IN DISEASE CONTROL
Tuesday, August 16, 2016
Docket No. FDA-2011-D-0376 Dietary Supplements: New Dietary Ingredient
Notifications and Related Issues; Revised Draft Guidance for Industry Singeltary
Submission
Your comment was submitted successfully!
The Food and Drug Administration (FDA) Notice: Dietary Supplements: New
Dietary Ingredient Notifications and Related Issues; Revised Draft Guidance for
Industry; Availability
For related information, Open Docket Folder
3 . Your Receipt . 3 Your Receipt
2 Your Preview
1 Your Information
publicly viewable
Your Comment Tracking Number: xxxxxxxxxxxxx
Your comment may be viewable on Regulations.gov once the agency has
reviewed it.
This process is dependent on agency public submission policies/procedures
and processing times. Use your tracking number to find out the status of your
comment.
Thursday, August 04, 2016
MEETING ON THE FEASIBILITY OF CARRYING OUT EPIDEMIOLOGICAL STUDIES ON
CREUTZFELDT JAKOB DISEASE 1978 THE SCRAPIE FILES IN CONFIDENCE CONFIDENTIAL SCJD
Spongiform Encephalopathy in Captive Wild ZOO BSE INQUIRY
Evidence That Transmissible Mink Encephalopathy Results from Feeding
Infected Cattle
Over the next 8-10 weeks, approximately 40% of all the adult mink on the
farm died from TME.
snip...
The rancher was a ''dead stock'' feeder using mostly (>95%) downer or
dead dairy cattle...
In Confidence - Perceptions of unconventional slow virus diseases of
animals in the USA - APRIL-MAY 1989 - G A H Wells
3. Prof. A. Robertson gave a brief account of BSE. The US approach was to
accord it a very low profile indeed. Dr. A Thiermann showed the picture in the
''Independent'' with cattle being incinerated and thought this was a fanatical
incident to be avoided in the US at all costs. ...
”The occurrence of CWD must be viewed against the contest of the locations
in which it occurred. It was an incidental and unwelcome complication of the
respective wildlife research programmes. Despite it’s subsequent recognition as
a new disease of cervids, therefore justifying direct investigation, no specific
research funding was forthcoming. The USDA veiwed it as a wildlife problem and
consequently not their province!” ...page 26.
Terry S. Singeltary Sr. Bacliff, Texas USA flounder9@verizon.net
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.